Processing 00000000.tx.1: 1996 by The American Society for Biochemistry and Molecular Biology, Inc. 

Phrase: "1996 by The American Society"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037455:society [Organization]
   760   C0596070:American [Population Group]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."
Processing 00000000.tx.2: Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion (*) (Received for publication, September 14, 1995; and in revised form, December 5, 1995) Roger M. 

Phrase: "Serotonin 5-HT2a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1424232:HT2A [Gene or Genome]

Phrase: "and"

Phrase: "5-HT2c Receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C0528200:5-HT2C Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   734   C1415811:5-HT2C [Gene or Genome]

Phrase: "Stimulate"

Phrase: "Amyloid Precursor Protein Ectodomain Secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1159339:Protein Secretion [Cell Function]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "("

Phrase: "*"

Phrase: ")"

Phrase: "("

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "September 14,"

Phrase: "1995"

Phrase: ";"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "December 5,"

Phrase: "1995"

Phrase: ")"

Phrase: "Roger M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.3: Nitsch (1), (2),(), Meihua Deng (1), John H. 

Phrase: "Nitsch"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "Meihua Deng"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549988:DEng [Intellectual Product]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "John H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.4: Growdon (2), Richard J. 

Phrase: "Growdon"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "Richard J."
Processing 00000000.tx.5: Wurtman (1) From the (1)Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 and the (2)Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114 ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION FOOTNOTES ACKNOWLEDGEMENTS REFERENCES ABSTRACT Alzheimer's disease amyloid consists of amyloid -peptides (A) derived from the larger precursor amyloid precursor protein (APP). 

Phrase: "Wurtman"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "From the (1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "Department of Brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Cognitive Sciences,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376542:Sciences, Cognitive [Biomedical Occupation or Discipline]
   861   C0036397:Sciences [Occupation or Discipline]

Phrase: "Massachusetts Institute of Technology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0021622:institute [Organization]
   812   C0024874:Massachusetts [Geographic Area]
   812   C0039421:Technology [Occupation or Discipline]
   812   C1272753:Institute [Idea or Concept]

Phrase: "Cambridge,"

Phrase: "Massachusetts 02139"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024874:Massachusetts [Geographic Area]

Phrase: "and"

Phrase: "the (2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "Department of Neurology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587475:Neurology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "Massachusetts General Hospital,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0205246:General [Spatial Concept]
   827   C1510665:Hospital [Qualitative Concept]
   827   C1553889:General [Idea or Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "Massachusetts 02114 ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION FOOTNOTES ACKNOWLEDGEMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "ABSTRACT Alzheimer's disease amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "consists of amyloid -peptides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0332529:CONSIST [Qualitative Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A)"

Phrase: "derived from the larger precursor amyloid precursor protein (APP)."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
           Amyloid Protein Precursor
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   767   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0443228:larger [Quantitative Concept]
   744   C0549177:Larger [Quantitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1441547:Derived [Qualitative Concept]
   744   C1704243:Larger [Quantitative Concept]
   744   C1709634:Precursor [Idea or Concept]
   744   C3245521:derived [Idea or Concept]
Processing 00000000.tx.6: Non-amyloidogenic APP processing involves regulated cleavage within the A domain followed by secretion of the ectodomain (APPs). 

Phrase: "Non-amyloidogenic APP processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033666:protein processing [Molecular Function]
   799   C1709694:Processing [Activity]

Phrase: "involves"

Phrase: "regulated cleavage within the"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "A domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "followed by secretion of the ectodomain"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "(APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.7: APPs secretion can be stimulated by muscarinic acetylcholine receptors coupled to phospholipases and kinases. 

Phrase: "APPs secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "can"

Phrase: "be"

Phrase: "stimulated by muscarinic acetylcholine receptors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   806   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   760   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0026815:muscarinic [Pharmacologic Substance]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "coupled to phospholipases"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0031671:Phospholipases [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1948027:Coupled [Functional Concept]
   756 E C0010222:couple [Family Group]

Phrase: "and"

Phrase: "kinases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.8: To determine whether other receptor classes can regulate APP processing, we examined the relation between serotonin receptors and APPs secretion. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "other receptor classes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "can"

Phrase: "regulate"

Phrase: "APP processing,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the relation between serotonin receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0080103:Relation [Family Group]
   760   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "APPs secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.9: Serotonin increased APPs release 3-4-fold in 3T3 cells stably overexpressing 5-HT2aR or 5-HT2cR. 

Phrase: "Serotonin increased APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C3538722:APP [Laboratory Procedure]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "3-4-fold in 3T3 cells stably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332462:Fold [Spatial Concept]
   748   C1880834:FOLD [Phenomenon or Process]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "5-HT2aR"

Phrase: "or"

Phrase: "5-HT2cR."
Processing 00000000.tx.10: The increase was dose-dependent and was blocked by serotoninergic antagonists. 

Phrase: "The increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "dose-dependent"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1512045:Dose-dependent [Quantitative Concept]
   861   C0178602:Dose [Quantitative Concept]
   861   C0851827:Dependent [Qualitative Concept]
   861   C0869039:Dose [Quantitative Concept]
   861   C1114758:Dose # [Clinical Attribute]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "was"

Phrase: "blocked by serotoninergic antagonists."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0028778:Blocked [Pathologic Function]
   770   C0243076:antagonists [Chemical Viewed Functionally]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C0231491:Antagonist [Organ or Tissue Function]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.11: Phorbol esters also increased APPs secretion, but neither kinase inhibitors nor down-regulation of PKC blocked the serotonin-induced increase in APPs secretion. 

Phrase: "Phorbol esters also increased APPs secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]

Phrase: "but"

Phrase: "neither kinase inhibitors"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C1152564:Kinase Inhibitors [Molecular Function]
   983 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   983 E C3537023:kinase inhibitor [Molecular Function]
   983 E C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "nor"

Phrase: "down-regulation of PKC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0013081:Down-Regulation [Cell Function,Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the serotonin-induced increase in APPs secretion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]
Processing 00000000.tx.12: Thus PKC is not necessary to stimulate APPs secretion. 

Phrase: "Thus PKC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   875   C1168438:Protein C [Laboratory Procedure]
   875   C1418943:PROTEIN C [Gene or Genome]
   875   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "not necessary to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Not [Functional Concept]

Phrase: "stimulate"

Phrase: "APPs secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.13: Phospholipase A (PLA) inhibitors blocked the 5-HT2aR-mediated increase in APPs secretion, suggesting a role of PLA in coupling 5-HT2aR to APP processing. 

Phrase: "Phospholipase A (PLA) inhibitors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   896   C0597220:phospholipase inhibitor [Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C1999216:Inhibitor [Qualitative Concept]
   734   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
   734   C2261240:phospholipase A [Molecular Function]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the 5-HT2aR-mediated increase in APPs secretion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a role of PLA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in coupling 5-HT2aR"

Phrase: "to APP processing."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.14: In contrast, coupling of 5-HT2cR to APPs secretion involved both PKC and PLA. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "coupling of 5-HT2cR"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1948027:Coupling [Functional Concept]
   737 E C0010222:couple [Family Group]

Phrase: "to APPs secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "both PKC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "PLA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2261240:phospholipase A [Molecular Function]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.15: Serotonin also stimulated the release of the APLP2 ectodomain, suggesting that additional members of the APP multigene family are processed via similar regulated pathways. 

Phrase: "Serotonin also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036751:Serotonin [Neuroreactive Substance or Biogenic Amine,Organic Chemical]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "the release of the APLP2 ectodomain,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that additional members of the APP multigene family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   757   C0086282:Family Members [Family Group]
   741 E C1611821:Family Member [Intellectual Product]
   739   C0680022:members [Population Group]
   706 E C2698041:Member [Professional or Occupational Group]

Phrase: "are"

Phrase: "processed via similar regulated pathways."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1522240:Processed [Phenomenon or Process]
   760   C1704259:Pathways [Molecular Function]
   760   C1705987:Pathways [Conceptual Entity]
   760   C2348205:Similar [Qualitative Concept]
   726 E C1184743:Process [Body Part, Organ, or Organ Component]
Processing 00000000.tx.16: Inasmuch as generation of APPs precludes the formation of amyloidogenic derivatives, serotonin receptors provide a novel pharmacological target to reduce these derivatives in Alzheimer's disease. 

Phrase: "Inasmuch as"

Phrase: "generation of APPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0079411:Generation [Temporal Concept]
   790   C3146294:Generation [Activity]

Phrase: "precludes"

Phrase: "the formation of amyloidogenic derivatives,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "serotonin receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034838:Receptors, Serotonin [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a novel pharmacological target to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1521840:Target [Functional Concept]
   812   C2986546:TARGET [Diagnostic Procedure]

Phrase: "reduce"

Phrase: "these derivatives in Alzheimer's disease."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0243072:derivatives [Chemical Viewed Structurally]
   726 E C1527240:Derivative [Functional Concept]
Processing 00000000.tx.17: INTRODUCTION The amyloid precursor protein (APP) ()is an ubiquitous membrane-spanning glycoprotein (Kang et al., 1987; Weidemann et al., 1989) that is present at high levels in brain cells. 

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "The amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "("

Phrase: ")"

Phrase: "is"

Phrase: "an ubiquitous membrane-spanning glycoprotein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0025248:Membrane Glycoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]

Phrase: "(Kang et al.,"

Phrase: "1987"

Phrase: "; Weidemann et al.,"

Phrase: "1989"

Phrase: ")"

Phrase: "that"

Phrase: "is"

Phrase: "present at high levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "in brain cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0596208:brain cells [Cell]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0007634:Cells [Cell]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.18: It is the biological precursor of the amyloid -protein (A), the principal proteinaceous component of amyloid plaques in brains of Alzheimer's disease patients (for review, see Selkoe(1994)). 

Phrase: "It"

Phrase: "is"

Phrase: "the biological precursor of the amyloid -protein (A"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   793   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   789   C0002723:Amyloid A Precursor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   789 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   767   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "the principal proteinaceous component of amyloid plaques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1882460:Principal Component [Quantitative Concept]
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "in brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of Alzheimer's disease patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "("

Phrase: "for review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Selkoe"

Phrase: "(1994"

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.19: APP or its derivatives may be involved in the pathogenesis of Alzheimer's disease because several familial forms of the disease are linked to APP mutations within or close to the -amyloid domain. 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "or"

Phrase: "its derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243072:derivatives [Chemical Viewed Structurally]
   966 E C1527240:Derivative [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "involved in the pathogenesis of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
   748   C1314939:Involved [Functional Concept]

Phrase: "because"

Phrase: "several familial forms of the disease"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   773   C1832428:Familial form [Finding]
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "are"

Phrase: "linked to APP mutations"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0065011:linked protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0026882:Mutations [Genetic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "within"

Phrase: "or"

Phrase: "close to the -amyloid domain."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0587267:Close [Functional Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.20: In cell culture, these mutations cause misprocessing of APP and related increases in the formation of A (Cai et al., 1993; Citron et al., 1992, 1994) or the generation of longer than normal A molecules (Suzuki et al., 1994). 

Phrase: "In cell culture,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0007585:Cell Culture [Laboratory Procedure]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "these mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "misprocessing of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "related increases in the formation of A (Cai et al.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:increases [Functional Concept]

Phrase: "1993"

Phrase: "; Citron et al.,"

Phrase: "1992,"

Phrase: "1994"

Phrase: ")"

Phrase: "or"

Phrase: "the generation of longer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]

Phrase: "than normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "A molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "(Suzuki et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.21: Moreover, the overexpression of APP in transgenic mice causes formation of brain amyloid plaques (Games et al., 1995) that resemble those in Alzheimer's disease. 

Phrase: "Moreover,"

Phrase: "the overexpression of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "formation of brain amyloid plaques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "(Games et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: "that"

Phrase: "resemble"

Phrase: "those in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.22: APP is a secretory glycoprotein. 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "a secretory glycoprotein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]
Processing 00000000.tx.23: The secreted APP ectodomain (APPs) has neurotrophic and neuroprotective activities in selected experimental systems. 

Phrase: "The secreted APP ectodomain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: ")"

Phrase: "has"

Phrase: "neurotrophic"

Phrase: "and"

Phrase: "neuroprotective activities in selected experimental systems."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.24: It promotes neurite outgrowth and branching in PC-12 cells (Milward et al., 1992), mediates cell adhesion in cultured fibroblasts (Saitoh et al., 1989), and it can protect primary neuronal cultures from excitotoxic damage (Barger et al., 1995; Mattson et al., 1993). 

Phrase: "It"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "neurite outgrowth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3158384:neurite outgrowth [Cell Function]
   861   C0085103:Neurite [Cell Component]

Phrase: "and"

Phrase: "branching in PC-12 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205384:Branching [Spatial Concept]

Phrase: "(Milward et al.,"

Phrase: "1992"

Phrase: ")"

Phrase: ","

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "cell adhesion in cultured fibroblasts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0007577:Cell Adhesion [Cell Function]
   760   C0001511:Adhesion [Pathologic Function]
   760   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "(Saitoh et al.,"

Phrase: "1989"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "can"

Phrase: "protect"

Phrase: "primary neuronal cultures from excitotoxic damage"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0010453:Cultures [Idea or Concept]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "(Barger et al.,"

Phrase: "1995"

Phrase: "; Mattson et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.25: Furthermore, moderate overexpression of human APP in mouse brain can increase synaptic density (Mucke et al. 1994), and it protects neurons in vivo from neurotoxic events caused by overexpression of the HIV-1 surface protein pg120 (Mucke et al., 1995b) or by excitotoxic damage (Mucke et al., 1995a). 

Phrase: "Furthermore,"

Phrase: "moderate overexpression of human APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "in mouse brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1521713:Mouse Brain [Tissue]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "can"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "synaptic density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0178587:density [Quantitative Concept]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "(Mucke et al. 1994"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "protects"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in vivo from neurotoxic events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "caused by overexpression of the HIV-1 surface protein pg120"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0019704:HIV-1 [Virus]
   760   C0025252:surface protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   739   C0019682:HIV [Virus]
   739   C0019699:HIV+ [Finding]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205148:Surface [Spatial Concept]
   706   C0015127:cause [Functional Concept]
   706   C1524003:Cause [Conceptual Entity]

Phrase: "(Mucke et al.,"

Phrase: "1995b"

Phrase: ")"

Phrase: "or by excitotoxic damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010957:Damage [Injury or Poisoning]
   770   C1883709:Damage [Functional Concept]

Phrase: "(Mucke et al.,"

Phrase: "1995a"

Phrase: ")."
Processing 00000000.tx.26: In selected experimental systems, APPs activates cellular signaling pathways, including p21 microtubule-associated protein kinases (Greenberg et al., 1994), and cGMP-mediated signaling in primary hippocampal neurons (Barger et al., 1995). 

Phrase: "In selected experimental systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "cellular signaling pathways,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0037080:Signal Pathways [Molecular Function]
   884   C0037083:signaling pathway [Cell Function]
   884   C0086982:Signaling Pathway [Molecular Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "p21 microtubule-associated protein kinases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Greenberg et al.,"

Phrase: "1994"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cGMP-mediated signaling in primary hippocampal neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C1155590:cGMP-mediated signaling [Molecular Function]
   748   C0037083:Signaling [Cell Function]
   748   C3537152:signaling [Biologic Function]

Phrase: "(Barger et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.27: Secretory APP processing involves either proteolytic cleavage within the A domain (Esch et al., 1990; Sisodia et al., 1990) or, alternatively, cleavage at both the N and C termini of A followed by rapid secretion of A (Haass et al., 1992; Shoji et al., 1992). 

Phrase: "Secretory APP processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0033666:protein processing [Molecular Function]
   804   C1709694:Processing [Activity]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C0597427:secretory protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "involves"

Phrase: "either proteolytic cleavage within the"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "A domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "(Esch et al.,"

Phrase: "1990"

Phrase: "; Sisodia et al.,"

Phrase: "1990"

Phrase: ")"

Phrase: "or"

Phrase: ","

Phrase: "alternatively,"

Phrase: "cleavage at both"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010813:cleavage [Cell Function]
   790   C0596311:Cleavage [Phenomenon or Process]
   790   C1330957:cleavage [Cell Function]

Phrase: "the N"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C termini of A"

Phrase: "followed by rapid secretion of A (Haass et al.,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   764   C0332283:Followed by [Temporal Concept]
           followed
   762   C0217843:ET-A [Amino Acid, Peptide, or Protein,Receptor]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C0439831:Rapid [Qualitative Concept]
   708 E C1719822:Follow [Intellectual Product]

Phrase: "1992"

Phrase: "; Shoji et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.28: Thus, APP can be processed by at least two alternative secretory pathways to yield either APPs and p3, a derivative of the cell-associated C terminus produced by APPs secretion (Haass et al., 1993), or A and a C-terminally truncated form of APPs (Seubert et al., 1993). 

Phrase: "Thus,"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "processed by"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1522240:Processed [Phenomenon or Process]
   799 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "at least two alternative secretory pathways to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1159342:Secretory Pathways [Cell Function]
   799   C1704259:Pathways [Molecular Function]
   799   C1705987:Pathways [Conceptual Entity]

Phrase: "yield"

Phrase: "either APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538722:APP [Laboratory Procedure]

Phrase: "and"

Phrase: "p3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412751:P3 [Gene or Genome]
  1000   C1427831:P3 [Gene or Genome]
  1000   C1539372:p3 [Gene or Genome]

Phrase: "a derivative of the cell-associated C terminus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1527240:Derivative [Functional Concept]

Phrase: "produced by APPs secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   737   C3538722:APP [Laboratory Procedure]

Phrase: "(Haass et al.,"

Phrase: "1993"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "A"

Phrase: "and"

Phrase: "a C-terminally truncated form of APPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "(Seubert et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.29: Secretory APP processing and the formation of APPs can be readily accelerated by an unusual mechanism coupled to a variety of extra- and intracellular signals. 

Phrase: "Secretory APP processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0033666:protein processing [Molecular Function]
   804   C1709694:Processing [Activity]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C0597427:secretory protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "the formation of APPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "readily"

Phrase: "accelerated by an unusual mechanism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441712:Mechanism [Functional Concept]
   760   C0521110:Accelerated [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]
   760   C2700116:Unusual [Qualitative Concept]

Phrase: "coupled to a variety of extra-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C1883525:Variety [Conceptual Entity]
   753   C1948027:Coupled [Functional Concept]
   753   C2346866:Variety [Conceptual Entity]
   719 E C0010222:couple [Family Group]

Phrase: "and"

Phrase: "intracellular signals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.30: These include muscarinic acetylcholine receptors (Buxbaum et al., 1992; Nitsch et al., 1992; Wolf et al., 1995), metabotropic glutamate receptors (Lee et al., 1995), protein kinase C (PKC) (Caporaso et al., 1992; Slack et al., 1993), tyrosine kinases (Slack et al., 1995), and arachidonic acid (Emmerling et al., 1993). 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "muscarinic acetylcholine receptors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0034826:Muscarinic Acetylcholine Receptors [Amino Acid, Peptide, or Protein,Receptor]
           Receptors, Muscarinic
   901   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   827   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   827   C0026815:muscarinic [Pharmacologic Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Buxbaum et al.,"

Phrase: "1992"

Phrase: "; Nitsch et al.,"

Phrase: "1992"

Phrase: "; Wolf et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: ","

Phrase: "metabotropic glutamate receptors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0206529:Receptors, Metabotropic Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   901   C0061465:Receptors, Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   896   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   827   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Lee et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: ","

Phrase: "protein kinase C (PKC)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Caporaso et al.,"

Phrase: "1992"

Phrase: "; Slack et al.,"

Phrase: "1993"

Phrase: ")"

Phrase: ","

Phrase: "tyrosine kinases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Slack et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003695:Arachidonic Acid [Eicosanoid]
  1000   C2316832:Arachidonic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(Emmerling et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.31: In rat brain tissue slices, the regulation of APP processing appears to be a function of neuronal activity: APPs secretion is stimulated by electrical depolarization in a frequency-dependent, tetrodotoxin-sensitive fashion (Nitsch et al., 1993), and by muscarinic receptor agonists (Farber et al., 1995). 

Phrase: "In rat brain tissue slices,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1519355:Slice [Substance]

Phrase: "the regulation of APP processing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   835   C2753370:regulation of protein processing [Genetic Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a function of neuronal activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: ":"

Phrase: "APPs secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "is"

Phrase: "stimulated by electrical depolarization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0013790:Electrical [Natural Phenomenon or Process]
   770   C0442828:Electrical [Functional Concept]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "in a frequency-dependent, tetrodotoxin-sensitive fashion"

Phrase: "(Nitsch et al.,"

Phrase: "1993"

Phrase: ")"

Phrase: ","

Phrase: "and by muscarinic receptor agonists"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0034826:Muscarinic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   797   C0242947:Muscarinic Agonists [Pharmacologic Substance]
   781 E C3536929:Muscarinic Agonist [Pharmacologic Substance]
   760   C0026815:muscarinic [Pharmacologic Substance]
   760   C0243192:agonists [Pharmacologic Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1515981:And [Idea or Concept]
   760   C2987634:agonists [Pharmacologic Substance]

Phrase: "(Farber et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.32: The rate of A formation appears to be inversely coupled to the rate of APPs secretion: in several cell culture systems, stimulated APPs secretion was accompanied by reductions in secreted A (Buxbaum et al., 1993; Gabuzda et al., 1993; Hung et al., 1993; Wolf et al., 1995), suggesting that stimulated secretory processing of APP into secreted APPs is associated with reduced formation of potentially amyloidogenic derivatives. 

Phrase: "The rate of A formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "inversely"

Phrase: "coupled to the rate of APPs secretion"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]
   748   C1948027:Coupled [Functional Concept]
   714 E C0010222:couple [Family Group]
   714   C3538722:APP [Laboratory Procedure]

Phrase: ":"

Phrase: "in several cell culture systems,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   890   C1516329:Cell Culture System [Molecular Biology Research Technique]
   861   C0007585:Cell Culture [Laboratory Procedure]
   812   C0007634:Cell [Cell]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   812   C2242979:Culture [Laboratory Procedure]
   779   C0449913:System [Functional Concept]
   779   C1553451:System [Manufactured Object]
   779   C1704459:System [Medical Device]
   729 E C0205373:Systemic [Functional Concept]

Phrase: "stimulated APPs secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "accompanied by reductions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0301630:reductions [Natural Phenomenon or Process]
   790   C0441610:reductions [Therapeutic or Preventive Procedure]
   756 E C0392756:Reduction [Qualitative Concept]

Phrase: "in secreted A (Buxbaum et al.,"

Phrase: "1993"

Phrase: "; Gabuzda et al.,"

Phrase: "1993"

Phrase: "; Hung et al.,"

Phrase: "1993"

Phrase: "; Wolf et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that stimulated secretory processing of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0033666:protein processing [Molecular Function]
   744   C1709694:Processing [Activity]

Phrase: "into secreted APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538722:APP [Laboratory Procedure]

Phrase: "is"

Phrase: "associated with reduced formation of potentially amyloidogenic derivatives."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0220781:formation [Biologic Function]
   744   C0243072:derivatives [Chemical Viewed Structurally]
   744   C0392756:Reduced [Qualitative Concept]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1527240:Derivative [Functional Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.33: The physiological relevance of regulated APPs secretion is unknown, but may be related to the functions of APPs as a paracrine neurotrophic factor or a signaling molecule that is secreted in an activity-dependent manner in response to neuronal activation by neurotransmitters. 

Phrase: "The physiological relevance of regulated APPs secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347946:Relevance [Qualitative Concept]

Phrase: "is"

Phrase: "unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "but"

Phrase: "may"

Phrase: "be"

Phrase: "related to the functions of APPs"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C0542341:Functions [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0163712:Relate [Organic Chemical]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]
   719   C3538722:APP [Laboratory Procedure]

Phrase: "as a paracrine neurotrophic factor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "or"

Phrase: "a signaling molecule"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1519315:Signaling Molecule [Biologically Active Substance]
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "secreted in an activity-dependent manner"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1327616:Secreted [Cell Function]
   753   C1561536:*Activity [Idea or Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to neuronal activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "by neurotransmitters."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027908:Neurotransmitters [Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.34: In Alzheimer's disease brains, neurotransmission is impaired. 

Phrase: "In Alzheimer's disease brains,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "neurotransmission"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027793:Neurotransmission [Cell Function]

Phrase: "is"

Phrase: "impaired."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]
Processing 00000000.tx.35: In particular, cortical serotoninergic, glutamatergic, and peptidergic systems as well as the subcortical cholinergic projection systems are heavily damaged, indicating deafferentation of multiple cortical and hippocampal target regions. 

Phrase: "In particular, cortical serotoninergic, glutamatergic,"

Phrase: "and"

Phrase: "peptidergic systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "as well as"

Phrase: "the subcortical cholinergic projection systems"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   875   C0684164:cholinergic systems [Biologically Active Substance]
   779   C0449913:System [Functional Concept]
   779   C1553451:System [Manufactured Object]
   779   C1704459:System [Medical Device]
   729 E C0205373:Systemic [Functional Concept]

Phrase: "are"

Phrase: "heavily"

Phrase: "damaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0010957:Damage [Injury or Poisoning]
   966   C1883709:Damage [Functional Concept]

Phrase: ","

Phrase: "indicating"

Phrase: "deafferentation of multiple cortical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1522415:Deafferentation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "hippocampal target regions."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   896   C3496509:hippocampal region [Body Location or Region]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.36: Inasmuch as neuronal activation may be involved in regulating APP processing, impaired neuronal signaling may cause alterations in APP processing pathways (for review, see Nitsch and Growdon(1994)). 

Phrase: "Inasmuch as"

Phrase: "neuronal activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "may"

Phrase: "be"

Phrase: "involved in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1314939:Involved [Functional Concept]

Phrase: "regulating"

Phrase: "APP processing,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "neuronal signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "may"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "alterations in APP processing pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1515926:Alteration [Idea or Concept]

Phrase: "("

Phrase: "for review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Nitsch"

Phrase: "and"

Phrase: "Growdon"

Phrase: "(1994"

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.37: In the series of experiments reported here, we examined the effects of serotoninergic receptors on APP processing using 3T3 fibroblast lines that stably overexpress 5-HT2a and 5-HT2c receptor subtypes. 

Phrase: "In the series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "of experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "here,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effects of serotoninergic receptors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C3179161:Serotoninergic Effects [Physiologic Function]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on APP processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "3T3 fibroblast lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "that stably"

Phrase: "overexpress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "5-HT2a"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1415809:5-HT2A [Gene or Genome]
  1000   C1708300:5-HT2A [Gene or Genome]
   861   C1424232:HT2A [Gene or Genome]

Phrase: "and"

Phrase: "5-HT2c receptor subtypes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0449560:subtypes [Classification]
   756   C0528200:5-HT2C Receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.38: Wild-type 3T3 cells lack endogenous expression of serotonin receptors, and they provide the necessary cell biological background to assure appropriate signaling functions of transfected receptor subtypes (Julius et al., 1988; Stam et al., 1992). 

Phrase: "Wild-type 3T3 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0085087:3T3 Cells [Cell]
   858   C0449475:type cell [Intellectual Product]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "endogenous expression of serotonin receptors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0597360:receptor expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "they"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the necessary cell biological background to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1706907:Background [Conceptual Entity]

Phrase: "assure"

Phrase: "appropriate signaling functions of transfected receptor subtypes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0920644:function receptor [Molecular Function]
   748   C0542341:Functions [Functional Concept]
   714 E C0031843:function [Physiologic Function]
   714 E C0700205:FUNCTION [Classification]
   714 E C1705273:Function [Intellectual Product]

Phrase: "(Julius et al.,"

Phrase: "1988"

Phrase: "; Stam et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.39: Furthermore, 3T3 cells process APP via regulated cleavage and secretion (Slack et al., 1993). 

Phrase: "Furthermore,"

Phrase: "3T3 cells process APP via regulated cleavage"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0018956:cells precursor [Cell]
   762   C0033666:process protein [Molecular Function]
   762   C0597304:Protein Cleavage [Molecular Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "(Slack et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.40: They thus provide a valid model system to study the effects of specific transfected serotonin receptor subtypes on signaling as well as on APPs secretion. 

Phrase: "They thus"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a valid model system to"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0026339:Model System [Intellectual Product,Research Device]
   861   C3161035:Model System [Intellectual Product]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the effects of specific transfected serotonin receptor subtypes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C3179161:Serotonin Effects [Physiologic Function]
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]

Phrase: "as well as on APPs secretion."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C0205170:Well [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]
   719   C3538722:APP [Laboratory Procedure]
Processing 00000000.tx.41: MATERIALS AND METHODS Tissue CultureMouse 3T3 fibroblast lines stably overexpressing 5-HT2aR or 5-HT2cR (Julius et al., 1988) were generously provided by David Julius. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS Tissue CultureMouse 3T3 fibroblast lines stably"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   795   C0205132:lines [Spatial Concept]
   762 E C1550648:Line [Substance]
   762 E C1552960:Line [Quantitative Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "5-HT2aR"

Phrase: "or"

Phrase: "5-HT2cR"

Phrase: "(Julius et al.,"

Phrase: "1988"

Phrase: ")"

Phrase: "were"

Phrase: "generously"

Phrase: "provided by David Julius."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999230:Provided [Activity]
Processing 00000000.tx.42: Transfected lines were maintained in the presence of 500 g/ml G418. 

Phrase: "Transfected lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "maintained in the presence of 500 g/ml G418."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   764   C1300565:g/mL [Quantitative Concept]
   762 E C1637390:mL/g [Quantitative Concept]
   742   C0052009:G418 [Antibiotic,Organic Chemical]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0439267:g% [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C1314677:Maintained [Functional Concept]
   708 E C0024501:Maintain [Activity]
Processing 00000000.tx.43: Cells were plated onto poly-D-lysine-coated dishes and grown to 75% confluence in serum-containing (10% fetal calf serum) DMEM/F-12 medium, in the absence of G418. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated onto poly-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0747726:POLY [Conceptual Entity]
   756   C0005971:Plate [Medical Device]
   756   C1139930:plate [Medical Device]
   756   C3537155:Plate [Manufactured Object]

Phrase: "D-"

Phrase: "lysine-coated dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0020498:DISH [Disease or Syndrome]

Phrase: "and"

Phrase: "grown to 75% confluence"

Phrase: "in serum-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "(10% fetal calf serum"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: ")"

Phrase: "DMEM/F-12 medium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0009458:Medium [Intellectual Product]
   812   C0439536:Medium [Quantitative Concept]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of G418."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052009:G418 [Antibiotic,Organic Chemical]
Processing 00000000.tx.44: 24 h before an experiment, the culture medium was replaced with serum-free DMEM/F-12. 

Phrase: "24 h before an experiment,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]

Phrase: "the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced with serum-free DMEM/F-12."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   778   C0117953:f 12 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   748   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   748   C0229671:Serum [Body Substance]
   748   C0332296:free [Functional Concept]
   748   C0439133:(f) [Intellectual Product]
   748   C0559956:Replaced [Functional Concept]
   748   C1299987:replaced [Functional Concept]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
   748   C1553038:[f] [Quantitative Concept]
   748   C1880497:Free [Qualitative Concept]
   748   C1996904:Free [Qualitative Concept]
   714 E C1554078:Replace [Idea or Concept]
Processing 00000000.tx.45: Functional integrity of transfected receptors was assured by measuring receptor-mediated breakdown of metabolically labeled phosphatidylinositol (PI) (Sandmann et al., 1991). 

Phrase: "Functional integrity of transfected receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205266:integrity [Qualitative Concept]
   760   C0872403:integrity [Individual Behavior]
   760   C1947912:Integrity [Qualitative Concept]

Phrase: "was"

Phrase: "assured by measuring receptor-mediated breakdown of metabolically labeled phosphatidylinositol (PI)"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   757   C0070807:receptor, phosphatidylinositol [Amino Acid, Peptide, or Protein,Receptor]
   757   C1623073:phosphatidylinositol breakdown [Molecular Function]
   757   C1819635:receptor breakdown [Molecular Function]
   739   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C0443161:break down [Qualitative Concept]
   739   C0444706:measuring [Qualitative Concept]
   739   C0449770:measuring [Quantitative Concept]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0699900:breakdown [Organism Function]
   739   C1265875:breakdown [Acquired Abnormality]
   739   C1708632:Labeled [Qualitative Concept]
   739   C2348046:Phosphatidylinositol [Lipid]
   706 E C0079809:Measure [Quantitative Concept]
   706 E C0181496:Label [Manufactured Object]
   706 E C0242485:Measure [Functional Concept]
   706 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(Sandmann et al.,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.46: DrugsSerotonin (Sigma) was prepared freshly before each experiment and was used at 100 pM to 100 M. 

Phrase: "DrugsSerotonin"

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "freshly before each experiment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0681814:Experiment [Research Activity]
   770   C1706386:Experiment [Conceptual Entity]

Phrase: "and"

Phrase: "was"

Phrase: "used at 100 pM"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   819   C0662713:PM 100 [Organic Chemical]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "to 100 M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.47: The serotonin receptor antagonists ketanserin tartrate (20 M), mianserin HCl (50 M), and ritanserin (20 M) were purchased from Research Biochemicals International (Natick, MA). 

Phrase: "The serotonin receptor antagonists ketanserin tartrate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1517662:Ketanserin Tartrate [Organic Chemical,Pharmacologic Substance]
   804   C0039328:tartrate [Carbohydrate]
   804   C0144544:tartrate [Organic Chemical,Pharmacologic Substance]
   717   C0036753:Serotonin Receptor Antagonists [Pharmacologic Substance]

Phrase: "(20"

Phrase: "M)"

Phrase: ","

Phrase: "mianserin HCl (50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025912:Mianserin [Organic Chemical,Pharmacologic Substance]

Phrase: "M)"

Phrase: ","

Phrase: "and"

Phrase: "ritanserin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085260:Ritanserin [Organic Chemical,Pharmacologic Substance]

Phrase: "(20"

Phrase: "M)"

Phrase: "were"

Phrase: "purchased from Research Biochemicals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   770   C0869011:purchased [Activity]
   737   C0205474:Biochemical [Functional Concept]

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: "(Natick,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.48: Dexnorfenfluramine was obtained from Servier (Paris, France) and was used at 10 nM to 1 mM. 

Phrase: "Dexnorfenfluramine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2350698:Dexnorfenfluramine [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "obtained from Servier"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "was"

Phrase: "used at 10 nM"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0312860:NM [Cell Function]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "to 1 mM."
Processing 00000000.tx.49: Staurosporine (1 M), chelerythrine chloride (1 M), and melittin (2.5-5 g/ml) were purchased from Calbiochem. 

Phrase: "Staurosporine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "M)"

Phrase: ","

Phrase: "chelerythrine chloride"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0109289:chelerythrine chloride [Organic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "M)"

Phrase: ","

Phrase: "and"

Phrase: "melittin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025234:Melitten [Amino Acid, Peptide, or Protein,Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "(2.5-5 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "purchased from Calbiochem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]
Processing 00000000.tx.50: Phorbol myristate acetate (Sigma) was used at 1 M for both stimulation and 24-h down-regulation protocols. 

Phrase: "Phorbol myristate acetate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   827   C0031588:phorbol [Organic Chemical]
   827   C0070750:Phorbol [Organic Chemical]
   827   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "at 1 M for both stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "24-h down-regulation protocols."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0442711:Protocols [Intellectual Product]
   771 E C1507394:Protocol [Intellectual Product]
   771 E C1522729:Protocol [Intellectual Product]
   771 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.51: Manoalide (3.2-10 M), 7,7-dimethyleicosadienoic acid (20-50 M), and oleyloxyethyl phosphorylcholine (0.1-1 M) were purchased from Biomol (Plymouth Meeting, PA). 

Phrase: "Manoalide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0065711:manoalide [Organic Chemical,Pharmacologic Substance]

Phrase: "(3.2-10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: "M)"

Phrase: ","

Phrase: "7,"

Phrase: "7-dimethyleicosadienoic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "(20-50"

Phrase: "M)"

Phrase: ","

Phrase: "and"

Phrase: "oleyloxyethyl phosphorylcholine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031716:Phosphorylcholine [Organic Chemical,Pharmacologic Substance]

Phrase: "(0.1-1"

Phrase: "M)"

Phrase: "were"

Phrase: "purchased from Biomol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(Plymouth Meeting,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0556656:Meeting [Health Care Activity]

Phrase: "PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.52: Thapsigargin was purchased from Research Biochemicals International and was used at 20 nM. 

Phrase: "Thapsigargin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "was"

Phrase: "purchased from Research Biochemicals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   770   C0869011:purchased [Activity]
   737   C0205474:Biochemical [Functional Concept]

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: "and"

Phrase: "was"

Phrase: "used at 20 nM."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0312860:NM [Cell Function]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.53: PI TurnoverFor PI turnover assays, cells were labeled metabolically overnight with 1.25 Ci/dish of myo-[2-H]inositol (20.5 Ci/mmol; DuPont NEN) in inositol-deficient and serum-free DMEM/F-12 medium, washed twice with Hanks' balanced salt solution, and treated for 10 min with 10 mM lithium chloride. 

Phrase: "PI TurnoverFor PI turnover assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0005507:Assay [Laboratory Procedure]
   771   C0243073:assay [Qualitative Concept]
   771   C1510438:Assay [Laboratory Procedure]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "metabolically overnight with 1.25 Ci/dish of myo-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0020498:DISH [Disease or Syndrome]
   742   C0439583:Overnight [Temporal Concept]

Phrase: "[2-H]inositol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   734   C0011744:2 H [Element, Ion, or Isotope]

Phrase: "(20.5 Ci/mmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439190:MMOLE [Quantitative Concept]

Phrase: "; DuPont NEN"

Phrase: ")"

Phrase: "in inositol-deficient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011155:Deficient [Functional Concept]
   861   C1636779:% deficient [Quantitative Concept]

Phrase: "and"

Phrase: "serum-free DMEM/F-12 medium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0009458:Medium [Intellectual Product]
   799   C0439536:Medium [Quantitative Concept]
   799   C1705217:Medium [Substance]
   799   C3244283:medium [Intellectual Product]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with Hanks' balanced salt solution,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0120742:Hanks Balanced Salt Solution [Pharmacologic Substance]
   833   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   753   C0036140:Salt [Chemical Viewed Structurally]
   753   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0037633:Solution [Substance]
   753   C0205415:Balanced [Functional Concept]
   753   C0206136:Salt [Food,Inorganic Chemical]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C1720725:Twice [Intellectual Product]
   753   C1948050:Twice [Quantitative Concept]
   719   C1423529:HANK [Gene or Genome]

Phrase: "and"

Phrase: "treated for 10 min"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0456692:/10 min [Temporal Concept]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0702093:/min [Temporal Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "with 10 mM lithium chloride."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   812   C0008203:Chloride, NOS [Inorganic Chemical]
   812   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0596019:Chloride [Element, Ion, or Isotope]
Processing 00000000.tx.54: Drugs were added in the presence of 10 mM lithium for 5-60 min at 37 C. 

Phrase: "Drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "were"

Phrase: "added in the presence of 10 mM lithium"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1524062:Added [Functional Concept]
   711 E C1883712:Add [Functional Concept]

Phrase: "for 5-60 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "at 37 C."
Processing 00000000.tx.55: To determine the amount of water-soluble inositol phosphates formed, cells were lysed with ice-cold methanol, and lipids were removed by chloroform/methanol/water (2:2:1; 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the amount of water-soluble inositol phosphates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: ","

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed with ice-cold methanol,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0456963:Ice cold [Qualitative Concept]
   760   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0020746:Ice [Inorganic Chemical]
   760   C0024348:lysed [Pathologic Function]
   760   C0234192:Cold [Physiologic Function]

Phrase: "and"

Phrase: "lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]

Phrase: "were"

Phrase: "removed by chloroform/methanol/water"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   760   C0599638:WATER [Substance]
   760   C0849355:Removed [Qualitative Concept]
   760   C1550678:Water [Inorganic Chemical]
   726 E C1883720:Remove [Activity]
   726 E C3244314:remove [Functional Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.56: v:v) extraction. 

Phrase: "v:v) extraction."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0185115:Extraction [Therapeutic or Preventive Procedure]
   827   C0684295:extraction [Laboratory Procedure]
   734   C0560268:%V/V [Quantitative Concept]
   734   C2349105:V(V) [Element, Ion, or Isotope]
Processing 00000000.tx.57: Water-soluble inositol phosphates were separated from free inositol by ion exchange chromatography, using AG 1-X8 columns (Bio-Rad) and 1 M ammonium formate and 0.1 M formic acid as eluent. 

Phrase: "Water-soluble inositol phosphates"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021554:Inositol Phosphates [Carbohydrate]
   812   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   812   C0031603:Phosphates [Inorganic Chemical,Pharmacologic Substance]
   779 E C0031701:phosphate [Organophosphorus Compound]
   779 E C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "separated from free inositol"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   819   C0369528:Inositol.free [Clinical Attribute]
   770   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   770   C0086972:Separated [Finding]
   770   C0332296:free [Functional Concept]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1880497:Free [Qualitative Concept]
   770   C1996904:Free [Qualitative Concept]

Phrase: "by ion exchange chromatography,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0008564:Chromatography, Ion Exchange [Laboratory Procedure]
  1000   C0687342:ION-EXCHANGE CHROMATOGRAPHY [Medical Device]
   901   C0022013:Ion Exchange [Molecular Function]
   827   C0008550:Chromatography [Laboratory Procedure]
   827   C0022023:Ion [Element, Ion, or Isotope]
   827   C0678640:exchange [Social Behavior]
   827   C1700702:ION [Functional Concept]
   727 E C0302647:chromatograph [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "AG 1-X8 columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1185738:Column [Body Part, Organ, or Organ Component]
   779   C1706132:Column [Idea or Concept]

Phrase: "(Bio-Rad)"

Phrase: "and"

Phrase: "1 M ammonium formate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0103071:ammonium formate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0016572:formate [Organic Chemical]
   812   C0220832:formate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "0.1 M formic acid as eluent."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   778   C0885348:formic acid [Organic Chemical]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.58: Radioactivity was measured by liquid scintillation spectrometry. 

Phrase: "Radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "measured by liquid scintillation spectrometry."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0597425:scintillation spectrometry [Diagnostic Procedure]
   760   C0302908:Liquid [Substance]
   760   C0436196:Spectrometry [Laboratory Procedure]
   760   C0444706:Measured [Qualitative Concept]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1304698:Liquid [Finding]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1561501:Liquid NOS [Substance]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.59: APPs SecretionCells were washed twice with serum-free DMEM/F-12 medium and were incubated at 37 C in the presence or absence of test substances freshly dissolved in DMEM/F-12. 

Phrase: "APPs SecretionCells"

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with serum-free DMEM/F-12 medium"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   770   C0117953:f 12 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   744   C0009458:Medium [Intellectual Product]
   744   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   744   C0229671:Serum [Body Substance]
   744   C0332296:free [Functional Concept]
   744   C0439133:(f) [Intellectual Product]
   744   C0439536:Medium [Quantitative Concept]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
   744   C1553038:[f] [Quantitative Concept]
   744   C1705217:Medium [Substance]
   744   C1720725:Twice [Intellectual Product]
   744   C1880497:Free [Qualitative Concept]
   744   C1948050:Twice [Quantitative Concept]
   744   C1996904:Free [Qualitative Concept]
   744   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "were"

Phrase: "incubated at 37 C in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of test substances freshly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439861:Substances [Substance]

Phrase: "dissolved in DMEM/F-12."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0117953:f 12 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   760   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   760   C0439133:(f) [Intellectual Product]
   760   C1553038:[f] [Quantitative Concept]
   726   C1549535:Dissolve [Functional Concept]
Processing 00000000.tx.60: After discrete time intervals of 5-60 min, conditioned media were collected, cooled to 4 C, and centrifuged, and supernatant fluids were desalted by gel filtration chromatography using Sephadex G-25 (Pharmacia Biotech Inc.) columns, with water as eluent. 

Phrase: "After discrete time intervals"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   867   C0872291:Time Interval [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C1272706:intervals [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "of 5-60 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "conditioned media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "cooled to 4 C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1548792:Cool [Qualitative Concept]

Phrase: "and"

Phrase: "centrifuged,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "and"

Phrase: "supernatant fluids"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0005889:Fluids [Body Substance]
   861   C0302908:fluids [Substance]
   861   C1521806:Fluids [Tissue]
   861   C1550101:Supernatant [Body Substance]
   827 E C0444611:Fluid [Qualitative Concept]
   827 E C1704353:Fluid [Substance]

Phrase: "were"

Phrase: "desalted by gel filtration chromatography"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0008559:Gel Filtration Chromatography [Laboratory Procedure]
           Gel Filtration
           Gel Chromatography
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0016107:filtration [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C1382104:Gel [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Sephadex G-25"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0141992:sephadex G 25 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   901   C1119999:sephadex G [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0074343:sephadex [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0439267:g% [Quantitative Concept]

Phrase: "(Pharmacia Biotech Inc.) columns,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1185738:Column [Body Part, Organ, or Organ Component]
   779   C1706132:Column [Idea or Concept]

Phrase: "with water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "as eluent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3469601:Eluent [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.61: Desalted proteins were dried by vacuum centrifugation, reconstituted in water followed by 2 Laemmli gel loading buffer, and boiled for 3 min. 

Phrase: "Desalted"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "dried by vacuum centrifugation,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0007703:Centrifugation [Laboratory Procedure]
   770   C0042221:Vacuum [Natural Phenomenon or Process]
   770   C1512080:Dried [Qualitative Concept]
   770   C2827485:Dried [Body Substance]
   737 E C0011682:Dry [Natural Phenomenon or Process]
   737 E C0205222:Dry [Qualitative Concept]

Phrase: "reconstituted in water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1550678:Water [Inorganic Chemical]
   718 E C0443350:Watery [Qualitative Concept]

Phrase: "followed by 2 Laemmli gel loading buffer,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0332283:Followed by [Temporal Concept]
           followed
   774   C0258024:Laemmli buffer [Organic Chemical]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C1382104:Gel [Substance]
   748   C1708715:Loading [Activity]
   714 E C1550025:Load [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "boiled for 3 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0242301:Boil [Disease or Syndrome]
   737   C1546559:Boil [Intellectual Product]
Processing 00000000.tx.62: Cell protein was extracted with 2% SDS in Tris-buffered saline and was quantitated by the bicinchoninic acid assay (Pierce). 

Phrase: "Cell protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007634:Cell [Cell]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "extracted with 2% SDS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "in Tris-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "and"

Phrase: "was"

Phrase: "quantitated by the bicinchoninic acid assay"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0053554:bicinchoninic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "(Pierce"

Phrase: ")."
Processing 00000000.tx.63: Equal volumes of reconstituted secretory protein solutions normalized to total cell protein were separated by SDS-polyacrylamide gel electrophoresis, electroblotted onto polyvinylidene difluoride (Immobilon-P, Waters) membranes, and blocked with 5% non-fat dry milk (Carnation) in Tris-buffered saline containing 0.05% Tween 80. 

Phrase: "Equal volumes of reconstituted secretory protein solutions"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0449468:volumes [Quantitative Concept]
   714 E C1690016:% volume [Qualitative Concept]
   714 E C1705102:Volume [Intellectual Product]
   714 E C2700258:Volume [Laboratory Procedure]

Phrase: "normalized to total cell protein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   797   C0439177:Protein.total [Quantitative Concept]
   797   C0555903:Total protein [Laboratory Procedure]
   797   C1261360:total protein [Laboratory or Test Result]
   760   C0007634:Cell [Cell]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1882115:Normalized [Research Activity]
   760   C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "separated by SDS-polyacrylamide gel electrophoresis,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1382104:Gel [Substance]

Phrase: "electroblotted onto polyvinylidene difluoride"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0071710:polyvinylidene difluoride [Organic Chemical]

Phrase: "(Immobilon-P,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123400:Immobilon P [Organic Chemical]

Phrase: "Waters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0043047:Waters [Inorganic Chemical,Pharmacologic Substance]
   966 E C0599638:WATER [Substance]
   966 E C1550678:Water [Inorganic Chemical]
   916 E C0443350:Watery [Qualitative Concept]

Phrase: ")"

Phrase: "membranes,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "blocked with 5% non-fat dry milk"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   774   C0991850:MILK FAT [Lipid,Pharmacologic Substance]
   748   C0011682:Dry [Natural Phenomenon or Process]
   748   C0026131:Milk [Body Substance]
   748   C0028778:Blocked [Pathologic Function]
   748   C0205222:Dry [Qualitative Concept]
   748   C0332206:Blocked [Functional Concept]
   748   C0349374:Milk [Food]
   748   C0424612:FAT [Organism Attribute]
   748   C0444318:Milk [Substance]
   748   C1512080:Dry [Qualitative Concept]
   748   C1518422:Non [Functional Concept]
   748   C2825079:Milk [Food]
   748   C2983591:BLOCKED [Research Activity]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]

Phrase: "(Carnation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949999:Carnation [Plant]

Phrase: ")"

Phrase: "in Tris-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.05% Tween 80."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041417:Tween 80 [Organic Chemical,Pharmacologic Substance]
   833 E C0032601:Polysorbate 80 [Biomedical or Dental Material,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.64: Membranes were probed with antibodies directed against various domains of APP and APLP2. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "probed with antibodies"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "directed against various domains of APP"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0162808:Protein Domains [Spatial Concept]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   750 E C1514562:Protein Domain [Amino Acid Sequence]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]
   711   C0439851:Direct [Qualitative Concept]
   711   C1880389:Domain [Functional Concept]
   711   C1883221:Domain [Conceptual Entity]
   711   C1947931:Direct [Qualitative Concept]
   711   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "APLP2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412467:APLP2 [Gene or Genome]
Processing 00000000.tx.65: Specifically, the monoclonal antibody 22C11, as well as the polyclonal antisera R1736, anti-C8 and D2-1 were used. 

Phrase: "Specifically,"

Phrase: "the monoclonal antibody 22C11,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "as well as"

Phrase: "the polyclonal antisera R1736,"

Phrase: "anti-C8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1305854:C8 [Body Location or Region]

Phrase: "and"

Phrase: "D2-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.66: Secondary antibodies were visualized on preflashed x-ray films (Kodak) by enhanced chemiluminescence (ECL, Amersham Corp.). 

Phrase: "Secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "visualized on preflashed x-ray films"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   833   C0043303:X-Ray Films [Medical Device]
   790   C0034571:X-ray [Functional Concept]
   790   C0043299:X-ray, NOS [Diagnostic Procedure]
   790   C0043309:X-ray [Natural Phenomenon or Process]
   790   C1306645:X-ray [Diagnostic Procedure]
   790   C1962945:X-ray [Diagnostic Procedure]
   753   C0086296:Films [Manufactured Object]
   753   C0086894:ray [Fish]
   753   C0234621:Visualized [Functional Concept]
   753   C0851346:ray [Natural Phenomenon or Process]
   753   C2314876:ray [Fish]
   719 E C1561571:film [Biomedical or Dental Material]
   719 E C1561572:film [Substance]

Phrase: "(Kodak"

Phrase: ")"

Phrase: "by enhanced chemiluminescence"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   861   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   861   C2349975:Enhanced [Activity]
   789 E C1627358:Enhancement [Therapeutic or Preventive Procedure]

Phrase: "(ECL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332684:ECL [Gene or Genome]

Phrase: "Amersham Corp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: ")."
Processing 00000000.tx.67: Immunoreactive bands were quantitated by laser scanning densitometry with an LKB ultroscan densitometer set to 40-m vertical interval size and 2.4-mm horizontal slit width. 

Phrase: "Immunoreactive bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "quantitated by laser scanning densitometry"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   762   C0011321:densitometric scanning [Laboratory Procedure]
           Densitometry
   760   C0023089:Laser [Manufactured Object]
   760   C0034606:Scanning [Diagnostic Procedure]
   760   C0441633:Scanning [Diagnostic Procedure]
   760   C0458142:Laser [Phenomenon or Process]
   760   C1023865:Laser [Plant]
   760   C1706315:Laser [Medical Device]
   726 E C2826292:SCAN [Finding]

Phrase: "with an LKB ultroscan densitometer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0180321:Densitometer [Medical Device]
   827   C1706216:Densitometer [Medical Device]

Phrase: "set to 40-m vertical interval size"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   774   C0213052:M 40 [Amino Acid, Peptide, or Protein]
   748   C0036849:Set [Mental Process]
   748   C0205128:Vertical [Spatial Concept]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439509:/40 [Temporal Concept]
   748   C0441923:M+ [Intellectual Product]
   748   C0456389:size [Spatial Concept]
   748   C1272706:Interval [Temporal Concept]
   748   C1442518:Set [Functional Concept]
   748   C1552654:Interval [Idea or Concept]
   748   C1552713:Interval [Intellectual Product]
   748   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "2.4-mm horizontal slit width."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0487742:Width [Quantitative Concept]
   727 E C0332464:Wide [Spatial Concept]
Processing 00000000.tx.68: Areas under the optical density curves were expressed as arbitrary units and normalized to areas generated by immunoreactive proteins secreted under control conditions determined on the same blot. 

Phrase: "Areas under the optical density curves"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   847   C0376690:Area under the curve [Quantitative Concept]
           Area Under Curves
   753   C0205146:areas [Spatial Concept]
   719 E C0017446:Area [Geographic Area]

Phrase: "were"

Phrase: "expressed as arbitrary units"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0439183:Arbitrary unit [Quantitative Concept]
   770   C0439148:Units [Quantitative Concept]
   770   C1264693:*Arbitrary [Quantitative Concept]
   770   C1519795:Units [Quantitative Concept]
   737 E C1704753:Unit [Manufactured Object]
   737 E C1880519:Unit [Quantitative Concept]

Phrase: "and"

Phrase: "normalized to areas"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205146:areas [Spatial Concept]
   790   C1882115:Normalized [Research Activity]
   756 E C0017446:Area [Geographic Area]

Phrase: "generated by immunoreactive proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C3146294:Generated [Activity]

Phrase: "secreted under control conditions"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   770   C0243148:control [Qualitative Concept]
   770   C1327616:Secreted [Cell Function]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
   715 E C0040607:Training [Educational Activity]
   715 E C0220931:Training [Educational Activity]
   715 E C0336809:Train [Manufactured Object]
   715 E C1552514:Train [Manufactured Object]
   715 E C2673163:training [Qualitative Concept]

Phrase: "determined on the same blot."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0445247:Same [Qualitative Concept]
Processing 00000000.tx.69: Measurements were performed in the linear range of the ECL reaction as determined from serial dilution curves of secreted proteins. 

Phrase: "Measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "performed in the linear range of the ECL reaction"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   742   C0205132:Linear [Spatial Concept]
   742   C0443286:Reaction [Functional Concept]
   742   C0884358:Performed [Functional Concept]
   742   C1114821:Reaction [Clinical Attribute]
   742   C1332684:ECL [Gene or Genome]
   742   C1514721:Range [Quantitative Concept]
   742   C2348147:Range [Quantitative Concept]
   742   C3542016:Range [Intellectual Product]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "determined from serial dilution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031082:serial [Intellectual Product,Manufactured Object]
   770   C0079240:Dilution [Laboratory Procedure]
   770   C1948037:Dilution [Functional Concept]

Phrase: "curves of secreted proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205134:Curve [Spatial Concept]
   770   C1327616:Secreted [Cell Function]
Processing 00000000.tx.70: Control and stimulated conditions were always handled in parallel, processed identically, and run in parallel lanes on the same blot. 

Phrase: "Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "stimulated conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "always"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003902:Always [Temporal Concept]

Phrase: "handled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708320:Handle [Conceptual Entity]

Phrase: "in parallel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C2348042:Parallel [Qualitative Concept]
   861   C2826345:PARALLEL [Research Activity]

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "identically,"

Phrase: "and"

Phrase: "run in parallel lanes on the same blot."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1708639:Lane [Spatial Concept]
Processing 00000000.tx.71: All experiments were done in triplicate dishes and were repeated at least three times. 

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "done in triplicate dishes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205174:Triplicate [Quantitative Concept]
   770   C1272695:Done [Qualitative Concept]
   770   C2746065:Done [Temporal Concept]
   737   C0020498:DISH [Disease or Syndrome]

Phrase: "and"

Phrase: "were"

Phrase: "repeated at least three times."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205341:Repeated [Functional Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C1547730:Repeat [Temporal Concept]
   726 E C1705914:Repeat [Conceptual Entity]
   726 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.72: Statistical analysis was performed by analysis of variance, using treatments as the independent variable. 

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed by analysis of variance,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   806   C1550369:Performed By [Qualitative Concept]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0884358:Performed [Functional Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1711260:Variance [Qualitative Concept]
   760   C2348152:Variance [Quantitative Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "treatments as the independent variable."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   760   C0087111:Treatments [Therapeutic or Preventive Procedure]
   726 E C0039798:treatment [Functional Concept]
   726 E C1522326:Treatment [Functional Concept]
   726 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   726 E C1705169:Treatment [Conceptual Entity]
   726 E C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.73: RESULTS In 3T3 fibroblasts stably transfected with cDNA expression constructs encoding either 5-HT2aR or 5-HT2cR, serotonin caused rapid and dose-dependent increases in PI turnover (Fig.1). 

Phrase: "RESULTS In 3T3 fibroblasts stably"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "transfected with cDNA expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1515563:cDNA Expression [Molecular Biology Research Technique]
   770   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "encoding either 5-HT2aR"

Phrase: "or"

Phrase: "5-HT2cR,"

Phrase: "serotonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036751:Serotonin [Neuroreactive Substance or Biogenic Amine,Organic Chemical]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "dose-dependent increases in PI turnover"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:increases [Functional Concept]

Phrase: "(Fig.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.74: Serotonin increased PI turnover to 29-fold (range 7.8-53, n = 4) compared to that observed basally in cells overexpressing 5-HT2aR (Fig.1A) and to 7.9-fold (range 4.1-9.9, n = 4) basal levels in cells overexpressing 5-HT2cR (Fig.1B). 

Phrase: "Serotonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036751:Serotonin [Neuroreactive Substance or Biogenic Amine,Organic Chemical]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "PI turnover to 29-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0031227:turnover [Quantitative Concept]
   760   C0243127:turnover [Functional Concept]
   760   C0443331:Turnover [Health Care Activity]

Phrase: "(range 7.8-53,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1514721:Range [Quantitative Concept]
   812   C2348147:Range [Quantitative Concept]
   812   C3542016:Range [Intellectual Product]

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "compared to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "basally in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "5-HT2aR"

Phrase: "(Fig.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "and to 7.9-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332462:Fold [Spatial Concept]
   760   C1515981:And [Idea or Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "(range 4.1-9.9,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1514721:Range [Quantitative Concept]
   804   C2348147:Range [Quantitative Concept]
   804   C3542016:Range [Intellectual Product]

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "basal levels in cells"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "5-HT2cR"

Phrase: "(Fig.1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.75: The EC of the inositol phosphate (IP) accumulation in response to serotonin was 30 nM in the 5-HT2aR-expressing cells and 2 nM in the 5-HT2cR-expressing cells. 

Phrase: "The EC of the inositol phosphate (IP) accumulation"

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to serotonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036751:Serotonin [Neuroreactive Substance or Biogenic Amine,Organic Chemical]

Phrase: "was"

Phrase: "30 nM in the 5-HT2aR-expressing cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "2 nM in the 5-HT2cR-expressing cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0312860:NM [Cell Function]
Processing 00000000.tx.76: Serotonin also caused APPs secretion to increase in both cell lines (Fig.2). 

Phrase: "Serotonin also caused APPs secretion to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   876   C1325900:serotonin secretion [Cell Function]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]

Phrase: "increase in both cell lines"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0007600:Cell lines [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C0442805:Increase [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]
   704 E C1517378:Gain [Quantitative Concept]

Phrase: "(Fig.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.77: The maximal stimulation of APPs secretion was 4.5-fold (range 2.3-10.8, n = 9) basal levels in cells expressing 5-HT2aR and 3-fold (range 1.6-3.9) in cells expressing 5-HT2cR. 

Phrase: "The maximal stimulation of APPs secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C2259155:stimulation of secretion [Cell Function]
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "4.5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0450367:4 5 [Quantitative Concept]

Phrase: "(range 2.3-10.8,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1514721:Range [Quantitative Concept]
   804   C2348147:Range [Quantitative Concept]
   804   C3542016:Range [Intellectual Product]

Phrase: "n = 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "basal levels in cells"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "expressing"

Phrase: "5-HT2aR"

Phrase: "and"

Phrase: "3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "(range 1.6-3.9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1514721:Range [Quantitative Concept]
   804   C2348147:Range [Quantitative Concept]
   804   C3542016:Range [Intellectual Product]

Phrase: ")"

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "5-HT2cR."
Processing 00000000.tx.78: The EC of 5-HT-mediated APPs secretion was 200 nM in cells expressing 5-HT2aR (Fig.2A) and 120 nM in the 5-HT2cR-expressing cells (Fig.2B). 

Phrase: "The EC of 5-HT-mediated APPs secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   767   C0022202:EC 5 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "200 nM in cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0312860:NM [Cell Function]

Phrase: "expressing"

Phrase: "5-HT2aR"

Phrase: "(Fig.2A"

Phrase: ")"

Phrase: "and"

Phrase: "120 nM in the 5-HT2cR-expressing cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0312860:NM [Cell Function]

Phrase: "(Fig.2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.79: Time course analyses showed that the 5-HT-mediated stimulation of APPs secretion was rapid, with significant increases in both cell lines occurring as soon as 5 min following the application of 5-HT (Fig.2, C and D). 

Phrase: "Time course analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
   734   C0449247:Time course [Temporal Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the 5-HT-mediated stimulation of APPs secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C2259155:stimulation of secretion [Cell Function]
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "rapid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "with significant increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:increases [Functional Concept]

Phrase: "in both cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "occurring as soon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1709305:Occur [Activity]
   756   C2745955:OCCUR [Temporal Concept]

Phrase: "as 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the application of 5-HT (Fig.2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0185125:Application [Health Care Activity]
   748   C1947919:Application [Intellectual Product]
   748   C2347934:Application [Intellectual Product]
   748   C3539080:APPLICATION [Quantitative Concept]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.80: The increase in APPs secretion caused by 5-HT2aR stimulation was blocked by the serotoninergic antagonists ketanserin, mianserin, and ritanserin (Fig.3), and the 5-HT2cR-mediated increase was blocked by mianserin (Fig.3), indicating that the effects on APP processing in both cell lines were specifically mediated by activation of the overexpressed 5-HT2 receptor subtypes. 

Phrase: "The increase in APPs secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "caused by 5-HT2aR stimulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]

Phrase: "was"

Phrase: "blocked by the serotoninergic antagonists ketanserin,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   753   C0022616:Ketanserin [Organic Chemical,Pharmacologic Substance]
   753   C0028778:Blocked [Pathologic Function]
   753   C0243076:antagonists [Chemical Viewed Functionally]
   753   C0332206:Blocked [Functional Concept]
   753   C2983591:BLOCKED [Research Activity]
   719 E C0231491:Antagonist [Organ or Tissue Function]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "mianserin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025912:Mianserin [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ritanserin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085260:Ritanserin [Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the 5-HT2cR-mediated increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "blocked by mianserin"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0025912:Mianserin [Organic Chemical,Pharmacologic Substance]
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "(Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the effects on APP processing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "in both cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "specifically"

Phrase: "mediated by activation of the overexpressed 5-HT2 receptor subtypes."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   757   C1514758:Receptor Activation [Cell Function]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C0449560:subtypes [Classification]
   739   C0450566:HT2 [Body Location or Region]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C1879547:Activation [Activity]
   706   C1514559:overexpress [Genetic Function]
Processing 00000000.tx.81: Direct stimulation of PKC by the phorbol ester PMA mimicked the 5-HT-induced increase in APPs secretion (Fig.4A and 5A). 

Phrase: "Direct stimulation of PKC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by the phorbol ester PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   911   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   804   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   804   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "mimicked"

Phrase: "the 5-HT-induced increase in APPs secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "(Fig.4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "and"

Phrase: "5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.82: In both cell lines, however, the kinase inhibitors staurosporine and chelerythrine chloride failed to block the response to 5-HT (Fig.4A and 5A). 

Phrase: "In both cell lines,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "however,"

Phrase: "the kinase inhibitors staurosporine"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
   734   C1152564:Kinase Inhibitors [Molecular Function]
   717 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   717 E C3537023:kinase inhibitor [Molecular Function]
   717 E C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "chelerythrine chloride"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0109289:chelerythrine chloride [Organic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the response to 5-HT (Fig.4A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.83: Moreover, down-regulation of PKC in these cells by chronic (24 h) pretreatment with PMA also failed to block the ability of 5-HT to stimulate APPs secretion (Fig.4A and 5A). 

Phrase: "Moreover,"

Phrase: "down-regulation of PKC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0013081:Down-Regulation [Cell Function,Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "in these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "by chronic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205191:chronic [Temporal Concept]

Phrase: "(24 h) pretreatment with PMA also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1550147:Pretreatment [Substance]
   744   C2709094:pre treatment [Temporal Concept]
   744   C3539075:Pretreatment [Temporal Concept]
   744   C3539076:Pretreatment [Activity]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the ability of 5-HT to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "stimulate"

Phrase: "APPs secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "(Fig.4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "and"

Phrase: "5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.84: The PMA response, however, was completely blocked by prior chronic pretreatment with PMA (Fig.4A and 5A). 

Phrase: "The PMA response,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   756   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "however,"

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "blocked by prior chronic pretreatment"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   760   C0028778:Blocked [Pathologic Function]
   760   C0205191:chronic [Temporal Concept]
   760   C0332152:Prior [Temporal Concept]
   760   C0332206:Blocked [Functional Concept]
   760   C1550147:Pretreatment [Substance]
   760   C2709094:pre treatment [Temporal Concept]
   760   C2826257:PRIOR [Event]
   760   C2983591:BLOCKED [Research Activity]
   760   C3539075:Pretreatment [Temporal Concept]
   760   C3539076:Pretreatment [Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "with PMA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   827   C0031588:phorbol [Organic Chemical]
   827   C0070750:Phorbol [Organic Chemical]
   827   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "(Fig.4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "and"

Phrase: "5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.85: In 5-HT2aR-expressing cells, the 5-HT-mediated increase in APPs secretion was effectively blocked by the PLA-inhibitors manoalide (ML), dimethyleicosadienoic acid (DEDA), and oleyloxyethyl phosphorylcholine (OPC) (Fig.4B), indicating that PLA may be also involved in the cellular signaling cascade that couples 5-HT2aR activation to APPs secretion. 

Phrase: "In 5-HT2aR-expressing cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "the 5-HT-mediated increase in APPs secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "effectively"

Phrase: "blocked by the PLA-inhibitors manoalide (ML),"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   778   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
   778   C2261240:phospholipase A [Molecular Function]
   757   C0597220:phospholipase inhibitor [Pharmacologic Substance]
   748   C0028778:Blocked [Pathologic Function]
   748   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0065711:manoalide [Organic Chemical,Pharmacologic Substance]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0332206:Blocked [Functional Concept]
   748   C2983591:BLOCKED [Research Activity]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C1999216:Inhibitor [Qualitative Concept]
   714 E C2828370:Block [Quantitative Concept]

Phrase: "dimethyleicosadienoic acid (DEDA),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "oleyloxyethyl phosphorylcholine (OPC)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031716:Phosphorylcholine [Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig.4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that PLA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2261240:phospholipase A [Molecular Function]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "be"

Phrase: "also"

Phrase: "involved in the cellular signaling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0007634:Cellular [Cell]
   760   C0037083:Signaling [Cell Function]
   760   C0178539:Cellular [Functional Concept]
   760   C1314939:Involved [Functional Concept]
   760   C3537152:signaling [Biologic Function]

Phrase: "cascade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707310:Cascade [Manufactured Object]

Phrase: "that couples 5-HT2aR activation to APPs secretion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1879547:Activation [Activity]
Processing 00000000.tx.86: This hypothesis is supported by the finding that activation of PLA by melittin mimicked the 5-HT-mediated increase in APPs secretion (Fig.4B), while the calcium-releasing agent thapsigargin failed to change APPs secretion from these cells (Fig.4B). 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "supported by the finding"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0037088:Finding [Sign or Symptom]
   770   C0243095:Finding [Finding]
   770   C1521721:Supported [Conceptual Entity]
   770   C2825141:Finding [Finding]
   737 E C0183683:Support [Medical Device]

Phrase: "that activation of PLA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "by melittin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025234:Melitten [Amino Acid, Peptide, or Protein,Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "mimicked"

Phrase: "the 5-HT-mediated increase in APPs secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "(Fig.4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "the calcium-releasing agent thapsigargin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "APPs secretion from these cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1327616:Cell secretion [Cell Function]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]

Phrase: "(Fig.4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.87: Down-regulation of PKC by prior chronic preincubation with PMA (Fig.4C) failed to block either the inhibition of APPs secretion by PLA inhibitors or its stimulation by melittin, indicating that the signaling mediated by PLA is independent of cellular PKC activity. 

Phrase: "Down-regulation of PKC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0013081:Down-Regulation [Cell Function,Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "by prior chronic preincubation"

Phrase: "with PMA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   827   C0031588:phorbol [Organic Chemical]
   827   C0070750:Phorbol [Organic Chemical]
   827   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "(Fig.4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "either"

Phrase: "the inhibition of APPs secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C2259158:inhibition of secretion [Cell Function]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "by PLA inhibitors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   896   C0597220:phospholipase inhibitor [Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C1999216:Inhibitor [Qualitative Concept]
   734   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
   734   C2261240:phospholipase A [Molecular Function]

Phrase: "or"

Phrase: "its stimulation by melittin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "indicating"

Phrase: "that"

Phrase: "the signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]

Phrase: "mediated by PLA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
   833   C2261240:phospholipase A [Molecular Function]
   770   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "is independent of cellular PKC activity."
Meta Candidates (Total=24; Excluded=2; Pruned=0; Remaining=22)
   833   C1150572:protein kinase C activity [Molecular Function]
   800   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   793   C1150527:protein kinase activity [Molecular Function]
   793 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   793   C3642159:Protein C Activity [Laboratory Procedure]
   774 E C2261495:protein phosphokinase activity [Molecular Function]
   770   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0332291:Independent of [Functional Concept]
   767   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C1150423:kinase activity [Molecular Function]
   767   C1168438:Protein C [Laboratory Procedure]
   767   C1418943:PROTEIN C [Gene or Genome]
   767   C1537044:protein activity [Molecular Function]
   767   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0007634:Cellular [Cell]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0085862:Independent [Idea or Concept]
   744   C0178539:Cellular [Functional Concept]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1299583:Independent [Finding]
   744   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.88: In the 5-HT2cR-expressing cells, the PLA inhibitor dimethyleicosadienoic acid only partly blocked 5-HT2cR-induced APPs secretion, and melittin was less effective in stimulating this secretion than in the 5-HT2aR-expressing cells (Fig.5B). 

Phrase: "In the 5-HT2cR-expressing cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "the PLA inhibitor dimethyleicosadienoic acid only partly"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   829   C0597220:phospholipase inhibitor [Pharmacologic Substance]
   818   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
   818   C2261240:phospholipase A [Molecular Function]
   795   C0001128:Acid [Chemical]
   795   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0202406:Acid [Laboratory Procedure]
   795   C0205171:Only [Quantitative Concept]
   795   C1720467:Only [Intellectual Product]
   795   C1999216:Inhibitor [Qualitative Concept]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "5-HT2cR-induced APPs secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "melittin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025234:Melitten [Amino Acid, Peptide, or Protein,Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "was"

Phrase: "less effective in stimulating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280519:effective [Qualitative Concept]
   770   C1704419:Effective [Qualitative Concept]

Phrase: "this secretion than"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0036536:secretion [Biologic Function]
   790   C0036537:Secretion [Body Substance]

Phrase: "in the 5-HT2aR-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig.5B"

Phrase: ")."
Processing 00000000.tx.89: When PKC was down-regulated by prior chronic preincubation with PMA, all PLA inhibitors effectively blocked the 5-HT2cR-mediated increase in APPs secretion (Fig.5C), suggesting that PKC and PLA are both involved in coupling of 5-HT2cR activation to APPs secretion. 

Phrase: "When"

Phrase: "PKC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "down-regulated by prior chronic preincubation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205191:chronic [Temporal Concept]
   753   C0332152:Prior [Temporal Concept]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C2826257:PRIOR [Event]

Phrase: "with PMA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   827   C0031588:phorbol [Organic Chemical]
   827   C0070750:Phorbol [Organic Chemical]
   827   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "all PLA inhibitors effectively"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   858   C0597220:phospholipase inhibitor [Pharmacologic Substance]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   779 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the 5-HT2cR-mediated increase in APPs secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "(Fig.5C"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that PKC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "PLA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2261240:phospholipase A [Molecular Function]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "both"

Phrase: "involved in coupling of 5-HT2cR activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1314939:Involved [Functional Concept]
   748   C1879547:Activation [Activity]
   748   C1948027:Coupling [Functional Concept]

Phrase: "to APPs secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.90: The serotoninergic agonist dexnorfenfluramine (DNF) stimulated PI breakdown in 3T3 cells expressing 5-HT2cR, indicating that it is a potent agonist of these receptors (Fig.6A). 

Phrase: "The serotoninergic agonist dexnorfenfluramine (DNF)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2350698:Dexnorfenfluramine [Organic Chemical,Pharmacologic Substance]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "PI breakdown in 3T3 cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1623073:phosphatidylinositol breakdown [Molecular Function]
   760   C0443161:break down [Qualitative Concept]
   760   C0699900:breakdown [Organism Function]
   760   C1265875:breakdown [Acquired Abnormality]

Phrase: "expressing"

Phrase: "5-HT2cR,"

Phrase: "indicating"

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "a potent agonist of these receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2987634:Agonist [Pharmacologic Substance]

Phrase: "(Fig.6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.91: DNF dose-dependently stimulated APPs secretion in the 5-HT2cR expressing cells (Fig.6B), and this effect was inhibited by the serotonin receptor antagonists ketanserin, mianserin, and ritanserin (Fig.6C). 

Phrase: "DNF dose-dependently stimulated APPs secretion in the 5-HT2cR expressing cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0036536:secretion [Biologic Function]
   736   C0036537:Secretion [Body Substance]
   734   C1327616:Cell secretion [Cell Function]

Phrase: "(Fig.6B"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "inhibited by the serotonin receptor antagonists ketanserin,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   814   C0036753:Serotonin Receptor Antagonists [Pharmacologic Substance]
           Serotonin Antagonists
   778   C0034838:serotonin receptor [Amino Acid, Peptide, or Protein,Receptor]
   774   C2757052:Serotonin Antagonists [Molecular Function]
   748   C0022616:Ketanserin [Organic Chemical,Pharmacologic Substance]
   748   C0036751:Serotonin [Neuroreactive Substance or Biogenic Amine,Organic Chemical]
   748   C0243076:antagonists [Chemical Viewed Functionally]
   748   C0311403:Inhibited [Qualitative Concept]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   714 E C0231491:Antagonist [Organ or Tissue Function]

Phrase: "mianserin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025912:Mianserin [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ritanserin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085260:Ritanserin [Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig.6C"

Phrase: ")."
Processing 00000000.tx.92: In related experiments with cells that stably overexpress 5-HT2aR, serotonin also increased PI turnover as well as the secretion of APPs, indicating that DNF is a nonselective agonist of both 5-HT2aR and 5-HT2cR (data not shown). 

Phrase: "In related experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "with cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "that stably"

Phrase: "overexpress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "5-HT2aR,"

Phrase: "serotonin also increased PI turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0031227:turnover [Quantitative Concept]
   804   C0243127:turnover [Functional Concept]
   804   C0443331:Turnover [Health Care Activity]

Phrase: "as well as"

Phrase: "the secretion of APPs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "indicating"

Phrase: "that DNF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2350698:Dexnorfenfluramine [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "a nonselective agonist of both 5-HT2aR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2987634:Agonist [Pharmacologic Substance]

Phrase: "and"

Phrase: "5-HT2cR"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.93: In contrast to the responses of stably transfected cells lines, the untransfected parent cell line failed to exhibit changes in APPs secretion when exposed to serotonin (100 pM to 100 M). 

Phrase: "In contrast to the responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0871261:responses [Organism Attribute]
   966 E C1704632:Response [Finding]
   966 E C1706817:Response [Intellectual Product]
   966 E C2911692:Response [Mental Process]

Phrase: "of stably transfected cells lines,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0007600:cells lines [Cell]
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "the untransfected parent cell line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007600:Cell Line [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "changes in APPs secretion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "when"

Phrase: "exposed to serotonin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C0036751:Serotonin [Neuroreactive Substance or Biogenic Amine,Organic Chemical]

Phrase: "(100 pM to 100"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   819   C0662713:PM 100 [Organic Chemical]

Phrase: "M)."
Processing 00000000.tx.94: Figure 1: Serotonin stimulates phosphatidylinositol turnover in 3T3 fibroblasts stably expressing 5-HT2a or 5-HT2c receptors. 

Phrase: "Figure 1"

Phrase: ":"

Phrase: "Serotonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036751:Serotonin [Neuroreactive Substance or Biogenic Amine,Organic Chemical]

Phrase: "stimulates"

Phrase: "phosphatidylinositol turnover in 3T3 fibroblasts stably"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0031227:turnover [Quantitative Concept]
   753   C0243127:turnover [Functional Concept]
   753   C0443331:Turnover [Health Care Activity]

Phrase: "expressing"

Phrase: "5-HT2a"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1415809:5-HT2A [Gene or Genome]
  1000   C1708300:5-HT2A [Gene or Genome]
   861   C1424232:HT2A [Gene or Genome]

Phrase: "or"

Phrase: "5-HT2c receptors."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C0528200:5-HT2C Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   734   C1415811:5-HT2C [Gene or Genome]
Processing 00000000.tx.95: Cells were metabolically labeled with [H]inositol overnight, stimulated with increasing concentrations of 5-HT in the presence of 10 M lithium, and radiolabeled inositol phosphates derived from PI breakdown were measured by scintillation counting. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "metabolically"

Phrase: "labeled with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708632:Labeled [Qualitative Concept]
   799 E C0181496:Label [Manufactured Object]
   799 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[H]inositol overnight,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]

Phrase: "stimulated with increasing concentrations of 5-HT"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0018510:HT [Geographic Area]
   748   C0086045:Concentrations [Mental Process]
   748   C0442808:Increasing [Functional Concept]
   748   C0677607:HT [Disease or Syndrome]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 10 M lithium,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "radiolabeled inositol phosphates"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0021554:Inositol Phosphates [Carbohydrate]
   827   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   827   C0031603:Phosphates [Inorganic Chemical,Pharmacologic Substance]
   793 E C0031701:phosphate [Organophosphorus Compound]
   793 E C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "derived from PI breakdown"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1623073:phosphatidylinositol breakdown [Molecular Function]
   770   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   770   C0443161:break down [Qualitative Concept]
   770   C0699900:breakdown [Organism Function]
   770   C1265875:breakdown [Acquired Abnormality]
   770   C1441547:Derived [Qualitative Concept]
   770   C2348046:Phosphatidylinositol [Lipid]
   770   C3245521:derived [Idea or Concept]

Phrase: "were"

Phrase: "measured by scintillation counting."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0036406:Scintillation Counting [Laboratory Procedure]
   770   C0444706:Measured [Qualitative Concept]
   770   C0678573:scintillation [Natural Phenomenon or Process]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.96: A, 3T3 cells stably expressing 5-HT2aR. 

Phrase: "A,"

Phrase: "3T3 cells stably"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085087:3T3 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "5-HT2aR."
Processing 00000000.tx.97: B, 3T3 cells stably expressing 5-HT2cR. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "3T3 cells stably"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085087:3T3 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "5-HT2cR."
Processing 00000000.tx.98: Data are from representative experiments and are means  S.D. of triplicate culture dishes. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are from representative experiments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0681814:Experiments [Research Activity]
   770   C1551058:Are [Quantitative Concept]
   770   C1882932:Representative [Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "and"

Phrase: "are"

Phrase: "means  S.D."

Phrase: "of triplicate culture dishes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]
   793   C0020498:DISH [Disease or Syndrome]
Processing 00000000.tx.99: Similar dose-response curves were obtained in four independent experiments for each cell line. 

Phrase: "Similar dose-response curves"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   890   C0683162:dose-response curve [Quantitative Concept]
   812   C0178602:Dose [Quantitative Concept]
   812   C0869039:Dose [Quantitative Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1114758:Dose # [Clinical Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   779   C0205134:Curve [Spatial Concept]

Phrase: "were"

Phrase: "obtained in four independent experiments"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0085862:Independent [Idea or Concept]
   760   C0205450:Four [Quantitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1299583:Independent [Finding]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1706701:Obtain [Activity]

Phrase: "for each cell line."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007600:Cell Line [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:Line [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.100: IP, radiolabeled inositol phosphates. 

Phrase: "IP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021554:inositol phosphate [Carbohydrate]
   861   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   861   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0031701:phosphate [Organophosphorus Compound]
   861   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "radiolabeled inositol phosphates."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0021554:Inositol Phosphates [Carbohydrate]
   827   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   827   C0031603:Phosphates [Inorganic Chemical,Pharmacologic Substance]
   793 E C0031701:phosphate [Organophosphorus Compound]
   793 E C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.101: Figure 2: APPs secretion is increased by 5-HT receptor stimulation in 3T3 cells overexpressing 5-HT2aR or 5-HT2cR. 

Phrase: "Figure 2"

Phrase: ":"

Phrase: "APPs secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "is"

Phrase: "increased by 5-HT receptor stimulation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0018510:HT [Geographic Area]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0677607:HT [Disease or Syndrome]
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in 3T3 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085087:3T3 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "5-HT2aR"

Phrase: "or"

Phrase: "5-HT2cR."
Processing 00000000.tx.102: Cells were stimulated with 5-HT and APPs secreted into the culture medium was measured by Western blotting and densitometry. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated with 5-HT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0018510:HT [Geographic Area]
   770   C0677607:HT [Disease or Syndrome]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "secreted into the culture medium"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0439536:Medium [Quantitative Concept]
   760   C1327616:Secreted [Cell Function]
   760   C1705217:Medium [Substance]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "measured by Western blotting"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0444706:Measured [Qualitative Concept]
   770   C1705493:Western [Spatial Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "densitometry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011321:Densitometry [Laboratory Procedure]
Processing 00000000.tx.103: A, dose response of 5-HT2aR-mediated APPs secretion. 

Phrase: "A,"

Phrase: "dose response of 5-HT2aR-mediated APPs secretion."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0870868:mediated response [Mental Process]
   744   C0178602:Dose [Quantitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C0871261:Response [Organism Attribute]
   744   C1114758:Dose # [Clinical Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]
Processing 00000000.tx.104: Filled symbols, stably transfected cells; 

Phrase: "Filled symbols,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "stably transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.105: open symbols, untransfected parent cell line. 

Phrase: "open symbols,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "untransfected parent cell line."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007600:Cell Line [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
Processing 00000000.tx.106: B, dose response of 5-HT2cR-induced APPs secretion. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "dose response of 5-HT2cR-induced APPs secretion."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0178602:Dose [Quantitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C0871261:Response [Organism Attribute]
   744   C1114758:Dose # [Clinical Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]
Processing 00000000.tx.107: Filled symbols, stably transfected cells; 

Phrase: "Filled symbols,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "stably transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.108: open symbols, untransfected parent cell line. 

Phrase: "open symbols,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "untransfected parent cell line."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007600:Cell Line [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
Processing 00000000.tx.109: C, time course of 5-HT2aR-mediated APPs secretion. 

Phrase: "C,"

Phrase: "time course of 5-HT2aR-mediated APPs secretion."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0449247:Time course [Temporal Concept]
   744   C0040223:Time [Temporal Concept]
   744   C0750729:Course [Temporal Concept]
   744   C3541383:Time [Temporal Concept]
Processing 00000000.tx.110: Filled symbols, 10 M 5-HT; 

Phrase: "Filled symbols,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "10 M 5-HT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0018510:HT [Geographic Area]
   812   C0677607:HT [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.111: open symbols, vehicle control. 

Phrase: "open symbols,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "vehicle control."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0042444:Vehicle [Biomedical or Dental Material]
   861   C0243148:control [Qualitative Concept]
   861   C0348005:Vehicle [Manufactured Object]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   789 E C0445373:Vehicular [Functional Concept]
Processing 00000000.tx.112: D, time course of 5-HT2cR-mediated APPs secretion. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "time course of 5-HT2cR-mediated APPs secretion."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0449247:Time course [Temporal Concept]
   744   C0040223:Time [Temporal Concept]
   744   C0750729:Course [Temporal Concept]
   744   C3541383:Time [Temporal Concept]
Processing 00000000.tx.113: Filled symbols, 10 M 5-HT; 

Phrase: "Filled symbols,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "10 M 5-HT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0018510:HT [Geographic Area]
   812   C0677607:HT [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.114: open symbols, vehicle control. 

Phrase: "open symbols,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "vehicle control."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0042444:Vehicle [Biomedical or Dental Material]
   861   C0243148:control [Qualitative Concept]
   861   C0348005:Vehicle [Manufactured Object]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   789 E C0445373:Vehicular [Functional Concept]
Processing 00000000.tx.115: Data are means  S.E. of three independent experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "of three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.116: Figure 3: APPs secretion induced by stimulating 5-HT receptors is blocked by 5-HT receptor antagonists. 

Phrase: "Figure 3"

Phrase: ":"

Phrase: "APPs secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "induced by stimulating 5-HT receptors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0018510:HT [Geographic Area]
   753   C0205263:Induced [Functional Concept]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   753   C0677607:HT [Disease or Syndrome]
   753   C1948023:Stimulating [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "blocked by 5-HT receptor antagonists."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   753   C0018510:HT [Geographic Area]
   753   C0028778:Blocked [Pathologic Function]
   753   C0243076:antagonists [Chemical Viewed Functionally]
   753   C0332206:Blocked [Functional Concept]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0677607:HT [Disease or Syndrome]
   753   C2983591:BLOCKED [Research Activity]
   719 E C0231491:Antagonist [Organ or Tissue Function]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.117: Cells were incubated with the antagonists 10 min prior to treatment with 10 M 5-HT, and the antagonists and APPs in the culture media were quantitated by Western blotting and densitometry. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with the antagonists 10 min"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0456692:/10 min [Temporal Concept]
   753   C0243076:antagonists [Chemical Viewed Functionally]
   753   C0702093:/min [Temporal Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   719 E C0231491:Antagonist [Organ or Tissue Function]

Phrase: "prior to treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with 10 M 5-HT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0018510:HT [Geographic Area]
   812   C0677607:HT [Disease or Syndrome]

Phrase: "and"

Phrase: "the antagonists"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0243076:antagonists [Chemical Viewed Functionally]
   966 E C0231491:Antagonist [Organ or Tissue Function]
   893 E C0680242:antagonism [Social Behavior]

Phrase: "and"

Phrase: "APPs in the culture media"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C3538722:APP [Laboratory Procedure]

Phrase: "were"

Phrase: "quantitated by Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "densitometry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011321:Densitometry [Laboratory Procedure]
Processing 00000000.tx.118: 5-HT, 10 M serotonin; 

Phrase: "5-HT,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036751:5-HT [Neuroreactive Substance or Biogenic Amine,Organic Chemical]
  1000   C0048996:5 ht [Organic Chemical,Pharmacologic Substance]
   861   C0018510:HT [Geographic Area]
   861   C0677607:HT [Disease or Syndrome]

Phrase: "10 M serotonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036751:Serotonin [Neuroreactive Substance or Biogenic Amine,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.119: KS, 20 M ketanserin; 

Phrase: "KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541894:ks [Quantitative Concept]

Phrase: "20 M ketanserin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022616:Ketanserin [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.120: MS, 50 M mianserin; 

Phrase: "MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2349943:Ms. [Conceptual Entity]
  1000   C3539704:MS [Gene or Genome]

Phrase: "50 M mianserin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025912:Mianserin [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.121: RS, 20 M ritanserin. 

Phrase: "RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539879:RS [Idea or Concept]

Phrase: "20 M ritanserin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0085260:Ritanserin [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.122: Data are means  S.E. of three independent experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "of three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.123: Figure 4: PLA couples activation of 5-HT2aR receptors to increased APPs secretion. 

Phrase: "Figure 4"

Phrase: ":"

Phrase: "PLA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2261240:phospholipase A [Molecular Function]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "couples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010222:Couples [Family Group]
  1000   C1948027:Couple [Functional Concept]

Phrase: "activation of 5-HT2aR receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1514758:Receptor Activation [Cell Function]
   760   C1879547:Activation [Activity]

Phrase: "to increased APPs secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
Processing 00000000.tx.124: A, no inhibition of 5-HT-mediated APPs secretion by the protein kinase inhibitors staurosporine (1 M; Stau) and chelerythrine chloride (1 M, CC). 

Phrase: "A,"

Phrase: "no inhibition of 5-HT-mediated APPs secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C2259158:inhibition of secretion [Cell Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "by the protein kinase inhibitors staurosporine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
   756   C1449702:Protein Kinase Inhibitors [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C2757016:Protein Kinase Inhibitors [Molecular Function]

Phrase: "(1 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "; Stau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "chelerythrine chloride"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0109289:chelerythrine chloride [Organic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "(1 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "CC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538933:CC [Cell Component]

Phrase: ")."
Processing 00000000.tx.125: Direct activation of PKC by phorbol myristate acetate (1 M; PMA) increased APPs secretion. 

Phrase: "Direct activation of PKC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   864   C3546691:protein kinase C activation [Molecular Function]
   820   C1819041:protein kinase activation [Cell Function]
   783   C0599177:protein activation [Genetic Function]
   753   C1879547:Activation [Activity]

Phrase: "by phorbol myristate acetate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   827   C0031588:phorbol [Organic Chemical]
   827   C0070750:Phorbol [Organic Chemical]
   827   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "(1 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "; PMA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   827   C0031588:phorbol [Organic Chemical]
   827   C0070750:Phorbol [Organic Chemical]
   827   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: ")"

Phrase: "increased APPs secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
Processing 00000000.tx.126: After down-regulation of PKC by 24-h pretreatment with PMA, the response to PMA was indifferent from the vehicle control condition (CTR). 

Phrase: "After"

Phrase: "down-regulation of PKC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0013081:Down-Regulation [Cell Function,Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "by 24-h pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1550147:Pretreatment [Substance]
   827   C2709094:pre treatment [Temporal Concept]
   827   C3539075:Pretreatment [Temporal Concept]
   827   C3539076:Pretreatment [Activity]

Phrase: "with PMA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   827   C0031588:phorbol [Organic Chemical]
   827   C0070750:Phorbol [Organic Chemical]
   827   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "the response to PMA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C1327571:response to acetate [Cell Function]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "indifferent from the vehicle control condition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332238:Indifferent [Qualitative Concept]

Phrase: "(CTR"

Phrase: ")."
Processing 00000000.tx.127: In contrast, 5-HT stimulated APPs secretion after PMA pretreatment. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "5-HT stimulated APPs secretion after PMA pretreatment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   777   C1325900:5-HT secretion [Cell Function]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]
Processing 00000000.tx.128: B, PLA inhibitors manoalide (3.2 M; ML), dimethyleicosadienoic acid (20 M; DEDA), and oleyloxyethyl phosphorylcholine (0.1 M; OPC) blocked 5-HT-mediated increase in APPs secretion. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "PLA inhibitors manoalide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0065711:manoalide [Organic Chemical,Pharmacologic Substance]

Phrase: "(3.2 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "; ML"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0065711:manoalide [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "dimethyleicosadienoic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(20 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "; DEDA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "oleyloxyethyl phosphorylcholine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031716:Phosphorylcholine [Organic Chemical,Pharmacologic Substance]

Phrase: "(0.1 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "; OPC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031716:Phosphorylcholine [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "5-HT-mediated increase in APPs secretion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]
Processing 00000000.tx.129: No alteration of basal APPs secretion by these PLA inhibitors. 

Phrase: "No alteration of basal APPs secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515926:Alteration [Idea or Concept]

Phrase: "by these PLA inhibitors."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   896   C0597220:phospholipase inhibitor [Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C1999216:Inhibitor [Qualitative Concept]
   734   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
   734   C2261240:phospholipase A [Molecular Function]
Processing 00000000.tx.130: The PLA activator melittin (2.5 g/ml) increased APPs secretion. 

Phrase: "The PLA activator melittin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025234:Melitten [Amino Acid, Peptide, or Protein,Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "(2.5 g/ml) increased APPs secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0036536:secretion [Biologic Function]
   795   C0036537:Secretion [Body Substance]
Processing 00000000.tx.131: No effect of the intracellular calcium-releasing agent thapsigargin (TG) on APPs secretion. 

Phrase: "No effect of the intracellular calcium-releasing agent thapsigargin (TG)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1301751:No effect [Qualitative Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "on APPs secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.132: C, inhibition and stimulation of PLA after PKC down-regulation. 

Phrase: "C,"

Phrase: "inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "and"

Phrase: "stimulation of PLA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "after PKC down-regulation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0013081:Down-Regulation [Cell Function,Molecular Function]
   804   C0851285:Regulation [Governmental or Regulatory Activity]
   804   C1327622:Regulation [Biologic Function]
   748   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   748   C2626739:Lanugo [Eukaryote]
   717   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.133: 5-HT-mediated APPs secretion is effectively blocked by the PLA inhibitors, and melittin (2.5 g/ml) retained its ability to increase APPs secretion. 

Phrase: "5-HT-mediated APPs secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   911   C1325900:5-HT secretion [Cell Function]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]

Phrase: "is"

Phrase: "effectively"

Phrase: "blocked by the PLA inhibitors,"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   790   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
   790   C2261240:phospholipase A [Molecular Function]
   767   C0597220:phospholipase inhibitor [Pharmacologic Substance]
   753   C0028778:Blocked [Pathologic Function]
   753   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   753   C0332206:Blocked [Functional Concept]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C1999216:Inhibitor [Qualitative Concept]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "melittin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025234:Melitten [Amino Acid, Peptide, or Protein,Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "(2.5 g/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439267:g% [Quantitative Concept]
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "APPs secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.134: Data are means  S.E. of three experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "of three experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.135: Figure 5: Combined action of PKC and PLA in coupling 5-HT2cR receptor activation to increased APPs secretion. 

Phrase: "Figure 5"

Phrase: ":"

Phrase: "Combined action of PKC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441472:Action [Functional Concept]
   753   C3266814:Action [Activity]

Phrase: "and"

Phrase: "PLA in coupling 5-HT2cR receptor activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
   770   C2261240:phospholipase A [Molecular Function]
   744   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "to increased APPs secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
Processing 00000000.tx.136: A, no inhibition of 5-HT-mediated APPs secretion by the protein kinase inhibitors staurosporine (1 M; Stau) and chelerythrine chloride (1 M; CC). 

Phrase: "A,"

Phrase: "no inhibition of 5-HT-mediated APPs secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C2259158:inhibition of secretion [Cell Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "by the protein kinase inhibitors staurosporine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
   756   C1449702:Protein Kinase Inhibitors [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C2757016:Protein Kinase Inhibitors [Molecular Function]

Phrase: "(1 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "; Stau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "chelerythrine chloride"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0109289:chelerythrine chloride [Organic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "(1 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "; CC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538933:CC [Cell Component]

Phrase: ")."
Processing 00000000.tx.137: Direct activation of PKC by phorbol myristate acetate (PMA) increased APPs secretion. 

Phrase: "Direct activation of PKC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   864   C3546691:protein kinase C activation [Molecular Function]
   820   C1819041:protein kinase activation [Cell Function]
   783   C0599177:protein activation [Genetic Function]
   753   C1879547:Activation [Activity]

Phrase: "by phorbol myristate acetate (PMA) increased APPs secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]
Processing 00000000.tx.138: After down-regulation of PKC by 24-h pretreatment with PMA, the response to PMA was indifferent from the vehicle control condition (CTR). 

Phrase: "After"

Phrase: "down-regulation of PKC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0013081:Down-Regulation [Cell Function,Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "by 24-h pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1550147:Pretreatment [Substance]
   827   C2709094:pre treatment [Temporal Concept]
   827   C3539075:Pretreatment [Temporal Concept]
   827   C3539076:Pretreatment [Activity]

Phrase: "with PMA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   827   C0031588:phorbol [Organic Chemical]
   827   C0070750:Phorbol [Organic Chemical]
   827   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "the response to PMA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C1327571:response to acetate [Cell Function]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "indifferent from the vehicle control condition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332238:Indifferent [Qualitative Concept]

Phrase: "(CTR"

Phrase: ")."
Processing 00000000.tx.139: In contrast, 5-HT stimulated APPs secretion after PMA pretreatment. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "5-HT stimulated APPs secretion after PMA pretreatment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   777   C1325900:5-HT secretion [Cell Function]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]
Processing 00000000.tx.140: B, PLA inhibitors manoalide (ML), dimethyleicosadienoic acid (DEDA), and oleyloxyethyl phosphorylcholine (OPC) failed to block 5-HT-mediated increase in APPs secretion. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "PLA inhibitors manoalide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0065711:manoalide [Organic Chemical,Pharmacologic Substance]

Phrase: "(ML"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0065711:manoalide [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "dimethyleicosadienoic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(DEDA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "oleyloxyethyl phosphorylcholine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031716:Phosphorylcholine [Organic Chemical,Pharmacologic Substance]

Phrase: "(OPC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031716:Phosphorylcholine [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "5-HT-mediated increase in APPs secretion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]
Processing 00000000.tx.141: No alteration of basal APPs secretion by the PLA activator melittin. 

Phrase: "No alteration of basal APPs secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515926:Alteration [Idea or Concept]

Phrase: "by the PLA activator melittin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025234:Melitten [Amino Acid, Peptide, or Protein,Biologically Active Substance,Hazardous or Poisonous Substance]
Processing 00000000.tx.142: No effect of the intracellular calcium releasing agent thapsigargin (TG) on APPs secretion. 

Phrase: "No effect of the intracellular calcium releasing agent thapsigargin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1301751:No effect [Qualitative Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "(TG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ")"

Phrase: "on APPs secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.143: C, inhibition and stimulation of PLA after PKC down-regulation. 

Phrase: "C,"

Phrase: "inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "and"

Phrase: "stimulation of PLA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "after PKC down-regulation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0013081:Down-Regulation [Cell Function,Molecular Function]
   804   C0851285:Regulation [Governmental or Regulatory Activity]
   804   C1327622:Regulation [Biologic Function]
   748   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   748   C2626739:Lanugo [Eukaryote]
   717   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.144: 5-HT-mediated APPs secretion is effectively blocked by all three PLA inhibitors, and melittin retained its ability to increase APPs secretion. 

Phrase: "5-HT-mediated APPs secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   911   C1325900:5-HT secretion [Cell Function]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]

Phrase: "is"

Phrase: "effectively"

Phrase: "blocked by all three PLA inhibitors,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   778   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
   778   C2261240:phospholipase A [Molecular Function]
   757   C0597220:phospholipase inhibitor [Pharmacologic Substance]
   748   C0028778:Blocked [Pathologic Function]
   748   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205449:Three [Quantitative Concept]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0332206:Blocked [Functional Concept]
   748   C2983591:BLOCKED [Research Activity]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C1999216:Inhibitor [Qualitative Concept]
   714 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "melittin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025234:Melitten [Amino Acid, Peptide, or Protein,Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "APPs secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.145: Data are means  S.E. of three experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "of three experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.146: Figure 6: Dexnorfenfluramine increases APPs secretion. 

Phrase: "Figure 6"

Phrase: ":"

Phrase: "Dexnorfenfluramine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2350698:Dexnorfenfluramine [Organic Chemical,Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "APPs secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.147: A, stimulation of 5-HT2aR-coupled PI turnover by increasing concentrations of dexnorfenfluramine (DNF). 

Phrase: "A,"

Phrase: "stimulation of 5-HT2aR-coupled PI turnover"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by increasing concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of dexnorfenfluramine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2350698:Dexnorfenfluramine [Organic Chemical,Pharmacologic Substance]

Phrase: "(DNF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2350698:Dexnorfenfluramine [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.148: IP, radiolabeled inositol phosphates. 

Phrase: "IP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021554:inositol phosphate [Carbohydrate]
   861   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   861   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0031701:phosphate [Organophosphorus Compound]
   861   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "radiolabeled inositol phosphates."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0021554:Inositol Phosphates [Carbohydrate]
   827   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   827   C0031603:Phosphates [Inorganic Chemical,Pharmacologic Substance]
   793 E C0031701:phosphate [Organophosphorus Compound]
   793 E C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.149: B, DNF increased APPs secretion in 3T3 cells expressing 5-HT2aR. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "DNF increased APPs secretion in 3T3 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1327616:Cell secretion [Cell Function]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]

Phrase: "expressing"

Phrase: "5-HT2aR."
Processing 00000000.tx.150: C, DNF-induced stimulation of APPs secretion was blocked by the 5-HT receptor antagonists ketanserin (20 M; KS), mianserin (50 M, MS), and ritanserin (20 M; RS). 

Phrase: "C,"

Phrase: "DNF-induced stimulation of APPs secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C2259155:stimulation of secretion [Cell Function]
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "blocked by the 5-HT receptor antagonists ketanserin"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   744   C0018510:HT [Geographic Area]
   744   C0022616:Ketanserin [Organic Chemical,Pharmacologic Substance]
   744   C0028778:Blocked [Pathologic Function]
   744   C0243076:antagonists [Chemical Viewed Functionally]
   744   C0332206:Blocked [Functional Concept]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C0677607:HT [Disease or Syndrome]
   744   C2983591:BLOCKED [Research Activity]
   711 E C0231491:Antagonist [Organ or Tissue Function]
   711 E C1533157:Block [Substance]
   711 E C1706084:Block [Geographic Area]
   711 E C2828370:Block [Quantitative Concept]

Phrase: "(20 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "; KS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541894:ks [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "mianserin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025912:Mianserin [Organic Chemical,Pharmacologic Substance]

Phrase: "(50 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "MS),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2349943:Ms. [Conceptual Entity]
  1000   C3539704:MS [Gene or Genome]

Phrase: "and"

Phrase: "ritanserin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085260:Ritanserin [Organic Chemical,Pharmacologic Substance]

Phrase: "(20 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "; RS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539879:RS [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.151: Data are means  S.E. from triplicate culture dishes of representative experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from triplicate culture dishes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]
   793   C0020498:DISH [Disease or Syndrome]

Phrase: "of representative experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.152: Increased APPs secretion was detected by the nonselective monoclonal antibody 22C11 (Fig.7), as well as by the antiserum R1736 (Fig.8), an APP-specific antiserum directed against the N-terminal 16 residues of the A domain. 

Phrase: "Increased APPs secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "detected by the nonselective monoclonal antibody 22C11"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0442726:Detected [Finding]
   748   C0746619:monoclonal [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Fig.7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "as well as by the antiserum R1736"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0205170:Well [Qualitative Concept]
   748   C3146287:Well [Manufactured Object]

Phrase: "(Fig.8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "an APP-specific antiserum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "directed against the N-terminal 16 residues of the"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0205088:Terminal [Temporal Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   708   C0439851:Direct [Qualitative Concept]
   708   C1709915:Residue [Conceptual Entity]
   708   C1882936:RESIDUE [Phenomenon or Process]
   708   C1947931:Direct [Qualitative Concept]

Phrase: "A domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.153: This observation, in combination with the finding that the antiserum anti-C8 raised against the C terminus did not detect any protein in the culture medium (data not shown), suggests that secreted APPs was derived by conventional -secretase processing. 

Phrase: "This observation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "the antiserum anti-C8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1305854:C8 [Body Location or Region]

Phrase: "raised against the C terminus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442818:Raised [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "any protein in the culture medium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that secreted APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538722:APP [Laboratory Procedure]

Phrase: "was"

Phrase: "derived by conventional -secretase processing."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439858:Conventional [Qualitative Concept]
   760   C1441547:Derived [Qualitative Concept]
   760   C1709694:Processing [Activity]
   760   C3245521:derived [Idea or Concept]
Processing 00000000.tx.154: The anti-serum D2-1, raised against full-length APLP2 expressed in a baculovirus system (Slunt et al., 1994), detected a secreted APLP2 derivative of the expected molecular mass in the conditioned culture media from cells overexpressing 5-HT2cR (Fig.8). 

Phrase: "The anti-serum D2-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0229671:Serum [Body Substance]
   812   C1414052:D2 [Gene or Genome]
   812   C1415944:D2 [Gene or Genome]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "raised against full-length APLP2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0442818:Raised [Quantitative Concept]
   760   C0443225:Full [Qualitative Concept]
   760   C1412467:APLP2 [Gene or Genome]
   760   C1444754:Length [Quantitative Concept]
   760   C1706316:LENGTH [Research Activity]

Phrase: "expressed in a baculovirus system"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0079005:Baculovirus [Virus]
   760   C0449913:System [Functional Concept]
   760   C0935640:Baculovirus [Virus]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
   704 E C0376406:Granulosis Virus [Virus]

Phrase: "(Slunt et al.,"

Phrase: "1994"

Phrase: ")"

Phrase: ","

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "a secreted APLP2 derivative of the expected molecular mass"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1527240:Derivative [Functional Concept]

Phrase: "in the conditioned culture media"
Meta Candidates (Total=25; Excluded=14; Pruned=0; Remaining=11)
  1000   C0162518:Culture Media, Conditioned [Indicator, Reagent, or Diagnostic Aid]
           Conditioned Media
   901   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   827   C0009458:Media [Intellectual Product]
   827   C0009647:Conditioned [Mental Process]
   827   C0010453:Culture [Idea or Concept]
   827   C0162867:Media [Tissue]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C1254021:Media [Tissue]
   827   C2242979:Culture [Laboratory Procedure]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]
   755 E C0012634:condition [Disease or Syndrome]
   755 E C0040607:Training [Educational Activity]
   755 E C0220931:Training [Educational Activity]
   755 E C0336809:Train [Manufactured Object]
   755 E C0348080:Condition [Qualitative Concept]
   755 E C1552514:Train [Manufactured Object]
   755 E C1705253:Condition [Conceptual Entity]
   755 E C2673163:training [Qualitative Concept]
   727 E C1701901:Conditional [Qualitative Concept]
   727 E C1963686:Conditional [Functional Concept]
   711 E C1519605:Conditionality [Conceptual Entity]

Phrase: "from cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "5-HT2cR"

Phrase: "(Fig.8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.155: Both serotonin and dexnorfenfluramine substantially increased this APLP2s secretion. 

Phrase: "Both serotonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036751:Serotonin [Neuroreactive Substance or Biogenic Amine,Organic Chemical]

Phrase: "and"

Phrase: "dexnorfenfluramine substantially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2350698:Dexnorfenfluramine [Organic Chemical,Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "this APLP2s secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.156: Figure 7: Western blot of secreted APPs with the monoclonal antibody 22C11. 

Phrase: "Figure 7"

Phrase: ":"

Phrase: "Western blot of secreted APPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0949466:Western Blot [Laboratory Procedure]
   760   C1705493:Western [Spatial Concept]

Phrase: "with the monoclonal antibody 22C11."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.157: A, 3T3 cells stably transfected with cDNA encoding 5-HT2aR. 

Phrase: "A,"

Phrase: "3T3 cells stably"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085087:3T3 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "5-HT2aR."
Processing 00000000.tx.158: B, 3T3 cells stably transfected with cDNA encoding 5-HT2cR. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "3T3 cells stably"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085087:3T3 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "5-HT2cR."
Processing 00000000.tx.159: Cell were incubated for 60 min with 10 M serotonin (5-HT), 1 M phorbol myristate acetate (PMA), 1 M staurosporine (Stau), 1 M chelerythrine chloride (Chel). 

Phrase: "Cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 60 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with 10 M serotonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036751:Serotonin [Neuroreactive Substance or Biogenic Amine,Organic Chemical]

Phrase: "(5-HT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036751:5-HT [Neuroreactive Substance or Biogenic Amine,Organic Chemical]
  1000   C0048996:5 ht [Organic Chemical,Pharmacologic Substance]
   861   C0018510:HT [Geographic Area]
   861   C0677607:HT [Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "1 M phorbol myristate acetate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   804   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   804   C0031588:phorbol [Organic Chemical]
   804   C0070750:Phorbol [Organic Chemical]
   804   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "(PMA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   827   C0031588:phorbol [Organic Chemical]
   827   C0070750:Phorbol [Organic Chemical]
   827   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "1 M staurosporine (Stau),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "1 M chelerythrine chloride (Chel)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0109289:chelerythrine chloride [Organic Chemical,Pharmacologic Substance]
   812   C0008203:Chloride, NOS [Inorganic Chemical]
   812   C0596019:Chloride [Element, Ion, or Isotope]
Processing 00000000.tx.160: Lanes 6-8, cells were preincubated with 1 M PMA for 24 h prior to the experiments. 

Phrase: "Lanes 6-8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated with 1 M PMA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   748   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   748   C0031588:phorbol [Organic Chemical]
   748   C0070750:Phorbol [Organic Chemical]
   748   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "prior to the experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.161: Media were analyzed for APPs using the monoclonal antibody 22C11 (lanes 1-5). 

Phrase: "Media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "analyzed for APPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0936012:Analyzed [Research Activity]
   756   C3538722:APP [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the monoclonal antibody 22C11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(lanes 1-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.162: Figure 8: Western blots of secreted APPs and APLP2s with the specific antisera R1736 and D2-1. 

Phrase: "Figure 8"

Phrase: ":"

Phrase: "Western blots of secreted APPs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0949466:Western Blots [Laboratory Procedure]
   773 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "APLP2s with the specific antisera R1736"

Phrase: "and"

Phrase: "D2-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]
Processing 00000000.tx.163: APPs, secreted APPs detected by the APP-specific antiserum R1736 directed against the 16 N-terminal residues of the A domain (absent in APLP2). 

Phrase: "APPs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "secreted APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538722:APP [Laboratory Procedure]

Phrase: "detected by the APP-specific antiserum R1736"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205369:Specific [Qualitative Concept]
   742   C0442726:Detected [Finding]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
   742   C1552740:specific [Intellectual Product]
   742   C1709634:Precursor [Idea or Concept]

Phrase: "directed against the 16 N-terminal residues of the"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0205088:Terminal [Temporal Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   708   C0439851:Direct [Qualitative Concept]
   708   C1709915:Residue [Conceptual Entity]
   708   C1882936:RESIDUE [Phenomenon or Process]
   708   C1947931:Direct [Qualitative Concept]

Phrase: "A domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "(absent in APLP2"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0332197:Absent [Quantitative Concept]
   790   C2699517:ABSENT [Finding]
   718 E C0424530:Absences [Finding]
   718 E C1689985:Absence [Anatomical Abnormality]

Phrase: ")."
Processing 00000000.tx.164: R1736 detects increased signals in 5-HT-treated 3T3 cells (lane 3, 0.01 M 5-HT; 

Phrase: "R1736"

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "increased signals in 5-HT-treated 3T3 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C0037083:cell signals [Cell Function]
   711   C1710082:Signal [Phenomenon or Process]

Phrase: "(lane 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "0.01 M 5-HT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0018510:HT [Geographic Area]
   804   C0677607:HT [Disease or Syndrome]
   708   C0444499:0/5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.165: lane 4, 20 M 5-HT stably transfected with 5-HT2cR as compared with vehicle-treated transfected cells (lane 1). 

Phrase: "lane 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "20 M 5-HT stably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0018510:HT [Geographic Area]
   804   C0677607:HT [Disease or Syndrome]

Phrase: "transfected with 5-HT2cR"

Phrase: "as"

Phrase: "compared with vehicle-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0042444:Vehicle [Biomedical or Dental Material]
   790   C0348005:Vehicle [Manufactured Object]
   790   C1707455:Compared [Activity]
   718 E C0445373:Vehicular [Functional Concept]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.166: APLPs, secreted APLP2s detected by the APLP2-specific antiserum D2-1 raised against baculovirus-expressed full-length APLP2. 

Phrase: "APLPs,"

Phrase: "secreted APLP2s"

Phrase: "detected by the APLP2-specific antiserum D2-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0205369:Specific [Qualitative Concept]
   744   C0442726:Detected [Finding]
   744   C1412467:APLP2 [Gene or Genome]
   744   C1414052:D2 [Gene or Genome]
   744   C1415944:D2 [Gene or Genome]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   744   C1552740:specific [Intellectual Product]

Phrase: "raised against baculovirus-expressed full-length APLP2."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0079005:Baculovirus [Virus]
   748   C0442818:Raised [Quantitative Concept]
   748   C0443225:Full [Qualitative Concept]
   748   C0935640:Baculovirus [Virus]
   748   C1412467:APLP2 [Gene or Genome]
   748   C1444754:Length [Quantitative Concept]
   748   C1706316:LENGTH [Research Activity]
Processing 00000000.tx.167: This antiserum does not cross-react with APPs. 

Phrase: "This antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cross-react with APPs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C2828360:Cross [Conceptual Entity]
   737   C3538722:APP [Laboratory Procedure]
Processing 00000000.tx.168: Compared with the vehicle-treated control condition (lane 5), D2-1 detected increased signals in 5-HT-treated (10 M; lanes 6 and 7) and DNF-treated (1 M; lane 8) 3T3 cells transfected with 5-HT2cR. 

Phrase: "Compared with the vehicle-treated control condition"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   774   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0012634:condition [Disease or Syndrome]
   748   C0042444:Vehicle [Biomedical or Dental Material]
   748   C0243148:control [Qualitative Concept]
   748   C0348005:Vehicle [Manufactured Object]
   748   C0348080:Condition [Qualitative Concept]
   748   C1522326:Treated [Functional Concept]
   748   C1550141:Control [Substance]
   748   C1705253:Condition [Conceptual Entity]
   748   C1707455:Compared [Activity]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "(lane 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "D2-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "increased signals in 5-HT-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1710082:Signal [Phenomenon or Process]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "(10 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "; lanes 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "7"

Phrase: ")"

Phrase: "and"

Phrase: "DNF-treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332293:treated [Therapeutic or Preventive Procedure]
   861   C1522326:Treated [Functional Concept]
   827 E C1292734:TREAT [Functional Concept]

Phrase: "(1 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "; lane 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "3T3 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085087:3T3 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with 5-HT2cR."
Processing 00000000.tx.169: DISCUSSION The results of this study show that the rates at which APPs is secreted by cultured 3T3 cells stably overexpressing 5-HT2aR and 5-HT2cR can be accelerated by serotonin or by the serotoninergic agonist DNF. 

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "The results of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results study [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the rates at which APPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "is"

Phrase: "secreted by cultured 3T3 cells stably"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0085087:3T3 Cells [Cell]
   783   C0007600:cultured cells [Cell]
   783   C0007635:Cultured Cells [Cell]
   783   C3282338:Cells, Cultured [Cell]
   753   C0007634:Cells [Cell]
   753   C1327616:Secreted [Cell Function]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "5-HT2aR"

Phrase: "and"

Phrase: "5-HT2cR"

Phrase: "can"

Phrase: "be"

Phrase: "accelerated by serotonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0036751:Serotonin [Neuroreactive Substance or Biogenic Amine,Organic Chemical]
   790   C0521110:Accelerated [Functional Concept]

Phrase: "or by the serotoninergic agonist DNF."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C2350698:Dexnorfenfluramine [Organic Chemical,Pharmacologic Substance]
   753   C2987634:Agonist [Pharmacologic Substance]
Processing 00000000.tx.170: This finding, coupled with previous observations that stimulating muscarinic acetylcholine receptor subtypes m1 and m3 (Buxbaum et al., 1992; Nitsch et al., 1992; Wolf et al., 1995) or metabotropic glutamate receptors (Lee et al., 1995) can increase APPs secretion, suggests that the regulation of APP processing may be a function of various cell surface receptor types, linked to a number of common second messenger systems. 

Phrase: "This finding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "coupled with previous observations"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0205156:Previous [Temporal Concept]
   770   C0302523:observations [Research Activity]
   770   C0700325:observations [Health Care Activity]
   770   C1552607:previous [Temporal Concept]
   770   C1948027:Coupled [Functional Concept]
   770   C3244290:observations [Functional Concept]
   737 E C0010222:couple [Family Group]
   737 E C1964257:Observation [Diagnostic Procedure]

Phrase: "that"

Phrase: "stimulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulating [Natural Phenomenon or Process]

Phrase: "muscarinic acetylcholine receptor subtypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0449560:subtypes [Classification]
   756   C0034826:Muscarinic Acetylcholine Receptor [Amino Acid, Peptide, or Protein,Receptor]
           Muscarinic Receptor

Phrase: "m1"

Phrase: "and"

Phrase: "m3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1300554:m3 [Quantitative Concept]
  1000   C3484373:M3 [Intellectual Product]

Phrase: "(Buxbaum et al.,"

Phrase: "1992"

Phrase: "; Nitsch et al.,"

Phrase: "1992"

Phrase: "; Wolf et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: "or"

Phrase: "metabotropic glutamate receptors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0206529:Receptors, Metabotropic Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   901   C0061465:Receptors, Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   896   C1178976:Metabotropic receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   827   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Lee et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: "can"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "APPs secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the regulation of APP processing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   835   C2753370:regulation of protein processing [Genetic Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "may"

Phrase: "be"

Phrase: "a function of various cell surface receptor types,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0007613:Cell Function [Cell Function]
   767   C0920644:function receptor [Molecular Function]
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]

Phrase: "linked to a number of common second messenger systems."
Meta Candidates (Total=23; Excluded=0; Pruned=0; Remaining=23)
   790   C0036522:Second Messenger Systems [Molecular Function]
           second messenger
   764   C1508748:second messenger [Biologically Active Substance]
   762   C0205436:second (number) [Quantitative Concept]
           Second
   762   C0870982:number systems [Intellectual Product]
   742   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C0205214:Common [Quantitative Concept]
   742   C0237753:*Number [Quantitative Concept]
   742   C0335218:Messenger [Professional or Occupational Group]
   742   C0449788:Number [Quantitative Concept]
   742   C0457385:Second [Temporal Concept]
   742   C0565930:/second [Quantitative Concept]
   742   C1522138:Common [Functional Concept]
   742   C1561503:second [Idea or Concept]
   742   C1705190:Second [Qualitative Concept]
   742   C3245511:common [Intellectual Product]
   726   C0175668:Secondary to [Temporal Concept]
   708   C0449913:System [Functional Concept]
   708   C1517892:Link [Intellectual Product]
   708   C1553451:System [Manufactured Object]
   708   C1704459:System [Medical Device]
   708   C1704666:Link [Intellectual Product]
Processing 00000000.tx.171: Stimulation of 3T3 cells overexpressing 5-HT2aR or 5-HT2cR caused rapid and dose-dependent increases in phosphatidylinositol breakdown, as indicated by the accumulation of labeled inositol phosphates in the presence of lithium after metabolic labeling of phosphatidylinositol. 

Phrase: "Stimulation of 3T3 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "5-HT2aR"

Phrase: "or"

Phrase: "5-HT2cR"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "dose-dependent increases in phosphatidylinositol breakdown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:increases [Functional Concept]

Phrase: "as"

Phrase: "indicated by the accumulation of labeled inositol phosphates"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0021554:Inositol Phosphates [Carbohydrate]
   744   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   744   C0031603:Phosphates [Inorganic Chemical,Pharmacologic Substance]
   744   C1444656:Indicated [Finding]
   744   C1708632:Labeled [Qualitative Concept]
   711 E C0031701:phosphate [Organophosphorus Compound]
   711 E C0181496:Label [Manufactured Object]
   711 E C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   711 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of lithium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "after metabolic labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "of phosphatidylinositol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
  1000   C2348046:Phosphatidylinositol [Lipid]
Processing 00000000.tx.172: These results confirm that both receptor subtypes are coupled to PI turnover signaling and assure that the stably transfected cell lines express functionally intact surface receptor proteins. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "both receptor subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449560:subtypes [Classification]

Phrase: "are"

Phrase: "coupled to PI turnover signaling"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0031227:turnover [Quantitative Concept]
   760   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   760   C0037083:Signaling [Cell Function]
   760   C0243127:turnover [Functional Concept]
   760   C0443331:Turnover [Health Care Activity]
   760   C1948027:Coupled [Functional Concept]
   760   C2348046:Phosphatidylinositol [Lipid]
   760   C3537152:signaling [Biologic Function]
   726 E C0010222:couple [Family Group]

Phrase: "and"

Phrase: "assure"

Phrase: "that"

Phrase: "the stably transfected cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "express"

Phrase: "functionally intact surface receptor proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0025252:Surface Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0597357:receptor proteins [Amino Acid, Peptide, or Protein,Receptor]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.173: Two additional lines of evidence demonstrated that stimulated APPs secretion was mediated by the activation of serotoninergic cell surface receptors: 5-HT failed to change APPs secretion from the untransfected parent 3T3 fibroblast line, and the increase in APPs secretion from the stably transfected cells was blocked by 5-HT receptor antagonists. 

Phrase: "Two additional lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0205132:lines [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "demonstrated"

Phrase: "that stimulated APPs secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "mediated by the activation of serotoninergic cell surface receptors"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C0034800:Receptors, Cell Surface [Amino Acid, Peptide, or Protein,Receptor]
   781   C0699040:Surface of cell [Cell Component]
           Cell surface
   762   C1326120:cell activation [Cell Function]
   745   C1514758:Receptor Activation [Cell Function]
   745   C1514760:Receptor Cell [Cell]
   742   C0007634:Cell [Cell]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0205148:Surface [Spatial Concept]
   742   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   742   C1269647:Cell [Cell]
   742   C1704653:Cell [Medical Device]
   742   C1879547:Activation [Activity]
   742   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "5-HT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036751:5-HT [Neuroreactive Substance or Biogenic Amine,Organic Chemical]
  1000   C0048996:5 ht [Organic Chemical,Pharmacologic Substance]
   861   C0018510:HT [Geographic Area]
   861   C0677607:HT [Disease or Syndrome]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "APPs secretion from the untransfected parent 3T3 fibroblast line,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "the increase in APPs secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "from the stably transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "blocked by 5-HT receptor antagonists."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   753   C0018510:HT [Geographic Area]
   753   C0028778:Blocked [Pathologic Function]
   753   C0243076:antagonists [Chemical Viewed Functionally]
   753   C0332206:Blocked [Functional Concept]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0677607:HT [Disease or Syndrome]
   753   C2983591:BLOCKED [Research Activity]
   719 E C0231491:Antagonist [Organ or Tissue Function]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.174: In agreement with previous reports (Caporaso et al., 1992; Slack et al., 1993), direct activation of PKC with the phorbol ester PMA increased APPs secretion in the cell lines used in this study. 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "(Caporaso et al.,"

Phrase: "1992"

Phrase: "; Slack et al.,"

Phrase: "1993"

Phrase: ")"

Phrase: ","

Phrase: "direct activation of PKC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   864   C3546691:protein kinase C activation [Molecular Function]
   820   C1819041:protein kinase activation [Cell Function]
   783   C0599177:protein activation [Genetic Function]
   753   C1879547:Activation [Activity]

Phrase: "with the phorbol ester PMA increased APPs secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0036536:secretion [Biologic Function]
   793   C0036537:Secretion [Body Substance]

Phrase: "in the cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "used in this study."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.175: In contrast to our previous observations with 293 cells overexpressing m1 and m3 acetylcholine receptors (Nitsch et al., 1992), however, inhibition of PKC by the kinase inhibitors staurosporine or chelerythrine chloride failed to block 5-HT-mediated increases in APPs secretion from 3T3 fibroblasts. 

Phrase: "In contrast to our previous observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "with 293 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "m1"

Phrase: "and"

Phrase: "m3 acetylcholine receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034792:Receptors, Acetylcholine [Amino Acid, Peptide, or Protein,Receptor]
   896   C0289799:M3 receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Nitsch et al.,"

Phrase: "1992"

Phrase: ")"

Phrase: ","

Phrase: "however,"

Phrase: "inhibition of PKC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "by the kinase inhibitors staurosporine"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
   734   C1152564:Kinase Inhibitors [Molecular Function]
   717 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   717 E C3537023:kinase inhibitor [Molecular Function]
   717 E C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "or"

Phrase: "chelerythrine chloride"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0109289:chelerythrine chloride [Organic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "5-HT-mediated increases in APPs secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:increases [Functional Concept]

Phrase: "from 3T3 fibroblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]
Processing 00000000.tx.176: Moreover, down-regulation of PKC by prior chronic pretreatment with PMA also failed to block the 5-HT-induced increase in APPs secretion (Fig.4A). 

Phrase: "Moreover,"

Phrase: "down-regulation of PKC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0013081:Down-Regulation [Cell Function,Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "by prior chronic pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1550147:Pretreatment [Substance]
   827   C2709094:pre treatment [Temporal Concept]
   827   C3539075:Pretreatment [Temporal Concept]
   827   C3539076:Pretreatment [Activity]

Phrase: "with PMA also"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   812   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   812   C0031588:phorbol [Organic Chemical]
   812   C0070750:Phorbol [Organic Chemical]
   812   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the 5-HT-induced increase in APPs secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "(Fig.4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.177: These data imply that activation of PKC can be sufficient to increase APPs secretion, but that this activation is not necessary for the 5-HT2R-mediated increase. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "imply"

Phrase: "that activation of PKC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   864   C3546691:protein kinase C activation [Molecular Function]
   820   C1819041:protein kinase activation [Cell Function]
   783   C0599177:protein activation [Genetic Function]
   753   C1879547:Activation [Activity]

Phrase: "can"

Phrase: "be"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "APPs secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "but"

Phrase: "that"

Phrase: "this activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "not necessary for the 5-HT2R-mediated increase."
Processing 00000000.tx.178: The concentrations of 5-HT necessary to elicit maximal acceleration of PI breakdown, as well as the EC of this effect, were 1 to 2 orders of magnitude lower than these for stimulated APPs secretion. 

Phrase: "The concentrations of 5-HT necessary to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0086045:Concentrations [Mental Process]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "maximal acceleration of PI breakdown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0000894:Acceleration [Phenomenon or Process]

Phrase: "as well as"

Phrase: "the EC of this effect,"

Phrase: "were"

Phrase: "1 to 2 orders of magnitude"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   783   C0580272:1/2 [Intellectual Product]
   783   C1519043:1-2 [Research Activity]
   753   C0449286:magnitude [Quantitative Concept]
   753   C1704240:Magnitude [Quantitative Concept]
   753   C2827734:1+ [Quantitative Concept]
   753   C2981698:1+ [Classification]
   753   C3244315:orders [Intellectual Product]
   719 E C1705175:Order [Intellectual Product]
   719 E C1705176:Order [Qualitative Concept]
   719 E C1705177:Order [Classification]
   719 E C1705178:Order [Activity]
   719 E C1882348:Order [Qualitative Concept]

Phrase: "lower than these"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "for stimulated APPs secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
Processing 00000000.tx.179: This is compatible with the possibility that APP processing is also coupled to other cellular signaling pathways besides PI turnover and PKC activation. 

Phrase: "This"

Phrase: "is"

Phrase: "compatible with the possibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:compatible [Idea or Concept]
   770   C1524057:Compatible [Qualitative Concept]

Phrase: "that APP processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "also"

Phrase: "coupled to other cellular signaling pathways"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   783   C0037080:pathways signaling [Molecular Function]
   773 E C0037083:signaling pathway [Cell Function]
           Signaling
   773 E C0086982:Signaling Pathway [Molecular Function]
   753   C0007634:Cellular [Cell]
   753   C0178539:Cellular [Functional Concept]
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]
   753   C1948027:Coupled [Functional Concept]
   753   C3537152:signaling [Biologic Function]
   719 E C0010222:couple [Family Group]
   719 E C1710082:Signal [Phenomenon or Process]

Phrase: "besides PI turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0031227:turnover [Quantitative Concept]
   861   C0243127:turnover [Functional Concept]
   861   C0443331:Turnover [Health Care Activity]

Phrase: "and"

Phrase: "PKC activation."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C3546691:protein kinase C activation [Molecular Function]
   923   C1819041:protein kinase activation [Cell Function]
   902   C0599177:protein activation [Genetic Function]
   812   C1879547:Activation [Activity]
   756   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   708   C1168438:Protein C [Laboratory Procedure]
   708   C1418943:PROTEIN C [Gene or Genome]
   708   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.180: To test whether PLA is involved in 5-HT-mediated APPs secretion, we examined the ability of drugs that inhibit this enzyme, and we also used melittin, a PLA-activating peptide. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "PLA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2261240:phospholipase A [Molecular Function]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "involved in 5-HT-mediated APPs secretion,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0018510:HT [Geographic Area]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0677607:HT [Disease or Syndrome]
   748   C1314939:Involved [Functional Concept]
   714   C3538722:APP [Laboratory Procedure]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the ability of drugs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "that"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "this enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "we also used melittin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025234:Melitten [Amino Acid, Peptide, or Protein,Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "a PLA-activating peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.181: Stimulation of 5-HT2aR-expressing cells with 5-HT in the presence of the PLA inhibitors manoalide, dimethyleicosadienoic acid, or oleyloxyethyl phosphorylcholine failed to affect basal APPs secretion, but all three drugs inhibited 5-HT-induced secretion. 

Phrase: "Stimulation of 5-HT2aR-expressing cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with 5-HT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036751:5-HT [Neuroreactive Substance or Biogenic Amine,Organic Chemical]
  1000   C0048996:5 ht [Organic Chemical,Pharmacologic Substance]
   861   C0018510:HT [Geographic Area]
   861   C0677607:HT [Disease or Syndrome]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the PLA inhibitors manoalide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0065711:manoalide [Organic Chemical,Pharmacologic Substance]

Phrase: "dimethyleicosadienoic acid,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "oleyloxyethyl phosphorylcholine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031716:Phosphorylcholine [Organic Chemical,Pharmacologic Substance]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "basal APPs secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]

Phrase: "but"

Phrase: "all three drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0013227:Drugs [Pharmacologic Substance]
   827 E C1254351:Drug [Pharmacologic Substance]
   789 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   789 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   761 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "5-HT-induced secretion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1325900:5-HT secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
Processing 00000000.tx.182: These results demonstrate that 5-HT2aR activation can accelerate APPs secretion by coupling to PLA. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that 5-HT2aR activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "can"

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "APPs secretion by coupling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "to PLA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2261240:phospholipase A [Molecular Function]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.183: A role of PLA in the regulation of APPs processing was also suggested by the finding that melittin accelerated APPs secretion. 

Phrase: "A role of PLA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "processing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]
   966 E C1522240:Process [Phenomenon or Process]

Phrase: "was"

Phrase: "also"

Phrase: "suggested by the finding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0037088:Finding [Sign or Symptom]
   770   C0243095:Finding [Finding]
   770   C2825141:Finding [Finding]
   737   C1705535:Suggest [Idea or Concept]

Phrase: "that melittin accelerated APPs secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
Processing 00000000.tx.184: Moreover, this effect was not blocked by down-regulation of PKC by chronic exposure to PMA, and manoalide, dimethyleicosadienoic acid, or oleyloxyethyl phosphorylcholine blocked 5-HT-induced increases in APPs secretion after down-regulation of PKC. 

Phrase: "Moreover,"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "blocked by down-regulation of PKC"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   800   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   793 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0013081:Down-Regulation [Cell Function,Molecular Function]
   770   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C1168438:Protein C [Laboratory Procedure]
   767   C1418943:PROTEIN C [Gene or Genome]
   767   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0028778:Blocked [Pathologic Function]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0332206:Blocked [Functional Concept]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
   744   C2983591:BLOCKED [Research Activity]
   711 E C1533157:Block [Substance]
   711 E C1706084:Block [Geographic Area]
   711 E C2828370:Block [Quantitative Concept]

Phrase: "by chronic exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205191:chronic [Temporal Concept]
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "to PMA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   827   C0031588:phorbol [Organic Chemical]
   827   C0070750:Phorbol [Organic Chemical]
   827   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "and"

Phrase: "manoalide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0065711:manoalide [Organic Chemical,Pharmacologic Substance]

Phrase: "dimethyleicosadienoic acid,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "oleyloxyethyl phosphorylcholine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031716:Phosphorylcholine [Organic Chemical,Pharmacologic Substance]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "5-HT-induced increases in APPs secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:increases [Functional Concept]

Phrase: "after"

Phrase: "down-regulation of PKC."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0013081:Down-Regulation [Cell Function,Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.185: Hence, 5-HT2aR-coupled and PLA-mediated acceleration of APPs secretion can occur independently of PKC. 

Phrase: "Hence,"

Phrase: "5-HT2aR-coupled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1948027:Coupled [Functional Concept]
   793 E C0010222:couple [Family Group]

Phrase: "and"

Phrase: "PLA-mediated acceleration of APPs secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0000894:Acceleration [Phenomenon or Process]

Phrase: "can"

Phrase: "occur independently of PKC."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   820 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   783   C1168438:Protein C [Laboratory Procedure]
   783   C1418943:PROTEIN C [Gene or Genome]
   783   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.186: These data are consistent with the previous observation that PLA can partially mediate the increase in APPs secretion induced by muscarinic stimulation (Emmerling et al., 1993). 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with the previous observation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that PLA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2261240:phospholipase A [Molecular Function]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "can"

Phrase: "partially"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the increase in APPs secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "induced by muscarinic stimulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0026815:muscarinic [Pharmacologic Substance]
   770   C0205263:Induced [Functional Concept]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "(Emmerling et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.187: Cellular signaling mechanisms that couple 5-HT2cR to APP processing were more complex than in the cells overexpressing 5-HT2aR. 

Phrase: "Cellular signaling mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "couple"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010222:couple [Family Group]
  1000   C1948027:Couple [Functional Concept]

Phrase: "5-HT2cR to APP processing"

Phrase: "were"

Phrase: "more complex than"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439855:Complex [Qualitative Concept]
   790   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "in the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "5-HT2aR."
Processing 00000000.tx.188: As with 5-HT2aR activation, cells expressing 5-HT2cR responded with increased APPs secretion to 5-HT after down-regulation of PKC, and the kinase inhibitors staurosporine and chelerythrine chloride failed to inhibit this increase. 

Phrase: "As with 5-HT2aR activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "5-HT2cR"

Phrase: "responded with increased APPs secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726   C3538722:APP [Laboratory Procedure]

Phrase: "to 5-HT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036751:5-HT [Neuroreactive Substance or Biogenic Amine,Organic Chemical]
  1000   C0048996:5 ht [Organic Chemical,Pharmacologic Substance]
   861   C0018510:HT [Geographic Area]
   861   C0677607:HT [Disease or Syndrome]

Phrase: "after"

Phrase: "down-regulation of PKC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0013081:Down-Regulation [Cell Function,Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "the kinase inhibitors staurosporine"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
   734   C1152564:Kinase Inhibitors [Molecular Function]
   717 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   717 E C3537023:kinase inhibitor [Molecular Function]
   717 E C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "chelerythrine chloride"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0109289:chelerythrine chloride [Organic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "this increase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
Processing 00000000.tx.189: In contrast to the findings in 5-HT2aR cells, however, the PLA inhibitors failed to block consistently the 5-HT-mediated increase in APPs secretion in 5-HT2cR cells. 

Phrase: "In contrast to the findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "in 5-HT2aR cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "however,"

Phrase: "the PLA inhibitors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   896   C0597220:phospholipase inhibitor [Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C1999216:Inhibitor [Qualitative Concept]
   734   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
   734   C2261240:phospholipase A [Molecular Function]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "consistently"

Phrase: "the 5-HT-mediated increase in APPs secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "in 5-HT2cR cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.190: The combination of PKC down-regulation and PLA inhibition did effectively inhibit the ability of 5-HT to stimulate APPs secretion. 

Phrase: "The combination of PKC down-regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205195:Combination [Qualitative Concept]
   744   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "PLA inhibition"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]
   734   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
   734   C2261240:phospholipase A [Molecular Function]

Phrase: "did"

Phrase: "effectively"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the ability of 5-HT to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "stimulate"

Phrase: "APPs secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.191: It is therefore possible that the coupling of 5-HT2cR to APPs secretion requires both PKC and PLA activities. 

Phrase: "It"

Phrase: "is"

Phrase: "therefore possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the coupling of 5-HT2cR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1948027:Coupling [Functional Concept]

Phrase: "to APPs secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "requires"

Phrase: "both PKC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "PLA activities."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C2261240:phospholipase A activity [Molecular Function]
           phospholipase A
   896   C1149838:phospholipase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
   734   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.192: Treatment of the 5-HT2R-expressing cells with thapsigargin, which discharges Ca from internal stores by inhibiting the Ca-ATPase of the endoplasmic reticulum membrane failed to affect APPs secretion in the 3T3 cells used. 

Phrase: "Treatment of the 5-HT2R-expressing cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "with thapsigargin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "which"

Phrase: "discharges"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0012621:Discharge [Body Substance]
  1000   C0030685:Discharge [Health Care Activity]
  1000   C2926602:Discharge [Body Substance]

Phrase: "Ca from internal stores"

Phrase: "by inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "the Ca-ATPase of the endoplasmic reticulum membrane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "APPs secretion in the 3T3 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1327616:Cell secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.193: Perhaps the previously reported effects of Ca on APPs secretion (Buxbaum et al., 1994) are cell type-specific. 

Phrase: "Perhaps"

Phrase: "the previously reported effects of Ca"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on APPs secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "(Buxbaum et al.,"

Phrase: "1994"

Phrase: ")"

Phrase: "are"

Phrase: "cell type-specific."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0007634:Cell Type [Cell]
           Cell
   901   C0449475:cell type [Intellectual Product]
   827   C0205369:Specific [Qualitative Concept]
   827   C0332307:Type [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1547052:*Type [Quantitative Concept]
   827   C1552740:specific [Intellectual Product]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.194: APP is a member of the multigene family of APP-like proteins (APLP). 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "a member of the multigene family of APP-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0086282:Family member [Family Group]
   757   C1611821:Family Member [Intellectual Product]
   739   C0680022:member [Population Group]
   739   C2698041:Member [Professional or Occupational Group]

Phrase: "like proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(APLP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412466:APLP [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.195: APLP2 is homologous to APP in the extreme C-terminal region, and has various homologous regions in the ectodomain (Slunt et al., 1994; von der Kammer et al., 1994; Wasco et al., 1992, 1993). 

Phrase: "APLP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412467:APLP2 [Gene or Genome]

Phrase: "is"

Phrase: "homologous to APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1512488:Homologous Protein [Amino Acid, Peptide, or Protein]
   760   C1334043:Homologous [Gene or Genome]

Phrase: "in the extreme C-terminal region,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C1707271:C-Terminal [Amino Acid Sequence]
   812   C0017446:Region [Geographic Area]
   812   C0205088:Terminal [Temporal Concept]
   812   C0205147:Region [Spatial Concept]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "has"

Phrase: "various homologous regions in the ectodomain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1334043:Homologous [Gene or Genome]
   719   C0017446:Region [Geographic Area]
   719   C0205147:Region [Spatial Concept]

Phrase: "(Slunt et al.,"

Phrase: "1994"

Phrase: "; von der Kammer et al.,"

Phrase: "1994"

Phrase: "; Wasco et al.,"

Phrase: "1992,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.196: However the A domain is not preserved; 

Phrase: "However"

Phrase: "the A domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "preserved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033085:Preserved [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.197: thus no amyloidogenic derivatives can be generated from APLP2. 

Phrase: "thus"

Phrase: "no amyloidogenic derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "generated from APLP2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1412467:APLP2 [Gene or Genome]
   790   C3146294:Generated [Activity]
Processing 00000000.tx.198: Because of its similarities to APP, APLP2 is detected by nonselective antibodies (Slunt et al., 1994), including the monoclonal antibody 22C11 that was raised initially against an APP fusion protein (Weidemann et al., 1989). 

Phrase: "Because of its similarities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348205:Similarity [Qualitative Concept]

Phrase: "to APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "APLP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412467:APLP2 [Gene or Genome]

Phrase: "is"

Phrase: "detected by nonselective antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Slunt et al.,"

Phrase: "1994"

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the monoclonal antibody 22C11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "that"

Phrase: "was"

Phrase: "raised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442818:Raised [Quantitative Concept]

Phrase: "initially against an APP fusion protein"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205265:Initially [Temporal Concept]
   744   C0332466:Fusion [Functional Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1293131:Fusion [Therapeutic or Preventive Procedure]
   744   C1709634:Precursor [Idea or Concept]

Phrase: "(Weidemann et al.,"

Phrase: "1989"

Phrase: ")."
Processing 00000000.tx.199: To differentiate between APPs and APLPs, we used the antiserum R1736 (Haass et al., 1992) directed against the 16 N-terminal residues of the A domain. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "differentiate between APPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205615:differentiate [Qualitative Concept]
   756   C3538722:APP [Laboratory Procedure]

Phrase: "and"

Phrase: "APLPs,"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the antiserum R1736"

Phrase: "(Haass et al.,"

Phrase: "1992"

Phrase: ")"

Phrase: "directed against the 16 N-terminal residues of the"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0205088:Terminal [Temporal Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   708   C0439851:Direct [Qualitative Concept]
   708   C1709915:Residue [Conceptual Entity]
   708   C1882936:RESIDUE [Phenomenon or Process]
   708   C1947931:Direct [Qualitative Concept]

Phrase: "A domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.200: R1736 detected the same receptor-mediated increase in secreted APPs as 22C11 (Fig.8). 

Phrase: "R1736"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "the same receptor-mediated increase in secreted APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "as 22C11"

Phrase: "(Fig.8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.201: The APLP2-specific antiserum D2-1 (Slunt et al., 1994) detected secreted APLP2 derivatives (APLP2s) with the expected molecular masses in the cell culture supernatants obtained from 3T3 cells overexpressing 5-HT2aR or 5-HT2cR. 

Phrase: "The APLP2-specific antiserum D2-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0205369:Specific [Qualitative Concept]
   804   C1412467:APLP2 [Gene or Genome]
   804   C1414052:D2 [Gene or Genome]
   804   C1415944:D2 [Gene or Genome]
   804   C1552740:specific [Intellectual Product]

Phrase: "(Slunt et al.,"

Phrase: "1994"

Phrase: ")"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "secreted APLP2 derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243072:derivatives [Chemical Viewed Structurally]
   793 E C1527240:Derivative [Functional Concept]

Phrase: "(APLP2s"

Phrase: ")"

Phrase: "with the expected molecular masses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   793   C0577559:Mass [Finding]
   793   C1306372:*Mass [Quantitative Concept]

Phrase: "in the cell culture supernatants"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0007585:Cell Culture [Laboratory Procedure]
   827   C0007634:Cell [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
   793   C1550101:Supernatant [Body Substance]

Phrase: "obtained from 3T3 cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0085087:3T3 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C1301820:Obtained [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1706701:Obtain [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "5-HT2aR"

Phrase: "or"

Phrase: "5-HT2cR."
Processing 00000000.tx.202: Stimulation of these cell lines with 5-HT substantially increased APLP2 s secretion (Fig.8). 

Phrase: "Stimulation of these cell lines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with 5-HT substantially increased APLP2 s secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   900   C1325900:5-HT secretion [Cell Function]
   795   C0036536:secretion [Biologic Function]
   795   C0036537:Secretion [Body Substance]

Phrase: "(Fig.8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.203: These data suggest that APP and APLP2 are processed by similar receptor-regulated proteolytic pathways, and they imply the possibility that APLP2 may compete with APP for enzymes involved in signal transduction and proteolytic processing. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "APLP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412467:APLP2 [Gene or Genome]

Phrase: "are"

Phrase: "processed by similar receptor-regulated proteolytic pathways,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0597304:Proteolytic [Molecular Function]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0851285:Regulated [Governmental or Regulatory Activity]
   748   C1522240:Processed [Phenomenon or Process]
   748   C1704259:Pathways [Molecular Function]
   748   C1705987:Pathways [Conceptual Entity]
   748   C1947941:proteolytic [Enzyme]
   748   C2348205:Similar [Qualitative Concept]
   714 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "they"

Phrase: "imply"

Phrase: "the possibility"

Phrase: "that APLP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412467:APLP2 [Gene or Genome]

Phrase: "may"

Phrase: "compete with APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "for enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "involved in signal transduction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0037083:Signal Transduction [Cell Function]
   770   C1160185:transduction [Organism Function]
   770   C1314939:Involved [Functional Concept]
   770   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "proteolytic processing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514570:Proteolytic Processing [Molecular Function]
   861   C1709694:Processing [Activity]
Processing 00000000.tx.204: Levels of APLP2 may thus influence the metabolism of APP. 

Phrase: "Levels of APLP2"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "thus"

Phrase: "influence"

Phrase: "the metabolism of APP."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   864   C1327340:amyloid precursor protein metabolism [Molecular Function]
   783   C0597299:Protein Metabolism [Molecular Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.205: The cellular mechanism of receptor-regulated APPs and APLP2s secretion is unclear. 

Phrase: "The cellular mechanism of receptor-regulated APPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "APLP2s secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.206: As in previously reported experiments, 5-HT2R-mediated increases in APPs secretion occurred in the absence protein synthesis confirming that pre-existing protein is processed in response to receptor activation. 

Phrase: "As in previously reported experiments,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0681814:Experiments [Research Activity]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C3273238:Report [Intellectual Product]

Phrase: "5-HT2R-mediated increases in APPs secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:increases [Functional Concept]

Phrase: "occurred in the absence protein synthesis"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0597295:Protein Synthesis [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0220781:synthesis [Biologic Function]
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]
   753   C1709305:Occurred [Activity]
   753   C1883254:Synthesis [Activity]
   748 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   719 E C2745955:OCCUR [Temporal Concept]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that pre-existing protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C2347662:Pre-existing [Qualitative Concept]

Phrase: "is"

Phrase: "processed in response"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   841   C0871261:Response process [Organism Attribute]
           Response
   790   C1522240:Processed [Phenomenon or Process]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]
   756 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "to receptor activation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514758:Receptor Activation [Cell Function]
   861   C1879547:Activation [Activity]
Processing 00000000.tx.207: It is possible that secretory vesicle formation, trafficking, or proteolytic cleavage events are accelerated by surface receptor-coupled signaling. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that secretory vesicle formation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1749557:vesicle formation [Cell Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0886515:Secretory Vesicle [Cell Component]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: ","

Phrase: "or"

Phrase: "proteolytic cleavage events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]

Phrase: "are"

Phrase: "accelerated by surface receptor-coupled signaling."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   783   C1514762:Receptor Signaling [Molecular Function]
   753   C0037083:Signaling [Cell Function]
   753   C0205148:Surface [Spatial Concept]
   753   C0521110:Accelerated [Functional Concept]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1948027:Coupled [Functional Concept]
   753   C3537152:signaling [Biologic Function]
   719 E C0010222:couple [Family Group]
Processing 00000000.tx.208: The first possibility is underscored by the recent finding that PKC stimulates vesicle budding from the trans-Golgi network and thus accelerates the formation of APP-containing secretory vesicles in a reconstituted cell-free system (Xu et al., 1995). 

Phrase: "The first possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "underscored by the recent finding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0037088:Finding [Sign or Symptom]
   760   C0243095:Finding [Finding]
   760   C0332185:Recent [Temporal Concept]
   760   C2825141:Finding [Finding]

Phrase: "that PKC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "stimulates"

Phrase: "vesicle budding from the trans-Golgi network"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C1326396:Golgi vesicle budding [Cell Function]
   778   C1326485:vesicle budding [Cell Function]
   748   C1155616:budding [Cell Function]
   714 E C2700462:Bud [Plant]
   714 E C2945744:bud [Anatomical Structure]

Phrase: "and"

Phrase: "thus"

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "the formation of APP-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   864   C1327111:amyloid precursor protein formation [Molecular Function]
   783   C0597295:protein formation [Molecular Function]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "secretory vesicles in a reconstituted cell-free system"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0886515:Secretory Vesicles [Cell Component]
   767   C1519221:Secretory cell [Cell]
   750   C1456849:cell vesicle [Cell Component]
   744   C0333262:VESICLES [Acquired Abnormality]
   744   C1327616:Secretory [Cell Function]
   711 E C1622418:vesicle [Cell Component]

Phrase: "(Xu et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.209: The physiological relevance of regulated APPs secretion is unclear. 

Phrase: "The physiological relevance of regulated APPs secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347946:Relevance [Qualitative Concept]

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.210: We speculate that having APP processing under neurotransmitter control may allow neuronal activity to control the formation of a secretory derivative (Farber et al., 1995; Nitsch et al., 1993) with possible paracrine neurotrophic and neuroprotective activities. 

Phrase: "We"

Phrase: "speculate"

Phrase: "that"

Phrase: "having"

Phrase: "APP processing under neurotransmitter control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0033666:protein processing [Molecular Function]
   748   C1709694:Processing [Activity]

Phrase: "may"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "neuronal activity to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the formation of a secretory derivative"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "(Farber et al.,"

Phrase: "1995"

Phrase: "; Nitsch et al.,"

Phrase: "1993"

Phrase: ")"

Phrase: "with possible paracrine neurotrophic"

Phrase: "and"

Phrase: "neuroprotective activities."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.211: Regulated cleavage of a membrane precursor followed by secretion of the ectodomain has been described for a variety of transmembrane proteins, including transforming growth factor- (Bosenberg et al., 1992; Pandiella et al., 1991), and the tumor necrosis factor receptor (Brakebusch et al., 1992), and it was proposed that regulated secretion is involved in switching transforming growth factor-'s activity from that of a juxtacrine to a paracrine growth factor (Pandiella and Massague, 1991). 

Phrase: "Regulated cleavage of a membrane precursor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "followed by secretion of the ectodomain"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "described for a variety of transmembrane proteins,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1167322:transmembrane [Cell Component]
   748   C1552738:described [Idea or Concept]
   748   C1883525:Variety [Conceptual Entity]
   748   C2346866:Variety [Conceptual Entity]
   748   C2752508:transmembrane [Cell Component]
   745   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "transforming growth factor-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "(Bosenberg et al.,"

Phrase: "1992"

Phrase: "; Pandiella et al.,"

Phrase: "1991"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the tumor necrosis factor receptor"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0077503:Tumor Necrosis Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   923   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C1323304:tumor necrosis factor [Molecular Function]
   923   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0333516:Tumor necrosis [Neoplastic Process]
   812   C0027540:Necrosis [Organ or Tissue Function]
   812   C0027651:Tumor [Neoplastic Process]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1334928:Necrosis [Finding]
   812   C1521761:Factor [Functional Concept]
   812   C1578706:Tumor [Intellectual Product]
   812   C2827422:Factor [Conceptual Entity]
   812   C3273930:Tumor [Finding]

Phrase: "(Brakebusch et al.,"

Phrase: "1992"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "was"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that regulated secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "is"

Phrase: "involved in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1314939:Involved [Functional Concept]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "transforming growth factor-'s activity from that of a juxtacrine"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   777   C1149472:growth factor activity [Molecular Function]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "to a paracrine growth factor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "(Pandiella"

Phrase: "and"

Phrase: "Massague,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.212: Growth factor-like activities of APPs have been observed in several cell culture models. 

Phrase: "Growth factor-like activities of APPs"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C1149472:growth factor activity [Molecular Function]
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "observed in several cell culture models."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0007585:Cell Culture [Laboratory Procedure]
   753   C0007634:Cell [Cell]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C1269647:Cell [Cell]
   753   C1441672:Observed [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2242979:Culture [Laboratory Procedure]
   753   C3161035:Models [Intellectual Product]
Processing 00000000.tx.213: In particular, a neurotrophin-like stimulation of neurite outgrowth and branching was observed in PC-12 cells (Milward et al., 1992). 

Phrase: "In particular,"

Phrase: "a neurotrophin-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0132298:Neurotrophin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1323315:neurotrophin [Molecular Function]
  1000   C1332408:neurotrophin [Gene or Genome]

Phrase: "like stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "of neurite outgrowth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3158384:neurite outgrowth [Cell Function]
   861   C0085103:Neurite [Cell Component]

Phrase: "and"

Phrase: "branching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205384:Branching [Spatial Concept]

Phrase: "was"

Phrase: "observed in PC-12 cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0085262:PC-12 [Cell]
   806   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   760   C0007634:Cells [Cell]
   760   C1441672:Observed [Functional Concept]
   760   C3282337:Cells [Cell]
   760   C3540812:PC [Gene or Genome]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Milward et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.214: Conversely, antisense constructs directed against APP transcripts inhibit neurite outgrowth in primary neurons (Allinquant et al., 1995). 

Phrase: "Conversely,"

Phrase: "antisense constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "directed against APP transcripts"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1709634:Precursor [Idea or Concept]
   719   C0439851:Direct [Qualitative Concept]
   719   C1947931:Direct [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "neurite outgrowth in primary neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C3158384:neurite outgrowth [Cell Function]
   797   C2753926:primary neurite [Cell Component]
   760   C0085103:Neurite [Cell Component]

Phrase: "(Allinquant et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.215: A biologically active domain that may promote trophic activities of APP in vivo was mapped to the N terminus of APPs (Roch et al., 1994). 

Phrase: "A biologically active domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "that"

Phrase: "may"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "trophic activities of APP"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   803   C1325278:amyloid protein activity [Molecular Function]
   767   C1537044:protein activity [Molecular Function]
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "was"

Phrase: "mapped to the N terminus of APPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0024779:Map [Manufactured Object]
   714   C1706473:Map [Conceptual Entity]
   714   C3538722:APP [Laboratory Procedure]

Phrase: "(Roch et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.216: APPs also protects primary neurons from glutamate-induced excitotoxic damage (Mattson et al., 1993), presumably by suppressing potentially toxic increases in intracellular calcium (Barger et al., 1995). 

Phrase: "APPs also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538722:APP [Laboratory Procedure]

Phrase: "protects"

Phrase: "primary neurons from glutamate-induced excitotoxic damage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0027882:Neurons [Cell]

Phrase: "(Mattson et al.,"

Phrase: "1993"

Phrase: ")"

Phrase: ","

Phrase: "presumably by suppressing potentially toxic increases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0442805:increases [Functional Concept]
   753   C0600688:toxic [Injury or Poisoning]
   753   C1260953:suppressing [Functional Concept]
   753   C1407029:Toxic [Qualitative Concept]
   753   C2003921:Suppressing [Phenomenon or Process]

Phrase: "in intracellular calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0006726:Calcium [Inorganic Chemical]
   861   C2936886:Calcium [Pharmacologic Substance]

Phrase: "(Barger et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.217: Thus, it is possible that secreted APPs has trophic functions in brain that are unrelated to APP's role as an amyloid precursor. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that secreted APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538722:APP [Laboratory Procedure]

Phrase: "has"

Phrase: "trophic functions in brain"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   819   C0678908:brain functions [Organ or Tissue Function]
   788   C1442959:Nutrition function [Organism Function]
   770   C0542341:Functions [Functional Concept]
   737 E C0031843:function [Physiologic Function]
   737 E C0700205:FUNCTION [Classification]
   737 E C1705273:Function [Intellectual Product]

Phrase: "that"

Phrase: "are"

Phrase: "unrelated to APP's role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0445356:Unrelated [Finding]
   770   C1704623:Unrelated [Qualitative Concept]

Phrase: "as an amyloid precursor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.218: Regulated APPs secretion can be mediated by cholinergic (Buxbaum et al., 1992; Nitsch et al., 1992; Wolf et al., 1995) and glutamatergic (Lee et al., 1995) agonists, and electrical activity of brain cells activated APPs secretion from freshly prepared tissue slices. 

Phrase: "Regulated APPs secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]

Phrase: "can"

Phrase: "be"

Phrase: "mediated by cholinergic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C0599668:cholinergic [Functional Concept]

Phrase: "(Buxbaum et al.,"

Phrase: "1992"

Phrase: "; Nitsch et al.,"

Phrase: "1992"

Phrase: "; Wolf et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: "and"

Phrase: "glutamatergic"

Phrase: "(Lee et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: "agonists,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243192:agonists [Pharmacologic Substance]
  1000   C2987634:agonists [Pharmacologic Substance]

Phrase: "and"

Phrase: "electrical activity of brain cells"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   926   C0234388:Electrical activity of brain [Organ or Tissue Function]
           brain electrical activity
           Electrical activity, NOS
   797   C0443158:Brain activity [Physiologic Function]
   760   C0013790:Electrical [Natural Phenomenon or Process]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0442828:Electrical [Functional Concept]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "APPs secretion from freshly prepared tissue slices."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C2246301:tissue secretion [Physiologic Function]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
Processing 00000000.tx.219: Hence, receptor-coupled APP processing may normally occur throughout the brain at muscarinic, glutamatergic, and, now, serotoninergic synapses. 

Phrase: "Hence,"

Phrase: "receptor-coupled APP processing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033666:protein processing [Molecular Function]
   799   C1709694:Processing [Activity]
   709   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "may"

Phrase: "normally"

Phrase: "occur throughout the brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "at muscarinic, glutamatergic,"

Phrase: "and"

Phrase: ","

Phrase: "now,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "serotoninergic synapses."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0039062:Synapses [Body Space or Junction]
   827 E C0598501:Synapsis [Cell Function]
   827 E C1633000:Synapsis [Plant]
Processing 00000000.tx.220: In most (Buxbaum et al., 1993; Gabuzda et al., 1993; Hung et al., 1993; Wolf et al., 1995), but not all (Dyrks et al., 1994) cell types, receptor-mediated activation of APPs secretion is associated with decreased generation of A. 

Phrase: "In most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "(Buxbaum et al.,"

Phrase: "1993"

Phrase: "; Gabuzda et al.,"

Phrase: "1993"

Phrase: "; Hung et al.,"

Phrase: "1993"

Phrase: "; Wolf et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all (Dyrks et al.,"

Phrase: "1994"

Phrase: ")"

Phrase: "cell types,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "receptor-mediated activation of APPs secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C2259154:activation of secretion [Cell Function]
   783   C1514758:Receptor Activation [Cell Function]
   753   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "associated with decreased generation of A."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0079411:Generation [Temporal Concept]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C3146294:Generation [Activity]
   719 E C0547047:Decrease [Quantitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.221: We were unable to measure A secreted from the 3T3 fibroblasts within the short time intervals used for receptor stimulation in this study. 

Phrase: "We"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "A"

Phrase: "secreted from the 3T3 fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0016030:Fibroblasts [Cell]
   760   C1327616:Secreted [Cell Function]

Phrase: "within the short time intervals"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   867   C0872291:Time Interval [Temporal Concept]
   827   C1272706:intervals [Temporal Concept]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]

Phrase: "used for receptor stimulation"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C1273517:used [Finding]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "in this study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.222: Because cultured fibroblasts secrete very little amounts of A, time periods of more than 24 h are necessary to detect measurable levels with current immunoadsorbent assays. 

Phrase: "Because"

Phrase: "cultured fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "very little amounts of A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "time periods of more"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0439582:Time periods [Temporal Concept]
   805 E C0585019:Temporal periods [Temporal Concept]
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   737   C0439531:/period [Temporal Concept]
   737   C1948053:Period [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "than 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "are"

Phrase: "necessary to"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "measurable levels with current immunoadsorbent assays."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.223: Thus it remains to be investigated whether serotonin receptor-induced stimulation of APPs secretion is associated with changes in the rate of A secretion. 

Phrase: "Thus"

Phrase: "it"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "serotonin receptor-induced stimulation of APPs secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   831   C2265746:stimulation of serotonin secretion [Cell Function]
   804   C2259155:stimulation of secretion [Cell Function]
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "associated with changes"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1705241:Change [Quantitative Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "of A secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]
Processing 00000000.tx.224: In Alzheimer's disease brain, amyloid deposits are present throughout the brain cortex, and they are not co-localized with any specific neurotransmitter system. 

Phrase: "In Alzheimer's disease brain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936349:Amyloid Deposits [Acquired Abnormality]
   861   C0333562:Deposits [Functional Concept]

Phrase: "are"

Phrase: "present throughout the brain cortex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "they"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "co-localized with any specific neurotransmitter system."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0027908:Neurotransmitter [Neuroreactive Substance or Biogenic Amine]
   748   C0205369:Specific [Qualitative Concept]
   748   C0392752:Localized [Spatial Concept]
   748   C0449913:System [Functional Concept]
   748   C1552740:specific [Intellectual Product]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
Processing 00000000.tx.225: Similarly, many neurotransmitter systems, including the cholinergic, serotoninergic, glutamatergic, and peptidergic systems, are heavily damaged in Alzheimer's disease brains, and this damage is associated with significant losses in cortical synapses (Terry et al., 1991). 

Phrase: "Similarly,"

Phrase: "many neurotransmitter systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the cholinergic, serotoninergic, glutamatergic,"

Phrase: "and"

Phrase: "peptidergic systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "are"

Phrase: "heavily"

Phrase: "damaged in Alzheimer's disease brains,"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   781   C0006111:Brain Disease [Disease or Syndrome]
   764   C0270611:Brain damage [Injury or Poisoning]
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   760   C0012634:Disease [Disease or Syndrome]
   726   C0010957:Damage [Injury or Poisoning]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]
   726   C1883709:Damage [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "this damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010957:Damage [Injury or Poisoning]
  1000   C1883709:Damage [Functional Concept]

Phrase: "is"

Phrase: "associated with significant losses"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0237881:significant [Quantitative Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737   C1517945:Loss [Quantitative Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in cortical synapses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0039062:Synapses [Body Space or Junction]
   827 E C0598501:Synapsis [Cell Function]
   827 E C1633000:Synapsis [Plant]

Phrase: "(Terry et al.,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.226: Inasmuch as these pathological alterations and the resulting deafferentation of target cells are associated with amyloidogenic APP processing, they may be involved in promoting the amyloid formation in Alzheimer's disease brain. 

Phrase: "Inasmuch as"

Phrase: "these pathological alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "the resulting deafferentation of target cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1522415:Deafferentation [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "associated with amyloidogenic APP processing,"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   800   C0368670:Amyloid associated protein [Amino Acid, Peptide, or Protein]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0033666:protein processing [Molecular Function]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]
   748   C1709694:Processing [Activity]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "they"

Phrase: "may"

Phrase: "be"

Phrase: "involved in promoting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033414:Promoting [Activity]
   790   C1314939:Involved [Functional Concept]

Phrase: "the amyloid formation in Alzheimer's disease brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]
Processing 00000000.tx.227: Identifying cell surface receptors, such as 5-HT2aR and 5-HT2cR, whose stimulation increases APPs secretion, could constitute a useful novel pharmacological strategy for manipulating of APP processing in brain, for promoting the potential functions of APPs as a paracrine neurotrophic/neuroprotective factor, and for concomitantly reducing the formation of amyloidogenic derivatives. 

Phrase: "Identifying cell surface receptors,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0034800:Receptors, Cell Surface [Amino Acid, Peptide, or Protein,Receptor]
   861   C0699040:Cell surface [Cell Component]
   812   C0007634:Cell [Cell]
   812   C0205148:Surface [Spatial Concept]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "such as 5-HT2aR"

Phrase: "and"

Phrase: "5-HT2cR,"

Phrase: "whose stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "APPs secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "could"

Phrase: "constitute"

Phrase: "a useful novel pharmacological strategy for manipulating of APP processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0679199:strategy [Mental Process]

Phrase: "in brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "for promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promoting [Activity]

Phrase: "the potential functions of APPs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0542341:Functions [Functional Concept]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]

Phrase: "as a paracrine neurotrophic/neuroprotective factor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   875   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "and for concomitantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the formation of amyloidogenic derivatives."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
Processing 00000000.tx.228: A possible candidate compound may be dexfenfluramine, a widely used anti-obesity drug which is metabolized to dexnorfenfluramine in vivo. 

Phrase: "A possible candidate compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205198:Compound [Qualitative Concept]
   827   C1706082:Compound [Chemical]

Phrase: "may"

Phrase: "be"

Phrase: "dexfenfluramine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011786:Dexfenfluramine [Organic Chemical,Pharmacologic Substance]

Phrase: "a widely"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-obesity drug"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376607:anti obesity drug [Pharmacologic Substance]
   827   C0013227:Drug [Pharmacologic Substance]
   827   C1254351:Drug [Pharmacologic Substance]
   771 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   771 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   734 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "which"

Phrase: "is"

Phrase: "metabolized to dexnorfenfluramine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1524026:Metabolized [Cell Function]
   790   C2350698:Dexnorfenfluramine [Organic Chemical,Pharmacologic Substance]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.229: Brain levels of dexnorfenfluramine in subjects taking therapeutic doses of dexfenfluramine (30 mg/day) are probably in the order of 1-3 M. 

Phrase: "Brain levels of dexnorfenfluramine"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0441889:Levels [Qualitative Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "taking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "therapeutic doses of dexfenfluramine"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   770   C0178602:Doses [Quantitative Concept]
   770   C0302350:Therapeutic [Functional Concept]
   737 E C0869039:Dose [Quantitative Concept]
   737 E C1114758:Dose # [Clinical Attribute]
   737 E C1428722:DOS [Gene or Genome]

Phrase: "(30 mg/day"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0439422:mg day [Quantitative Concept]
   901   C0439423:mg/day [Quantitative Concept]
   827   C0332173:/day [Temporal Concept]
   827   C0439228:day [Temporal Concept]
   827   C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: "are"

Phrase: "probably in the order of 1-3 M."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C0750492:Probably [Idea or Concept]
   744   C1705175:Order [Intellectual Product]
   744   C1705176:Order [Qualitative Concept]
   744   C1705177:Order [Classification]
   744   C1705178:Order [Activity]
   744   C1882348:Order [Qualitative Concept]
Processing 00000000.tx.230: ()In our transfected cell lines, this concentration of dexnorfenfluramine was sufficient to promote both APPs secretion and PI turnover (Fig.6). 

Phrase: "("

Phrase: ")"

Phrase: "In our transfected cell lines,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "this concentration of dexnorfenfluramine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "both APPs secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "PI turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0031227:turnover [Quantitative Concept]
   861   C0243127:turnover [Functional Concept]
   861   C0443331:Turnover [Health Care Activity]

Phrase: "(Fig.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.231: Clinical studies with highly selective receptor agonists are needed to determine whether this approach can modify the clinical course of Alzheimer's disease. 

Phrase: "Clinical studies with highly selective receptor agonists"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   778   C0008972:Clinical Studies [Research Activity]
   748   C0205210:Clinical [Qualitative Concept]
   748   C0947630:studies [Laboratory Procedure]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "this approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "can"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the clinical course of Alzheimer's disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   864   C0449259:Clinical Course of Disease [Temporal Concept]
           Clinical course
   783   C0242656:disease course [Pathologic Function]
   753   C0205210:Clinical [Qualitative Concept]
   753   C0750729:Course [Temporal Concept]
Processing 00000000.tx.232: FOOTNOTES * This work was supported by grants from National Institute on Aging, National Institute of Mental Health, Bundesministerium fr Bildung und Forschung, the Center for Brain Sciences and Metabolism, and the Hoffman Fellowship in Alzheimer's Disease at Massachusetts General Hospital. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from National Institute on Aging,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1955974:National Institute on Aging [Health Care Related Organization]
   812   C0001811:Ageing [Organism Function]
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]
   812   C3245503:national [Intellectual Product]
   779 E C0001779:Age [Organism Attribute]

Phrase: "National Institute of Mental Health,"
Meta Candidates (Total=16; Excluded=6; Pruned=0; Remaining=10)
  1000   C0027466:National Institute of Mental Health [Health Care Related Organization]
           national institute mental health
   911   C0027468:national institute health [Health Care Related Organization]
   840   C0025353:mental health [Mental Process]
   840   C1555896:Mental Health [Intellectual Product]
   804   C0018684:Health [Idea or Concept]
   804   C0021622:institute [Organization]
   804   C0229992:mental [Mental Process]
   804   C1272753:Institute [Idea or Concept]
   804   C3245503:national [Intellectual Product]
   721 E C0229993:Psychic [Functional Concept]
   704 E C0011980:Diaphragm [Body Part, Organ, or Organ Component]
   704 E C0031206:healthiness [Finding]
   704 E C0042241:DIAPHRAGM [Medical Device]
   704 E C1279038:Diaphragm [Body Part, Organ, or Organ Component]
   704 E C1705367:Diaphragm [Medical Device]

Phrase: "Bundesministerium fr Bildung und Forschung,"

Phrase: "the Center for Brain Sciences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "the Hoffman Fellowship in Alzheimer's Disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0015770:Fellowship [Educational Activity]

Phrase: "at Massachusetts General Hospital."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0205246:General [Spatial Concept]
   827   C1510665:Hospital [Qualitative Concept]
   827   C1553889:General [Idea or Concept]
   743 E C1609061:Hospitals [Intellectual Product]
Processing 00000000.tx.233: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.234: This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore by hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: "``advertisement''"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.235: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.236: To whom correspondence should be addressed. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.237: Present address: Center for Molecular Neurobiology, University of Hamburg, Martinistr. 

Phrase: "Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376649:Address [Intellectual Product]
   861   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Center for Molecular Neurobiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "University of Hamburg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Martinistr."
Processing 00000000.tx.238: 52, 20246 Hamburg, Germany. 

Phrase: "52,"

Phrase: "20246 Hamburg,"

Phrase: "Germany."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]
Processing 00000000.tx.239: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.240: 49-40-4717-4746; 

Phrase: "49-40-4717-4746"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439509:/40 [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.241: Fax: 49-40-4717-4774; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "49-40-4717-4774"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439509:/40 [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.242: :nitsch{at}zmnh.zmnh.uni-hamburg.de . () The abbreviations used are: APP, amyloid precursor protein; 

Phrase: ":"

Phrase: "nitsch{at}zmnh.zmnh.uni-hamburg.de ."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0011198:DE [Geographic Area]
   795   C0017480:DE [Geographic Area]
   795   C3541240:DE [Idea or Concept]

Phrase: "("

Phrase: ")"

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.243: APPs, secreted APP ectodomain; 

Phrase: "APPs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "secreted APP ectodomain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.244: PKC, protein kinase C; 

Phrase: "PKC,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.245: DMEM, Dulbecco's modified Eagle's medium; 

Phrase: "DMEM,"

Phrase: "Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0009458:Medium [Intellectual Product]
   812   C0325564:Eagle [Bird]
   812   C0392747:Modified [Functional Concept]
   812   C0439536:Medium [Quantitative Concept]
   812   C1551720:Eagle [Population Group]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.246: PI, phosphatidylinositol; 

Phrase: "PI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
  1000   C2348046:Phosphatidylinositol [Lipid]

Phrase: "phosphatidylinositol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
  1000   C2348046:Phosphatidylinositol [Lipid]

Phrase: ";"
Processing 00000000.tx.247: PMA, phorbol myristate acetate; 

Phrase: "PMA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   827   C0031588:phorbol [Organic Chemical]
   827   C0070750:Phorbol [Organic Chemical]
   827   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "phorbol myristate acetate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   827   C0031588:phorbol [Organic Chemical]
   827   C0070750:Phorbol [Organic Chemical]
   827   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.248: PLA, phospholipase A. 

Phrase: "PLA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2261240:phospholipase A [Molecular Function]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phospholipase A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031672:Phospholipase A [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2261240:phospholipase A [Molecular Function]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.249: () B. 

Phrase: "("

Phrase: ")"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.250: Sandage, personal communication. 

Phrase: "Sandage,"

Phrase: "personal communication."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086792:Personal Communication [Social Behavior]
   861   C0009452:Communication [Social Behavior]
Processing 00000000.tx.251: ACKNOWLEDGEMENTS We thank Dennis Selkoe and Sangram Sisodia for antibodies, David Julius for cell lines, and Chris Bilmazes for technical assistance. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dennis Selkoe"

Phrase: "and"

Phrase: "Sangram Sisodia for antibodies,"

Phrase: "David Julius for cell lines,"

Phrase: "and"

Phrase: "Chris Bilmazes for technical assistance."
Processing 00000000.tx.252: REFERENCES Allinquant, B., Hantraye, P., Mailleux, P., Moya, K., Bouillot, C., and Prochiantz, A. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Allinquant,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hantraye,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Mailleux,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Moya,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2303040:Moya [Plant]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bouillot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Prochiantz,"

Phrase: "A."
Processing 00000000.tx.253: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.254: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.255: 128, 919-927 [Abstract] Barger, S. 

Phrase: "128,"

Phrase: "919-927"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Barger,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.256: W., Fiscus, R. 

Phrase: "W., Fiscus,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.257: R., Ruth, P., Hofmann, F., and Mattson, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ruth,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hofmann,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.258: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.259: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.260: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.261: 64, 2087-2096 [Medline] [OrderarticleviaInfotrieve] Bosenberg, M. 

Phrase: "64,"

Phrase: "2087-2096"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bosenberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.262: W., Pandiella, A., and Massague, J. 

Phrase: "W., Pandiella,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Massague,"

Phrase: "J."
Processing 00000000.tx.263: (1992) Cell 71, 1157-1165 [Medline] [OrderarticleviaInfotrieve] Brakebusch, C., Nophar, Y., Kemper, O., Engelmann, H., and Wallach, D. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Cell 71,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007634:Cell [Cell]
   861   C0450389:71 [Intellectual Product]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1157-1165"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Brakebusch,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Nophar,"

Phrase: "Y.,"

Phrase: "Kemper,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Engelmann,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Wallach,"

Phrase: "D."
Processing 00000000.tx.264: (1992) EMBO J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.265: 11, 943-950 [Abstract] Buxbaum, J. 

Phrase: "11,"

Phrase: "943-950"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Buxbaum,"

Phrase: "J."
Processing 00000000.tx.266: D., Oishi, M., Chen, H. 

Phrase: "D."

Phrase: ","

Phrase: "Oishi,"

Phrase: "M."

Phrase: ","

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.267: I., Pinkas-Kramarski, R., Jaffe, E. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pinkas-Kramarski,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Jaffe,"

Phrase: "E."
Processing 00000000.tx.268: A., Gandy, S. 

Phrase: "A.,"

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.269: E., and Greengard, P. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Greengard,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.270: (1992) Proc. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.271: Natl. 

Phrase: "Natl."
Processing 00000000.tx.272: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.273: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.274: U. 

Phrase: "U."
Processing 00000000.tx.275: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.276: A. 

Phrase: "A."
Processing 00000000.tx.277: 89, 10075-10078 [Abstract] Buxbaum, J. 

Phrase: "89,"

Phrase: "10075-10078"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Buxbaum,"

Phrase: "J."
Processing 00000000.tx.278: D., Koo, E. 

Phrase: "D."

Phrase: ","

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.279: H., and Greengard, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Greengard,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.280: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.281: Natl. 

Phrase: "Natl."
Processing 00000000.tx.282: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.283: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.284: U. 

Phrase: "U."
Processing 00000000.tx.285: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.286: A. 

Phrase: "A."
Processing 00000000.tx.287: 90, 9195-9198 [Abstract] Buxbaum, J., Ruefli, A., Parker, C., Cypess, A., and Greengard, P. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "9195-9198"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Buxbaum,"

Phrase: "J.,"

Phrase: "Ruefli,"

Phrase: "A.,"

Phrase: "Parker,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Cypess,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Greengard,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.288: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.289: Natl. 

Phrase: "Natl."
Processing 00000000.tx.290: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.291: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.292: U. 

Phrase: "U."
Processing 00000000.tx.293: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.294: A. 

Phrase: "A."
Processing 00000000.tx.295: 91, 4489-4493 [Abstract] Cai, X.-D., Golde, T. 

Phrase: "91,"

Phrase: "4489-4493"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X.-"

Phrase: "D."

Phrase: ","

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.296: E., and Younkin, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.297: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.298: (1993) Science 259, 514-516 [Medline] [OrderarticleviaInfotrieve] Caporaso, G. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Science 259,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "514-516"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Caporaso,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.299: L., Gandy, S. 

Phrase: "L., Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.300: E., Buxbaum, J. 

Phrase: "E.,"

Phrase: "Buxbaum,"

Phrase: "J."
Processing 00000000.tx.301: D., Ramabhadran, T. 

Phrase: "D."

Phrase: ","

Phrase: "Ramabhadran,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.302: V., and Greengard, P. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Greengard,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.303: (1992) Proc. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.304: Natl. 

Phrase: "Natl."
Processing 00000000.tx.305: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.306: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.307: U. 

Phrase: "U."
Processing 00000000.tx.308: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.309: A. 

Phrase: "A."
Processing 00000000.tx.310: 89, 3055-3059 [Abstract] Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. 

Phrase: "89,"

Phrase: "3055-3059"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McConlogue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.311: Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., and Selkoe, D. 

Phrase: "Y.,"

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.312: J. 

Phrase: "J."
Processing 00000000.tx.313: (1992) Nature 360, 672-674 [CrossRef][Medline] [OrderarticleviaInfotrieve] Citron, M., Vigo-Pelfrey, C., Teplow, D. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature 360,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "672-674"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.314: B., Miller, C., Schenk, D., Johnston, J., Winblad, B., Venizelos, N., Lannfelt, L., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Johnston,"

Phrase: "J.,"

Phrase: "Winblad,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Venizelos,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.315: J. 

Phrase: "J."
Processing 00000000.tx.316: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.317: Natl. 

Phrase: "Natl."
Processing 00000000.tx.318: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.319: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.320: U. 

Phrase: "U."
Processing 00000000.tx.321: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.322: A. 

Phrase: "A."
Processing 00000000.tx.323: 91, 11993-11997 [Abstract/Free FullText] Dyrks, T., Mnning, K., Beyreuther, K., and Turner, J. 

Phrase: "91,"

Phrase: "11993-11997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Dyrks,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mnning,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Turner,"

Phrase: "J."
Processing 00000000.tx.324: (1994) FEBS Lett. 

Phrase: "(1994"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.325: 349, 210-214 [CrossRef][Medline] [OrderarticleviaInfotrieve] Emmerling, M. 

Phrase: "349,"

Phrase: "210-214"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Emmerling,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.326: R., Moore, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.327: J., Doyle, P. 

Phrase: "J.,"

Phrase: "Doyle,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.328: D., Carroll, R. 

Phrase: "D."

Phrase: ","

Phrase: "Carroll,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.329: T., and Davis, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.330: E. 

Phrase: "E."
Processing 00000000.tx.331: (1993) Biochem. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.332: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.333: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.334: Commun. 

Phrase: "Commun."
Processing 00000000.tx.335: 197, 292-297 [CrossRef][Medline] [OrderarticleviaInfotrieve] Esch, F. 

Phrase: "197,"

Phrase: "292-297"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Esch,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.336: S., Keim, P. 

Phrase: "S."

Phrase: ","

Phrase: "Keim,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.337: S., Beattie, E. 

Phrase: "S."

Phrase: ","

Phrase: "Beattie,"

Phrase: "E."
Processing 00000000.tx.338: C., Blacher, R. 

Phrase: "C., Blacher,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.339: W., Culwell, A. 

Phrase: "W., Culwell,"

Phrase: "A."
Processing 00000000.tx.340: R., Oltersdorf, T., McClure, D., and Ward, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "McClure,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Ward,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1305702:Ward [Health Care Related Organization,Manufactured Object]
  1000   C1547134:Ward [Idea or Concept]
  1000   C2355574:Ward [Population Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.341: J. 

Phrase: "J."
Processing 00000000.tx.342: (1990) Science 248, 1122-1124 [Medline] [OrderarticleviaInfotrieve] Farber, S. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Science 248,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1122-1124"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Farber,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.343: A., Nitsch, R. 

Phrase: "A.,"

Phrase: "Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.344: M., Schulz, J. 

Phrase: "M."

Phrase: ","

Phrase: "Schulz,"

Phrase: "J."
Processing 00000000.tx.345: G., and Wurtman, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Wurtman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.346: J. 

Phrase: "J."
Processing 00000000.tx.347: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.348: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.349: 15, 7442-7450 [Abstract] Gabuzda, D., Busciglio, J., and Yankner, B. 

Phrase: "15,"

Phrase: "7442-7450"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gabuzda,"

Phrase: "D."

Phrase: ","

Phrase: "Busciglio,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.350: A. 

Phrase: "A."
Processing 00000000.tx.351: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.352: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.353: 61, 2326-2329 [Medline] [OrderarticleviaInfotrieve] Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., Guido, T., Hagopian, S., Johnson-Wood, K., Khan, K., Lee, M., Leibowitz, P., Lieberburg, I., Little, S., Masliah, E., McConlogue, L., Montoya-Zavala, M., Mucke, L., Paganini, L., Penniman, E., Power, M., Schenk, D., Seubert, P., Snyder, B., Soriano, F., Tan, H., Vitale, J., Wadsworth, S., Wolozin, B., and Zhao, J. 

Phrase: "61,"

Phrase: "2326-2329"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:games [Daily or Recreational Activity]

Phrase: "D."

Phrase: ","

Phrase: "Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "D."

Phrase: ","

Phrase: "Alessandrini,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Barbour,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Berthelette,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Blackwell,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Carr,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Clemens,"

Phrase: "J.,"

Phrase: "Donaldson,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Gillespie,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Guido,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hagopian,"

Phrase: "S."

Phrase: ","

Phrase: "Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Khan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Leibowitz,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Little,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "S."

Phrase: ","

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "McConlogue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Montoya-Zavala,"

Phrase: "M."

Phrase: ","

Phrase: "Mucke,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Paganini,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Penniman,"

Phrase: "E.,"

Phrase: "Power,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "M."

Phrase: ","

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Snyder,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Soriano,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302595:tan [Individual Behavior]
  1000   C1537110:Tan [Clinical Attribute]
  1000   C3275241:Tan [Qualitative Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Vitale,"

Phrase: "J.,"

Phrase: "Wadsworth,"

Phrase: "S."

Phrase: ","

Phrase: "Wolozin,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Zhao,"

Phrase: "J."
Processing 00000000.tx.354: (1995) Nature 373, 523-527 [CrossRef][Medline] [OrderarticleviaInfotrieve] Greenberg, S., Koo, E., Selkoe, D., Qiu, W., and Kosik, K. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 373,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "523-527"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Greenberg,"

Phrase: "S."

Phrase: ","

Phrase: "Koo,"

Phrase: "E.,"

Phrase: "Selkoe,"

Phrase: "D."

Phrase: ","

Phrase: "Qiu,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Kosik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.355: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.356: Natl. 

Phrase: "Natl."
Processing 00000000.tx.357: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.358: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.359: U. 

Phrase: "U."
Processing 00000000.tx.360: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.361: A. 

Phrase: "A."
Processing 00000000.tx.362: 91, 7104-7108 [Abstract] Haass, C., Schlossmacher, M. 

Phrase: "91,"

Phrase: "7104-7108"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schlossmacher,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.363: G., Hung, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.364: Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. 

Phrase: "Y.,"

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Mellon,"

Phrase: "A.,"

Phrase: "Ostaszewski,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.365: L., Lieberburg, I., Koo, E. 

Phrase: "L., Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.366: H., Schenk, D., Teplow, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.367: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.368: J. 

Phrase: "J."
Processing 00000000.tx.369: (1992) Nature 359, 322-325 [CrossRef][Medline] [OrderarticleviaInfotrieve] Haass, C., Hung, A. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature 359,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "322-325"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.370: Y., Schlossmacher, M. 

Phrase: "Y.,"

Phrase: "Schlossmacher,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.371: G., Teplow, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.372: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.373: J. 

Phrase: "J."
Processing 00000000.tx.374: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.375: Biol. 

Phrase: "Biol."
Processing 00000000.tx.376: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.377: 268, 3021-3024 [Abstract/Free FullText] Hung, A. 

Phrase: "268,"

Phrase: "3021-3024"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.378: Y., Haass, C., Nitsch, R. 

Phrase: "Y.,"

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.379: M., Qiu, W. 

Phrase: "M."

Phrase: ","

Phrase: "Qiu,"

Phrase: "W."
Processing 00000000.tx.380: Q., Citron, M., Wurtman, R. 

Phrase: "Q., Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Wurtman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.381: J., Growdon, J. 

Phrase: "J.,"

Phrase: "Growdon,"

Phrase: "J."
Processing 00000000.tx.382: H., and Selkoe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.383: J. 

Phrase: "J."
Processing 00000000.tx.384: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.385: Biol. 

Phrase: "Biol."
Processing 00000000.tx.386: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.387: 268, 22959-22962 [Abstract/Free FullText] Julius, D., MacDermott, A. 

Phrase: "268,"

Phrase: "22959-22962"

Phrase: "[Abstract/Free FullText"

Phrase: "] Julius,"

Phrase: "D."

Phrase: ","

Phrase: "MacDermott,"

Phrase: "A."
Processing 00000000.tx.388: B., Axel., R., and Jessell, T. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Axel.,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Jessell,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.389: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.390: (1988) Science 241, 558-564 [Medline] [OrderarticleviaInfotrieve] Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Science 241,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "558-564"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kang,"

Phrase: "J.,"

Phrase: "Lemaire,"

Phrase: "H.-G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0560020:h g [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "Unterbeck,"

Phrase: "A.,"

Phrase: "Salbaum,"

Phrase: "J."
Processing 00000000.tx.391: M., Masters, C. 

Phrase: "M."

Phrase: ","

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.392: L., Grzeschik, K. 

Phrase: "L., Grzeschik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.393: H., Multhaup, G., Beyreuther, K., and Mller-Hill, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Mller-Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.394: (1987) Nature 325, 733-736 [CrossRef][Medline] [OrderarticleviaInfotrieve] Lee, R. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Nature 325,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "733-736"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lee,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.395: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.396: K., Wurtman, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wurtman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.397: J., Slack, B. 

Phrase: "J.,"

Phrase: "Slack,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425836:SLACK [Gene or Genome]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.398: E., Cox, A. 

Phrase: "E.,"

Phrase: "Cox,"

Phrase: "A."
Processing 00000000.tx.399: J., and Nitsch, R. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.400: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.401: (1995) Proc. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.402: Natl. 

Phrase: "Natl."
Processing 00000000.tx.403: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.404: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.405: U. 

Phrase: "U."
Processing 00000000.tx.406: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.407: A. 

Phrase: "A."
Processing 00000000.tx.408: 92, 8083-8087 [Abstract] Mattson, M. 

Phrase: "92,"

Phrase: "8083-8087"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.409: P., Cheng, B., Culwell, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cheng,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Culwell,"

Phrase: "A."
Processing 00000000.tx.410: R., Esch, F. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Esch,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.411: S., Lieberburg, I., and Rydel, R. 

Phrase: "S."

Phrase: ","

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Rydel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.412: E. 

Phrase: "E."
Processing 00000000.tx.413: (1993) Neuron 10, 243-254 [Medline] [OrderarticleviaInfotrieve] Milward, E. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Neuron 10,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "243-254"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Milward,"

Phrase: "E."
Processing 00000000.tx.414: A., Papadopoulos, R., Fuller, S. 

Phrase: "A.,"

Phrase: "Papadopoulos,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Fuller,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.415: J., Moir, R. 

Phrase: "J.,"

Phrase: "Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.416: D., Small, D., Beyreuther, K., and Masters, C. 

Phrase: "D."

Phrase: ","

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.417: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.418: (1992) Neuron 9, 129-137 [Medline] [OrderarticleviaInfotrieve] Mucke, L., Masliah, E., Johnson, W. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Neuron 9,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "129-137"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mucke,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Johnson,"

Phrase: "W."
Processing 00000000.tx.419: B., Ruppe, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ruppe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.420: D., Alford, M., Rockenstein, E. 

Phrase: "D."

Phrase: ","

Phrase: "Alford,"

Phrase: "M."

Phrase: ","

Phrase: "Rockenstein,"

Phrase: "E."
Processing 00000000.tx.421: M., Forss-Petter, S., Pietropaolo, M., Mallory, M., and Abraham, C. 

Phrase: "M."

Phrase: ","

Phrase: "Forss-Petter,"

Phrase: "S."

Phrase: ","

Phrase: "Pietropaolo,"

Phrase: "M."

Phrase: ","

Phrase: "Mallory,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Abraham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:Abraham [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.422: R (1994) Brain Res. 

Phrase: "R (1994"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.423: 666, 151-167 [CrossRef][Medline] [OrderarticleviaInfotrieve] Mucke, L., Abraham, C. 

Phrase: "666,"

Phrase: "151-167"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mucke,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Abraham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:Abraham [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.424: L., Ruppe, M. 

Phrase: "L., Ruppe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.425: D., Rockenstein, E. 

Phrase: "D."

Phrase: ","

Phrase: "Rockenstein,"

Phrase: "E."
Processing 00000000.tx.426: M., Toggas, S. 

Phrase: "M."

Phrase: ","

Phrase: "Toggas,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.427: M., Mallory, M., Alford, M., and Masliah, E. 

Phrase: "M."

Phrase: ","

Phrase: "Mallory,"

Phrase: "M."

Phrase: ","

Phrase: "Alford,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Masliah,"

Phrase: "E."
Processing 00000000.tx.428: (1995a) J. 

Phrase: "(1995a"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.429: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.430: Med. 

Phrase: "Med."
Processing 00000000.tx.431: 181, 1551-1556 [Abstract] Mucke, L., Abraham, C., and Masliah, E. 

Phrase: "181,"

Phrase: "1551-1556"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mucke,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Abraham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:Abraham [Intellectual Product]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Masliah,"

Phrase: "E."
Processing 00000000.tx.432: (1996) Ann. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.433: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.434: Y. 

Phrase: "Y."
Processing 00000000.tx.435: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.436: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.437: , in press Nitsch, R. 

Phrase: ","

Phrase: "in press Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.438: M., and Growdon, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Growdon,"

Phrase: "J."
Processing 00000000.tx.439: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.440: (1994) Biochem. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.441: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.442: 47, 1275-1284 [Medline] [OrderarticleviaInfotrieve] Nitsch, R. 

Phrase: "47,"

Phrase: "1275-1284"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.443: M., Slack, B. 

Phrase: "M."

Phrase: ","

Phrase: "Slack,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425836:SLACK [Gene or Genome]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.444: E., Wurtman, R. 

Phrase: "E.,"

Phrase: "Wurtman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.445: J., and Growdon, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Growdon,"

Phrase: "J."
Processing 00000000.tx.446: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.447: (1992) Science 258, 304-307 [Medline] [OrderarticleviaInfotrieve] Nitsch, R. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Science 258,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "304-307"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.448: M., Farber, S. 

Phrase: "M."

Phrase: ","

Phrase: "Farber,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.449: A., Growdon, J. 

Phrase: "A.,"

Phrase: "Growdon,"

Phrase: "J."
Processing 00000000.tx.450: H., and Wurtman, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Wurtman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.451: J. 

Phrase: "J."
Processing 00000000.tx.452: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.453: Natl. 

Phrase: "Natl."
Processing 00000000.tx.454: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.455: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.456: U. 

Phrase: "U."
Processing 00000000.tx.457: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.458: A. 

Phrase: "A."
Processing 00000000.tx.459: 90, 5191-5193 [Abstract] Pandiella, A., and Massague, J. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "5191-5193"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Pandiella,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Massague,"

Phrase: "J."
Processing 00000000.tx.460: (1991) Proc. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.461: Natl. 

Phrase: "Natl."
Processing 00000000.tx.462: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.463: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.464: U. 

Phrase: "U."
Processing 00000000.tx.465: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.466: A. 

Phrase: "A."
Processing 00000000.tx.467: 88, 1726-1730 [Abstract] Roch, J.-M., Masliah, E., Roch-Levecq, A.-C., Sundsmo, M. 

Phrase: "88,"

Phrase: "1726-1730"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Roch,"

Phrase: "J.-"

Phrase: "M."

Phrase: ","

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Roch-Levecq,"

Phrase: "A.-C.,"

Phrase: "Sundsmo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.468: P., Otero, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Otero,"

Phrase: "D."
Processing 00000000.tx.469: A. 

Phrase: "A."
Processing 00000000.tx.470: C., Veinbergs, I., and Saitoh, T. 

Phrase: "C., Veinbergs,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Saitoh,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.471: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.472: Natl. 

Phrase: "Natl."
Processing 00000000.tx.473: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.474: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.475: U. 

Phrase: "U."
Processing 00000000.tx.476: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.477: A. 

Phrase: "A."
Processing 00000000.tx.478: 91, 7450-7454 [Abstract] Saitoh, T., Sundsmo, M., Roch, J.-M., Kimura, N., Cole, G., Schubert, D., Oltersdorf, T., and Schenk, D. 

Phrase: "91,"

Phrase: "7450-7454"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Saitoh,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sundsmo,"

Phrase: "M."

Phrase: ","

Phrase: "Roch,"

Phrase: "J.-"

Phrase: "M."

Phrase: ","

Phrase: "Kimura,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cole,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Schubert,"

Phrase: "D."

Phrase: ","

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Schenk,"

Phrase: "D."
Processing 00000000.tx.479: (1989) Cell 58, 615-622 [Medline] [OrderarticleviaInfotrieve] Sandmann, J., Peralta, E. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Cell 58,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "615-622"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sandmann,"

Phrase: "J.,"

Phrase: "Peralta,"

Phrase: "E."
Processing 00000000.tx.480: G., and Wurtman, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Wurtman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.481: J. 

Phrase: "J."
Processing 00000000.tx.482: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.483: Biol. 

Phrase: "Biol."
Processing 00000000.tx.484: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.485: 266, 6031-6034 [Abstract/Free FullText] Selkoe, D. 

Phrase: "266,"

Phrase: "6031-6034"

Phrase: "[Abstract/Free FullText"

Phrase: "] Selkoe,"

Phrase: "D."
Processing 00000000.tx.486: J. 

Phrase: "J."
Processing 00000000.tx.487: (1994) Annu. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.488: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.489: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.490: 10, 373-403 [CrossRef] Seubert, P., Oltersdorf, T., Lee, M., Barbour, R., Blomquist, C., Davis, D., Bryant, K., Fritz, L. 

Phrase: "10,"

Phrase: "373-403"

Phrase: "[CrossRef"

Phrase: "] Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Barbour,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Blomquist,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Davis,"

Phrase: "D."

Phrase: ","

Phrase: "Bryant,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fritz,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414819:FRITZ [Gene or Genome]
  1000   C2681211:fritz [Gene or Genome]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.491: D. 

Phrase: "D."
Processing 00000000.tx.492: G., Thal, L., Lieberburg, I., and Schenk, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Thal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039736:THAL [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Schenk,"

Phrase: "D."
Processing 00000000.tx.493: (1993) Nature 361, 260-263 [CrossRef][Medline] [OrderarticleviaInfotrieve] Shoji, M., Golde, T. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Nature 361,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "260-263"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Shoji,"

Phrase: "M."

Phrase: ","

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.494: E., Ghiso, J., Cheung, T. 

Phrase: "E.,"

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "Cheung,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.495: T., Estus, S., Shaffer, L. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Estus,"

Phrase: "S."

Phrase: ","

Phrase: "Shaffer,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.496: M., Cai, X.-D., McKay, D. 

Phrase: "M."

Phrase: ","

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X.-"

Phrase: "D."

Phrase: ","

Phrase: "McKay,"

Phrase: "D."
Processing 00000000.tx.497: M., Tintner, R., Frangione, B., and Younkin, S. 

Phrase: "M."

Phrase: ","

Phrase: "Tintner,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.498: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.499: (1992) Science 258, 126-129 [Medline] [OrderarticleviaInfotrieve] Sisodia, S. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Science 258,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "126-129"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.500: S., Koo, E. 

Phrase: "S."

Phrase: ","

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.501: H., Beyreuther, K., Unterbeck, A., and Price, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Unterbeck,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.502: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.503: (1990) Science 248, 492-495 [Medline] [OrderarticleviaInfotrieve] Slack, B. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Science 248,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "492-495"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Slack,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425836:SLACK [Gene or Genome]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.504: E., Nitsch, R. 

Phrase: "E.,"

Phrase: "Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.505: M., Livneh, E., Kunz, G. 

Phrase: "M."

Phrase: ","

Phrase: "Livneh,"

Phrase: "E.,"

Phrase: "Kunz,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.506: M., Jr, Breu, J., Eldar, H., and Wurtman, R. 

Phrase: "M."

Phrase: ","

Phrase: "Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Breu,"

Phrase: "J.,"

Phrase: "Eldar,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Wurtman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.507: J. 

Phrase: "J."
Processing 00000000.tx.508: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.509: Biol. 

Phrase: "Biol."
Processing 00000000.tx.510: Chem 268, 21097-21101 [Abstract/Free FullText] Slack, B. 

Phrase: "Chem 268,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]

Phrase: "21097-21101"

Phrase: "[Abstract/Free FullText"

Phrase: "] Slack,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425836:SLACK [Gene or Genome]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.511: E., Breu, J., Petryniak, M. 

Phrase: "E.,"

Phrase: "Breu,"

Phrase: "J.,"

Phrase: "Petryniak,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.512: A., Srivastava, K., and Wurtman, R. 

Phrase: "A.,"

Phrase: "Srivastava,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Wurtman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.513: J. 

Phrase: "J."
Processing 00000000.tx.514: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.515: Biol. 

Phrase: "Biol."
Processing 00000000.tx.516: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.517: 270, 8337-8344 [Abstract/Free FullText] Slunt, H. 

Phrase: "270,"

Phrase: "8337-8344"

Phrase: "[Abstract/Free FullText"

Phrase: "] Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.518: H., Thinakaran, G., von Koch, C., Lo, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "von Koch,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lo,"

Phrase: "A."
Processing 00000000.tx.519: C. 

Phrase: "C."
Processing 00000000.tx.520: Y., Tanzi, R. 

Phrase: "Y.,"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.521: E., and Sisodia, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.522: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.523: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.524: Biol. 

Phrase: "Biol."
Processing 00000000.tx.525: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.526: 269, 2637-2644 [Abstract/Free FullText] Stam, N. 

Phrase: "269,"

Phrase: "2637-2644"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stam,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420451:STAM [Gene or Genome]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.527: J., Van Huizen, F., Van Alebeek, C., Brands, J., Dijkema, R., Tonnaer, J. 

Phrase: "J.,"

Phrase: "Van Huizen,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Van Alebeek,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Brands,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0645690:BrAnd [Pharmacologic Substance,Steroid]

Phrase: "J.,"

Phrase: "Dijkema,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tonnaer,"

Phrase: "J."
Processing 00000000.tx.528: A. 

Phrase: "A."
Processing 00000000.tx.529: D. 

Phrase: "D."
Processing 00000000.tx.530: M., and Olijve, W. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Olijve,"

Phrase: "W."
Processing 00000000.tx.531: (1992) Eur. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.532: J. 

Phrase: "J."
Processing 00000000.tx.533: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.534: 227, 153-162 [Medline] [OrderarticleviaInfotrieve] Suzuki, N., Cheung, T. 

Phrase: "227,"

Phrase: "153-162"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cheung,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.535: T., Cai, X.-D., Odaka, A., Otvos, L., Jr., Echman, C., Golde, T. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X.-"

Phrase: "D."

Phrase: ","

Phrase: "Odaka,"

Phrase: "A.,"

Phrase: "Otvos,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Echman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.536: E., and Younkin, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.537: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.538: (1994) Science 264, 1336-1340 [Medline] [OrderarticleviaInfotrieve] Terry, R. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Science 264,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1336-1340"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Terry,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.539: D., Masliah, E., Salmon, D. 

Phrase: "D."

Phrase: ","

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Salmon,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036110:Salmon [Fish]
  1000   C0327949:salmon [Fish]
  1000   C0459210:Salmon [Food]

Phrase: "D."
Processing 00000000.tx.540: P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Butters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006494:Butter [Food,Lipid]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "DeTeresa,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442532:Hill [Spatial Concept]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hansen,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.541: A., and Katzman, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Katzman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.542: (1991) Ann. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.543: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.544: 30, 572-580 [Medline] [OrderarticleviaInfotrieve] von der Kammer, H., Hanes, J., Klaudiny, J., and Scheit, K. 

Phrase: "30,"

Phrase: "572-580"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] von der Kammer,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hanes,"

Phrase: "J.,"

Phrase: "Klaudiny,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Scheit,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.545: (1994) DNA Cell Biol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "DNA Cell Biol."
Processing 00000000.tx.546: 13, 1137-1143 [Medline] [OrderarticleviaInfotrieve] Wasco, W., Bupp, K., Magendanz, M., Gusella, J. 

Phrase: "13,"

Phrase: "1137-1143"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wasco,"

Phrase: "W.,"

Phrase: "Bupp,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Magendanz,"

Phrase: "M."

Phrase: ","

Phrase: "Gusella,"

Phrase: "J."
Processing 00000000.tx.547: F., Tanzi, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.548: T., and Solomon, F. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Solomon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551833:Solomon [Population Group]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.549: (1992) Proc. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.550: Natl. 

Phrase: "Natl."
Processing 00000000.tx.551: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.552: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.553: U. 

Phrase: "U."
Processing 00000000.tx.554: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.555: A. 

Phrase: "A."
Processing 00000000.tx.556: 89, 10758-10762 [Abstract] Wasco, W., Gurubhagavatula, S., S., Paradis, M. 

Phrase: "89,"

Phrase: "10758-10762"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Wasco,"

Phrase: "W.,"

Phrase: "Gurubhagavatula,"

Phrase: "S."

Phrase: ","

Phrase: "S."

Phrase: ","

Phrase: "Paradis,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.557: D., Romano, D. 

Phrase: "D."

Phrase: ","

Phrase: "Romano,"

Phrase: "D."
Processing 00000000.tx.558: M., Sisodia, S. 

Phrase: "M."

Phrase: ","

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.559: S., Hyman, B. 

Phrase: "S."

Phrase: ","

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.560: T., Neve, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Neve,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.561: L., and Tanzi, R. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.562: E. 

Phrase: "E."
Processing 00000000.tx.563: (1993) Nature Genet. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Nature Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]
Processing 00000000.tx.564: 5, 95-99 [Medline] [OrderarticleviaInfotrieve] Weidemann, A., Knig, G., Bunke, D., Fischer, P., Salbaum, J. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "95-99"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Weidemann,"

Phrase: "A.,"

Phrase: "Knig,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bunke,"

Phrase: "D."

Phrase: ","

Phrase: "Fischer,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Salbaum,"

Phrase: "J."
Processing 00000000.tx.565: M., Masters, C. 

Phrase: "M."

Phrase: ","

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.566: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.567: (1989) Cell 57, 115-126 [Medline] [OrderarticleviaInfotrieve] Wolf, B. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Cell 57,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "115-126"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wolf,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325001:Wolf [Mammal]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.568: A., Wertkin, A. 

Phrase: "A.,"

Phrase: "Wertkin,"

Phrase: "A."
Processing 00000000.tx.569: M., Jolly, Y. 

Phrase: "M."

Phrase: ","

Phrase: "Jolly,"

Phrase: "Y."
Processing 00000000.tx.570: C., Yasuda, R. 

Phrase: "C., Yasuda,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.571: P., Wolfe, B. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wolfe,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.572: B., Konrad, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Konrad,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.573: J., Manning, D., Ravi, S., Williamson, J. 

Phrase: "J.,"

Phrase: "Manning,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0024554:MAN [Finding]
   966   C0025266:Man [Population Group]
   966   C0086418:Man [Human]

Phrase: "D."

Phrase: ","

Phrase: "Ravi,"

Phrase: "S."

Phrase: ","

Phrase: "Williamson,"

Phrase: "J."
Processing 00000000.tx.574: R., and Lee, V. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.575: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.576: Y. 

Phrase: "Y."
Processing 00000000.tx.577: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.578: Biol. 

Phrase: "Biol."
Processing 00000000.tx.579: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.580: 270, 4916-4922 [Abstract/Free FullText] Xu, H., Greengard, P., and Gandy, S. 

Phrase: "270,"

Phrase: "4916-4922"

Phrase: "[Abstract/Free FullText"

Phrase: "] Xu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.581: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.582: Biol. 

Phrase: "Biol."
Processing 00000000.tx.583: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.584: 270, 23243-23245 [Abstract/Free FullText] 1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "270,"

Phrase: "23243-23245"

Phrase: "[Abstract/Free FullText"

Phrase: "] 1996 by The American Society"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037455:society [Organization]
   760   C0596070:American [Population Group]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

